Horizon Technology Finance (HRZN) 10-Q 30 Jul 24 2024 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2024	Jul. 30, 2024
Document Information [Line Items]
Entity Central Index Key	0001487428
Entity Registrant Name	Horizon Technology Finance Corp
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	814-00802
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-2114934
Entity Address, Address Line One	312 Farmington Avenue
Entity Address, City or Town	Farmington
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06032
City Area Code	860
Local Phone Number	676‑8654
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		36,059,675
The 6.25% Notes due 2027 [Member]
Document Information [Line Items]
Title of 12(b) Security	6.25% Notes due 2027
Trading Symbol	HTFC
Security Exchange Name	NYSE
The 4.875% Notes due 2026 [Member]
Document Information [Line Items]
Title of 12(b) Security	4.875% Notes due 2026
Trading Symbol	HTFB
Security Exchange Name	NYSE
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	HRZN
Security Exchange Name	NASDAQ

Consolidated Statements of Asse

Consolidated Statements of Assets and Liabilities (Current Period Unaudited) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Assets
Investments at fair value	$ 646,862	$ 709,085
Cash	81,333	46,630
Investments in money market funds	32,320	26,450
Restricted investments in money market funds	3,221	2,642
Interest receivable	16,733	13,926
Other assets	6,936	3,623
Total assets	787,405	802,356
Liabilities
Borrowings (Note 7)	442,744	462,235
Distributions payable	11,894	11,011
Base management fee payable (Note 3)	978	1,052
Other accrued expenses	3,011	4,077
Total liabilities	458,627	478,375
Commitments and contingencies (Notes 3 and 8)
Net assets
Preferred stock, par value $0.001 per share, 1,000,000 shares authorized, zero shares issued and outstanding as of June 30, 2024 and December 31, 2023	0	0
Common stock, par value $0.001 per share, 100,000,000 shares authorized, 36,211,280 and 33,534,854 shares issued and 36,043,815 and 33,367,389 shares outstanding as of June 30, 2024 and December 31, 2023, respectively	40	36
Paid-in capital in excess of par	481,349	450,949
Distributable loss	(152,611)	(127,004)
Total net assets	328,778	323,981
Total liabilities and net assets	$ 787,405	$ 802,356
Net asset value per common share (in dollars per share)	$ 9.12	$ 9.71
Investment, Unaffiliated Issuer [Member]
Assets
Investments at fair value	$ 619,629	$ 693,730
Investment, Affiliated Issuer, Noncontrolled [Member]
Assets
Investments at fair value	15,847	1,132
Investment, Affiliated Issuer, Controlled [Member]
Assets
Investments at fair value	$ 11,386	$ 14,223

Consolidated Statements of As_2

Consolidated Statements of Assets and Liabilities (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Investments at cost	$ 725,430	$ 759,182
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares oustanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	36,211,280	33,534,854
Common stock, shares outstanding (in shares)	36,043,815	33,367,389
Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 679,477	$ 716,077
Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at cost	28,781	28,677
Investment, Affiliated Issuer, Controlled [Member]
Investments at cost	$ 17,172	$ 14,428

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Investment income
Total investment income	$ 25,678	$ 28,117	$ 51,807	$ 56,154
Expenses
Interest expense	7,940	7,179	16,101	14,299
Base management fee (Note 3)	3,027	3,207	6,189	6,408
Performance based incentive fee (Note 3)	0	118	295	3,094
Administrative fee (Note 3)	426	368	859	808
Professional fees	455	447	1,120	1,106
General and administrative	559	546	987	992
Total expenses	12,407	11,865	25,551	26,707
Net investment income before excise tax	13,271	16,252	26,256	29,447
Provision for excise tax	357	179	736	363
Net investment income	12,914	16,073	25,520	29,084
Net realized and unrealized loss
Net realized gain (loss) on investments	2,464	(16,529)	2,472	(16,697)
Net unrealized appreciation (depreciation) on investments	(24,511)	608	(28,471)	(6,929)
Net realized and unrealized loss	(22,047)	(15,921)	(25,999)	(23,626)
Net (decrease) increase in net assets resulting from operations	$ (9,133)	$ 152	$ (479)	$ 5,458
Net investment income per common share (in dollars per share)	$ 0.36	$ 0.54	$ 0.74	$ 1
Net (decrease) increase in net assets resulting from operations per common share (in dollars per share)	(0.26)	0.01	(0.01)	0.19
Distributions declared per share (in dollars per share)	$ 0.33	$ 0.33	$ 0.71	$ 0.66
Weighted average shares outstanding (in shares)	35,434,761	29,747,290	34,507,252	28,987,948
Investment, Unaffiliated Issuer [Member]
Investment income
Interest income	$ 24,480	$ 26,624	$ 50,164	$ 54,023
Fee income	1,010	1,493	1,278	2,131
Net realized and unrealized loss
Net realized gain (loss) on investments	2,424	(16,529)	2,435	(16,697)
Net unrealized appreciation (depreciation) on investments	(23,287)	548	(37,501)	(7,835)
Investment, Affiliated Issuer, Controlled [Member]
Investment income
Interest income	188	0	365	0
Net realized and unrealized loss
Net realized gain (loss) on investments	0		0
Net unrealized appreciation (depreciation) on investments	(4,402)	0	(5,581)	0
Investment, Affiliated Issuer, Noncontrolled [Member]
Net realized and unrealized loss
Net realized gain (loss) on investments	40	0	37	0
Net unrealized appreciation (depreciation) on investments	$ 3,178	$ 60	$ 14,611	$ 906

Consolidated Statements of Chan

Consolidated Statements of Changes in Net Assets (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Common Stock Outstanding [Member]
Balance (in shares)	34,469,878	28,377,357	33,367,389	27,753,373
Issuance of common stock, net of offering costs (in shares)	1,516,249	3,698,175	2,570,045	4,304,023
Issuance of common stock under dividend reinvestment plan (in shares)	57,688	20,727	106,381	38,863
Balance (in shares)	36,043,815	32,096,259	36,043,815	32,096,259
Common Stock [Member]
Balance	$ 37	$ 30	$ 36	$ 29
Issuance of common stock, net of offering costs	3	4	4	5
Net investment income, net of excise tax	0	0	0	0
Net realized gain (loss) on investments	0	0	0	0
Net unrealized appreciation (depreciation) on investments	0	0	0	0
Issuance of common stock under dividend reinvestment plan	0	0	0	0
Distributions declared	0	0	0	0
Net unrealized appreciation (depreciation) on investments	0	0	0	0
Balance	40	34	40	34
Additional Paid-in Capital [Member]
Balance	463,539	393,312	450,949	385,921
Issuance of common stock, net of offering costs	17,135	43,998	29,106	51,171
Net investment income, net of excise tax	0	0	0	0
Net realized gain (loss) on investments	0	0	0	0
Net unrealized appreciation (depreciation) on investments	0	0	0	0
Issuance of common stock under dividend reinvestment plan	675	251	1,294	469
Distributions declared	0	0	0	0
Net unrealized appreciation (depreciation) on investments	0	0	0	0
Balance	481,349	437,561	481,349	437,561
Retained Earnings [Member]
Balance	(131,455)	(71,659)	(127,004)	(67,502)
Issuance of common stock, net of offering costs	0	0	0	0
Net investment income, net of excise tax	12,914	16,073	25,520	29,084
Net realized gain (loss) on investments	2,464	(16,529)	2,472	(16,697)
Net unrealized appreciation (depreciation) on investments	(24,511)	608	(28,471)	(6,929)
Issuance of common stock under dividend reinvestment plan	0	0	0	0
Distributions declared	(12,023)	(10,669)	(25,128)	(20,132)
Net unrealized appreciation (depreciation) on investments	(24,511)	608	(28,471)	(6,929)
Balance	(152,611)	(82,176)	(152,611)	(82,176)
Balance	332,121	321,683	323,981	318,448
Issuance of common stock, net of offering costs	17,138	44,002	29,110	51,176
Net investment income, net of excise tax	12,914	16,073	25,520	29,084
Net realized gain (loss) on investments	2,464	(16,529)	2,472	(16,697)
Net unrealized appreciation (depreciation) on investments	(24,511)	608	(28,471)	(6,929)
Issuance of common stock under dividend reinvestment plan	675	251	1,294	469
Distributions declared	(12,023)	(10,669)	(25,128)	(20,132)
Net unrealized appreciation (depreciation) on investments	(24,511)	608	(28,471)	(6,929)
Balance	$ 328,778	$ 355,419	$ 328,778	$ 355,419

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net (decrease) increase in net assets resulting from operations	$ (9,133)	$ 152	$ (479)	$ 5,458
Adjustments to reconcile net (decrease) increase in net assets resulting from operations to net cash provided by operating activities:
Amortization of debt issuance costs	400	500	814	950
Net realized (gain) loss on investments			(2,472)	16,697
Net unrealized depreciation on investments	24,511	(608)	28,471	6,929
Purchase of investments			(35,384)	(87,553)
Principal payments received on investments			76,056	64,496
Payment-in-kind interest on investments			(1,737)	(2,154)
Proceeds from sale of investments			88	8,506
Equity received in settlement of fee income			0	(89)
Warrants received in settlement of fee income			(359)	0
Changes in assets and liabilities:
(Increase) decrease in interest receivable			(982)	65
Increase in end-of-term payments			(1,825)	(1,291)
Decrease in unearned income			(2,429)	(2,291)
Increase in other assets			(292)	(717)
Decrease in other accrued expenses			(1,066)	(484)
Decrease in base management fee payable			(74)	(2)
Increase (decrease) in incentive fee payable			0	(1,274)
Net cash provided by operating activities			58,330	7,246
Cash flows from financing activities:
Proceeds from issuance of common stock, net of offering costs			29,110	51,175
Advances on Credit Facilities			50,000	30,000
Repayment of Credit Facilities			(70,000)	(35,000)
Debt issuance costs			(3,337)	(729)
Distributions paid			(22,951)	(18,229)
Net cash (used in) provided by financing activities			(17,178)	15,452
Net increase in cash, cash equivalents and restricted cash			41,152	22,698
Cash, cash equivalents and restricted cash:
Beginning of period			75,722	30,466
End of period	116,874	53,164	116,874	53,164
Supplemental disclosure of cash flow information:
Cash paid for interest			15,237	13,409
Supplemental non-cash investing and financing activities:
Refinanced debt investment balances			11,250	0
Warrant investments received and recorded as unearned income			858	656
Distributions payable	11,894	10,592	11,894	10,592
End-of-term payments receivable			13,641	11,074
Non-cash income			7,983	7,182
Cash	81,333	24,395	81,333	24,395
Investments in money market funds	32,320	25,865	32,320	25,865
Restricted investments in money market funds	3,221	2,904	3,221	2,904
Total cash, cash equivalents and restricted cash	$ 116,874	$ 53,164	116,874	53,164
Asset-backed Notes 2019 [Member]
Cash flows from financing activities:
Repayment of notes			$ 0	$ (11,765)

Consolidated Schedule of Invest

Consolidated Schedule of Investments (Unaudited)	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Schedule of Investments [Text Block]	June 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Investments — 188.4 Non-Affiliate Debt Investments — 178.8 Non-Affiliate Debt Investments — Life Science — 71.5 Castle Creek Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 4,583 4,570 4,570 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 4,583 4,570 4,570 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 2,750 2,742 2,742 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 4,583 4,570 4,570 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 4,583 4,570 4,570 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 2,750 2,742 2,742 Emalex Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % November 1, 2025 5,000 4,964 4,964 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % May 1, 2026 5,000 4,967 4,967 Greenlight Biosciences, Inc. (2)(12) Biotechnology Term Loan 14.25 % Prime 5.75 % 9.00 % - 3.00 % July 1, 2025 2,167 2,110 2,110 Term Loan 14.25 % Prime 5.75 % 9.00 % - 3.00 % July 1, 2025 1,083 1,055 1,055 KSQ Therapeutics, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.50 % May 1, 2027 6,250 6,210 6,210 Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.50 % May 1, 2027 6,250 6,210 6,210 Native Microbials, Inc (2)(12) Biotechnology Term Loan 13.75 % Prime 5.25 % 8.50 % - 5.00 % November 1, 2026 3,625 3,605 3,605 Term Loan 13.75 % Prime 5.25 % 8.50 % - 5.00 % November 1, 2026 2,417 2,403 2,403 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 10,000 9,937 9,937 Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 3,750 3,726 3,726 Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 3,750 3,726 3,726 Provivi, Inc. (2)(12) Biotechnology Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.30 % January 1, 2027 3,482 3,399 3,206 Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.30 % January 1, 2027 3,482 3,399 3,206 Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.31 % January 1, 2027 1,741 1,696 1,598 Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.31 % January 1, 2027 1,741 1,696 1,598 Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.31 % January 1, 2027 1,741 1,695 1,597 Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.31 % January 1, 2027 1,741 1,695 1,597 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % October 1, 2025 3,238 3,197 3,197 Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % October 1, 2025 1,619 1,599 1,599 Tallac Therapeutics, Inc. (2)(12) Biotechnology Term Loan 12.75 % Prime 4.25 % 12.25 % - 4.00 % August 1, 2027 2,500 2,350 2,350 Term Loan 12.75 % Prime 4.25 % 12.25 % - 4.00 % August 1, 2027 2,500 2,465 2,465 Aerobiotix, LLC (2)(12) Medical Device Term Loan 9.00 % Fixed - - - 18.00 % April 1, 2028 2,500 2,474 2,354 Term Loan 9.00 % Fixed - - - 18.00 % April 1, 2028 2,500 2,474 2,354 Term Loan 9.00 % Fixed - - - 18.00 % April 1, 2028 200 187 178 Candesant Biomedical, Inc. (2)(12) Medical Device Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 5,000 4,770 4,770 Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 2,500 2,460 2,460 Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 2,500 2,460 2,460 Ceribell, Inc. (2)(12) Medical Device Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 5,000 4,814 4,814 Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 5,000 4,935 4,935 Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 4,000 3,948 3,948 Cognoa, Inc. (2)(12) Medical Device Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % August 1, 2026 4,028 3,993 3,993 Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % August 1, 2026 2,014 1,997 1,997 Conventus Orthopaedics, Inc. (2)(12) Medical Device Term Loan 13.32 % Prime 4.82 % 9.25 % - 10.36 % July 1, 2025 3,766 3,729 3,729 Term Loan 13.32 % Prime 4.82 % 9.25 % - 10.36 % July 1, 2025 3,766 3,729 3,729 CSA Medical, Inc. (2)(12) Medical Device Term Loan 13.59 % Prime 5.09 % 10.00 % - 5.00 % January 1, 2024 391 391 391 Term Loan 13.59 % Prime 5.09 % 10.00 % - 5.00 % March 1, 2024 533 533 533 MicroTransponder, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % - 3.50 % January 1, 2029 3,750 3,694 3,694 Term Loan 12.25 % Prime 3.75 % 12.25 % - 3.50 % January 1, 2029 3,750 3,694 3,694 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) June 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Scientia Vascular, Inc. (2)(12) Medical Device Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.00 % January 1, 2027 3,750 3,730 3,730 Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.00 % January 1, 2027 3,750 3,729 3,729 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % January 1, 2027 5,000 4,953 4,953 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % January 1, 2027 5,000 4,918 4,918 Sonex Health, Inc. (2)(12) Medical Device Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 2,500 2,477 2,477 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 2,500 2,477 2,477 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 5,000 4,953 4,953 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 5,000 4,953 4,953 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,708 3,708 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,708 3,708 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,708 3,708 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,708 3,708 Spineology, Inc. (2)(12) Medical Device Term Loan 15.50 % Prime 7.00 % 10.25 % - 1.00 % October 1, 2025 5,000 4,972 4,972 Term Loan 15.50 % Prime 7.00 % 10.25 % - 1.00 % April 1, 2026 2,500 2,488 2,488 Swift Health Systems Inc. (2)(12)(20) Medical Device Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,473 876 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,473 876 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,462 874 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,462 874 Vero Biotech, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 15,000 14,704 14,704 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 10,000 9,803 9,803 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 5,000 4,902 4,902 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 2,500 2,451 2,451 Total Non-Affiliate Debt Investments — Life Science 246,362 234,965 Non-Affiliate Debt Investments — Sustainability — 21.0 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 4.33 % December 1, 2026 3,750 3,705 3,705 Term Loan 15.25 % Prime 6.75 % 10.00 % - 4.33 % December 1, 2026 3,750 3,705 3,705 Nexii Building Solutions Inc. (2)(12)(13)(14)(18) Other Sustainability Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,871 8,222 2,189 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,871 7,996 2,129 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,871 7,996 2,129 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 5,914 5,325 1,418 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 5,914 5,325 1,418 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 773 705 188 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 616 561 149 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 307 280 75 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 305 278 74 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 183 166 44 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 842 767 204 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 1,145 1,050 279 Term Loan 15.50 % (11) Fixed - - - - August 30, 2024 422 384 102 Term Loan 15.50 % (11) Fixed - - - - August 30, 2024 557 485 129 Term Loan 15.50 % (11) Fixed - - - - August 30, 2024 414 392 104 Term Loan 15.50 % (11) Fixed - - - - August 30, 2024 491 471 125 Term Loan 15.50 % (11) Fixed - - - - August 30, 2024 490 486 129 Soli Organic, Inc. (2)(12) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % April 1, 2026 5,000 4,922 4,922 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % April 1, 2026 2,500 2,461 2,461 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % May 1, 2026 5,000 4,924 4,924 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % May 1, 2026 2,500 2,462 2,462 Term Loan 14.00 % Prime 5.50 % 11.75 % - 2.75 % December 1, 2026 5,000 4,936 4,936 Term Loan 14.00 % Prime 5.50 % 11.75 % - 2.75 % December 1, 2026 2,500 2,468 2,468 Temperpack Technologies, Inc. (2)(12) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,700 3,700 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,700 3,700 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 7,500 7,393 7,393 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,697 3,697 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,697 3,697 Term Loan 14.50 % Prime 6.00 % 10.00 % - 2.00 % January 1, 2029 4,500 4,449 4,449 Term Loan 14.50 % Prime 6.00 % 10.00 % - 2.00 % January 1, 2029 2,000 1,977 1,977 Total Non-Affiliate Debt Investments — Sustainability 99,085 69,081 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) June 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Debt Investments — Technology — 66.6 Axiom Space, Inc. (2)(12) Communications Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,000 4,975 4,975 Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,000 4,975 4,975 Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,000 4,975 4,975 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Term Loan 15.75 % Prime 7.25 % 10.50 % - 3.00 % March 1, 2027 2,033 1,975 1,975 Clara Foods Co. (2)(12) Consumer-related Technologies Term Loan 14.25 % Prime 5.75 % 9.00 % - 5.50 % August 1, 2025 1,083 1,076 1,076 Term Loan 14.25 % Prime 5.75 % 9.00 % - 5.50 % August 1, 2025 1,083 1,076 1,076 Havenly, Inc. (2)(12) Consumer-related Technologies Term Loan 13.50 % Prime 5.00 % 5.00 % - 10.40 % March 1, 2027 2,000 1,367 1,367 Term Loan 13.50 % Prime 5.00 % 5.00 % - 10.40 % March 1, 2027 3,000 2,354 2,354 Term Loan 12.00 % Prime 3.50 % 10.50 % - 7.78 % February 1, 2028 2,813 2,813 2,813 Term Loan 12.00 % Prime 3.50 % 10.50 % - 7.78 % February 1, 2028 2,813 2,813 2,813 Lyrical Foods, Inc. (2)(12) Consumer-related Technologies Term Loan 12.00 % Prime 3.50 % 9.00 % - 1.00 % September 1, 2027 2,500 2,591 2,228 MyForest Foods Co. (2)(12) Consumer-related Technologies Term Loan 15.25 % Prime 6.75 % 10.00 % - 3.00 % October 1, 2025 2,667 2,657 2,657 Term Loan 15.25 % Prime 6.75 % 10.00 % - 3.00 % October 1, 2025 1,333 1,328 1,328 NextCar Holding Company, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 5,780 5,572 3,331 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,890 2,786 1,665 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,312 2,229 1,332 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,890 2,786 1,665 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 3,468 3,343 1,999 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,890 2,786 1,665 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 5,780 5,572 3,331 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,890 2,786 1,665 Optoro, Inc. (2)(12) Consumer-related Technologies Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % August 1, 2027 2,500 2,432 2,432 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % July 1, 2028 1,875 1,796 1,796 Standvast Holdings, LLC (2)(12) Consumer-related Technologies Term Loan 12.75 % Prime 4.25 % 12.75 % - 3.00 % June 1, 2028 2,500 2,240 2,240 Term Loan 12.75 % Prime 4.25 % 12.75 % - 3.00 % June 1, 2028 2,500 2,415 2,415 Unagi, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 1,306 1,086 570 Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 653 543 285 Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 653 543 285 Liqid, Inc. (2)(12) Networking Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 333 329 329 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 333 329 329 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 167 164 164 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 167 164 164 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 167 161 161 BriteCore Holdings, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 5,000 4,902 4,902 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,469 2,469 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,469 2,469 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,469 2,469 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % April 1, 2029 2,500 2,466 2,466 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) June 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Dropoff, Inc. (2)(12) Software Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % April 1, 2026 6,777 6,695 6,093 Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % April 1, 2026 6,256 6,180 5,624 Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % August 1, 2026 2,607 2,576 2,345 Kodiak Robotics, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 10,000 9,929 9,929 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 10,000 9,929 9,929 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 5,000 4,964 4,964 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 5,000 4,964 4,964 Lemongrass Holdings, Inc. (2)(12) Software Term Loan 15.00 % Prime 6.50 % 9.75 % - 2.50 % March 1, 2026 4,375 4,358 4,358 Term Loan 15.00 % Prime 6.50 % 9.75 % - 2.50 % March 1, 2026 2,187 2,179 2,179 Lytics, Inc. (2)(12) Software Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % November 1, 2026 2,500 2,476 2,476 Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % December 1, 2026 1,250 1,240 1,240 Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % April 1, 2027 1,000 995 995 Mirantis, Inc. (2)(12) Software Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,788 4,788 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,924 4,924 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,924 4,924 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,924 4,924 Noodle Partners, Inc. (2)(12) Software Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 10,000 9,905 9,905 Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 5,000 4,953 4,953 Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 5,000 4,953 4,953 Reputation Institute, Inc. (2)(12) Software Term Loan 15.75 % Prime 7.25 % 10.50 % - 3.00 % August 1, 2025 2,583 2,542 2,542 Slingshot Aerospace, Inc. (2)(12) Software Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,971 4,971 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,971 4,971 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,971 4,971 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,971 4,971 Supply Network Visibility Holdings LLC (2)(12) Software Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 2,500 2,476 2,476 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 3,500 3,490 3,490 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 2,500 2,493 2,493 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 1,500 1,496 1,496 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % July 1, 2029 5,000 4,983 4,983 Viken Detection Corporation (2)(12) Software Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 5,000 4,945 4,945 Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 2,500 2,472 2,472 Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 2,500 2,472 2,472 Total Non-Affiliate Debt Investments — Technology 232,921 218,930 Non-Affiliate Debt Investments — Healthcare information and services — 19.7 Hound Labs Inc. (2) (12)(20) Diagnostics Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 1,607 1,596 1,124 Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 1,607 1,596 1,124 Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 3,214 3,193 2,248 Parse Biosciences, Inc. (2)(12) Diagnostics Term Loan 11.75 % Prime 3.25 % 11.50 % - 5.00 % January 1, 2028 5,000 4,645 4,645 Term Loan 11.75 % Prime 3.25 % 11.50 % - 5.00 % January 1, 2028 5,000 4,897 4,897 BrightInsight, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 7,000 6,807 6,807 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 3,500 3,470 3,470 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 3,500 3,470 3,470 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % April 1, 2028 2,750 2,715 2,715 Elligo Health Research, Inc. (2)(12) Software Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 10,000 9,675 9,675 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,935 4,935 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,935 4,935 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,935 4,935 SafelyYou, Inc. (2)(12) Software Term Loan 11.75 % Prime 3.25 % 11.00 % - 5.00 % June 1, 2027 5,000 4,784 4,784 Term Loan 11.75 % Prime 3.25 % 11.00 % - 5.00 % June 1, 2027 5,000 4,931 4,931 Total Non-Affiliate Debt Investments — Healthcare information and services 66,584 64,695 Total Non- Affiliate Debt Investments 644,952 587,671 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) June 30, 2024 (Dollars in thousands) Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrant Investments — 6.5 Non-Affiliate Warrants — Life Science — 1.9 Avalo Therapeutics, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 117 311 — Castle Creek Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 7,404 214 225 Emalex Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 110,402 176 136 Imunon, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 19,671 64 — KSQ Therapeutics, Inc. (2) (12) Biotechnology Preferred Stock Warrant 48,076 49 55 Mustang Bio, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 16,611 146 — Native Microbials, Inc (2)(12) Biotechnology Preferred Stock Warrant 103,679 64 64 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Common Stock Warrant 299,848 160 157 Provivi, Inc. (2)(12) Biotechnology Common Stock Warrant 175,098 278 — Provivi, Inc. (2)(12) Biotechnology Preferred Stock Warrant 709,981 312 229 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Common Stock Warrant 318,181 265 117 Tallac Therapeutics, Inc. (2)(12) Biotechnology Preferred Stock Warrant 1,600,002 195 173 Xeris Pharmaceuticals, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 126,000 73 29 AccuVein Inc. (2)(12) Medical Device Common Stock Warrant 271 7 — Aerin Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 1,818,183 66 1,036 Aerobiotix, LLC (2)(12) Medical Device Preferred Stock Warrant 8,800 48 10 Canary Medical Inc. (2)(12) Medical Device Preferred Stock Warrant 12,153 86 1,280 Candesant Biomedical, Inc. (2)(12) Medical Device Preferred Stock Warrant 93,336 152 139 Ceribell, Inc. (2)(12) Medical Device Preferred Stock Warrant 219,866 139 237 Cognoa, Inc. (2)(12) Medical Device Common Stock Warrant 30,585 — 1 Cognoa, Inc. (2)(12) Medical Device Preferred Stock Warrant 4,635,992 162 213 Conventus Orthopaedics, Inc. (2)(12) Medical Device Preferred Stock Warrant 9,313,541 256 208 CSA Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,839,739 174 135 CVRx, Inc. (2)(5)(12) Medical Device Common Stock Warrant 47,410 76 142 Infobionic, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,010,424 124 50 Magnolia Medical Technologies, Inc. (2)(12) Medical Device Preferred Stock Warrant 809,931 194 381 Meditrina, Inc. (2)(12) Medical Device Preferred Stock Warrant 233,993 83 41 MicroTransponder, Inc. (2)(12) Medical Device Preferred Stock Warrant 103,172 47 49 Scientia Vascular, Inc (2)(12) Medical Device Preferred Stock Warrant 34,410 103 341 Sonex Health, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,637,133 275 278 VERO Biotech LLC (2)(12) Medical Device Preferred Stock Warrant 4,109 432 355 Spineology, Inc. (2)(12) Medical Device Preferred Stock Warrant 128,848 21 21 Swift Health Systems Inc. (2)(12) Medical Device Preferred Stock Warrant 135,484 71 — Total Non-Affiliate Warrants — Life Science 4,823 6,102 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) June 30, 2024 (Dollars in thousands) Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrants — Sustainability — 0.2 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Preferred Stock Warrant 400,000 81 74 LiquiGlide, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 61,359 39 30 Nexii Building Solutions, Inc. (2)(12)(14)(18) Other Sustainability Common Stock Warrant 215,171 490 — Soli Organic, Inc. (2)(12) Other Sustainability Common Stock Warrant 296 19 19 Soli Organic, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 1,076 382 516 Temperpack Technologies, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 49,693 178 89 Total Non-Affiliate Warrants — Sustainability 1,189 728 Non-Affiliate Warrants — Technology — 4.0 Axiom Space Holdings, Inc. (2)(12) Communications Common Stock Warrant 1,991 46 62 Intelepeer Holdings, Inc. (2)(12) Communications Preferred Stock Warrant 2,936,535 138 2,838 PebblePost, Inc. (2)(12) Communications Preferred Stock Warrant 598,850 92 132 Alula Holdings, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 20,000 93 8 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 112,356 36 41 Clara Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 46,745 30 125 CZV, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 65,569 79 74 Divergent Technologies, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 53,264 454 622 Havenly, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 1,446,429 3,178 2,490 MyForest Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 250 28 27 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 12,618 188 — NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 1,224,752 9 — Optoro, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 11,550 181 145 Primary Kids, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 553,778 57 594 Quip NYC Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 6,191 325 — Standvast Holdings, LLC (2)(12) Consumer-related Technologies Preferred Stock Warrant 1,225,492 275 273 Unagi, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 171,081 32 — Updater, Inc.(2)(12) Consumer-related Technologies Preferred Stock Warrant 108,333 34 27 CPG Beyond, Inc. (2)(12) Data Storage Preferred Stock Warrant 500,000 242 300 Silk, Inc. (2)(12) Data Storage Preferred Stock Warrant 394,110 175 128 Global Worldwide LLC (2)(12) Internet and Media Preferred Stock Warrant 245,810 75 62 Rocket Lawyer Incorporated (2)(12) Internet and Media Preferred Stock Warrant 261,721 92 324 Skillshare, Inc. (2)(12) Internet and Media Preferred Stock Warrant 139,074 162 817 Liqid, Inc. (2)(12) Networking Preferred Stock Warrant 344,102 364 162 Halio, Inc. (2)(12) Power Management Common Stock Warrant 38,241,466 1,585 2,700 Avalanche Technology, Inc. (2)(12) Semiconductors Preferred Stock Warrant 5,938 45 — BriteCore Holdings, Inc. (2)(12) Software Preferred Stock Warrant 161,215 98 182 Dropoff, Inc. (2)(12) Software Common Stock Warrant 516,732 455 63 E La Carte, Inc. (2)(5)(12) Software Common Stock Warrant 147,361 60 — Everstream Holdings, LLC (2)(12) Software Preferred Stock Warrant 350,000 70 65 Kodiak Robotics, Inc. (2)(12) Software Preferred Stock Warrant 639,918 273 7 Lemongrass Holdings, Inc. (2)(12) Software Preferred Stock Warrant 101,308 34 138 Lotame Solutions, Inc. (2)(12) Software Preferred Stock Warrant 71,305 18 42 Lytics, Inc. (2)(12) Software Preferred Stock Warrant 85,543 43 — Mirantis, Inc. (2)(12) Software Common Stock Warrant 948,275 223 255 Noodle Partners, Inc. (2)(12) Software Preferred Stock Warrant 84,037 116 — Reputation Institute, Inc. (2)(12) Software Preferred Stock Warrant 4,104 63 94 Revinate Holdings, Inc. (2)(12) Software Preferred Stock Warrant 682,034 44 94 SIGNiX, Inc. (12) Software Preferred Stock Warrant 186,235 225 — Slingshot Aerospace, Inc. (2)(12) Software Preferred Stock Warrant 309,208 123 72 Supply Network Visibility Holdings LLC (2)(12) Software Preferred Stock Warrant 682 65 78 Topia Mobility, Inc. (2)(12) Software Preferred Stock Warrant 3,049,607 138 — Viken Detection Corporation (2)(12) Software Preferred Stock Warrant 345,443 120 212 xAd, Inc. (2)(12) Software Preferred Stock Warrant 4,343,348 177 8 Total Non-Affiliate Warrants — Technology 10,360 13,261 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) June 30, 2024 (Dollars in thousands) Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrants — Healthcare information and services — 0.4 Hound Labs, Inc (2)(12) Diagnostics Preferred Stock Warrant 171,370 46 — Parse Biosciences, Inc. (2)(12) Diagnostics Common Stock Warrant 32,244 71 70 Parse Biosciences, Inc. (2)(12) Diagnostics Preferred Stock Warrant 184,253 166 173 Kate Farms, Inc. (2)(12) Other Healthcare Preferred Stock Warrant 82,965 102 979 BrightInsight, Inc. (2)(12) Software Preferred Stock Warrant 85,066 167 — Elligo Health Research, Inc. (2)(12) Software Preferred Stock Warrant 652,250 191 95 Medsphere Systems Corporation (2)(12) Software Preferred Stock Warrant 7,097,792 60 — SafelyYou, Inc. (2)(12) Software Preferred Stock Warrant 150,353 163 51 Total Non-Affiliate Warrants — Healthcare information and services 966 1,368 Total Non-Affiliate Warrants 17,338 21,459 Non-Affiliate Other Investments — Life Science — 1.0 Lumithera, Inc. (12) Medical Device Royalty Agreement 1,146 100 Robin Healthcare, Inc. (2)(12) Medical Device Royalty Agreement 7,227 3,247 ZetrOZ, Inc. (12) Medical Device Royalty Agreement — — Total Non-Affiliate Other Investments 8,373 3,347 Non-Affiliate Equity — 2.1 Cadrenal Therapeutics, Inc. (5) Biotechnology Common Stock 600,000 — 283 Castle Creek Biosciences, Inc. (12) Biotechnology Common Stock 1,162 250 250 Emalex Biosciences, Inc. (12) Biotechnology Common Stock 32,831 355 355 Axiom Space, Inc. (12) Communications Preferred Stock 1,810 261 306 Caastle, Inc. (2)(12) Consumer-related Technologies Preferred Stock 242,180 2,681 2,681 Getaround, Inc. (2)(5) Consumer-related Technologies Common Stock 87,082 253 12 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock 2,688,971 89 — SnagAJob.com, Inc. (12) Consumer-related Technologies Common Stock 82,974 10 81 Lumithera, Inc. (12) Medical Device Common Stock 392,651 2,000 1,700 Tigo Energy, Inc. (5) Other Sustainability Common Stock 5,205 111 10 Decisyon, Inc. (12) Software Preferred Stock 280,000 2,800 1,281 Lotame, Inc. (12) Software Preferred Stock 66,127 4 193 Total Non-Affiliate Equity 8,814 7,152 Total Non-Affiliate Portfolio Investment Assets $ 679,477 $ 619,629 See Notes to Consolidated Financial Statements Consolidated Schedule of Investments (Unaudited) June 30, 2024 (Dollars in thousands) Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Controlled Affiliate Investments — 4.8 Non-Controlled Affiliate Debt Investments — Life Sciences — 4.8 Evelo Biosciences, Inc. (2)(5)(12)(13) Biotechnology Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 5,898 5,228 3,503 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 8,847 7,972 5,340 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 3,539 3,137 2,101 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 3,539 3,137 2,101 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 2,359 2,091 1,401 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 2,359 2,091 1,401 Total Non-Controlled Affiliate Debt Investments 23,656 15,847 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-controlled Affiliate Equity — Life Sciences — 0.0 Aulea Medical, Inc. (12)(16) Medical Device Common Stock 660,537 — — Evelo Biosciences, Inc. (5)(12) Biotechnology Common Stock 2,164,502 5,000 — Total Non-Controlled Affiliate Equity 5,000 — Non-controlled Affiliate Warrants — Life Sciences — 0.0 Evelo Biosciences, Inc. (2)(5)(12) Biotechnology Common Stock 23,196 125 — Total Non-Controlled Affiliate Warrants 125 — Total Non-Controlled Affiliate Portfolio Investment Assets $ 28,781 $ 15,847 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Controlled Affiliate Investments — 3.5 Controlled Affiliate Debt Investments — Technology — 1.7 Better Place Forests Co. (12) Consumer-related Technologies Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - 2.78 % August 1, 2029 3,772 3,814 3,166 Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - 2.78 % August 1, 2029 1,886 1,867 1,549 Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - - August 1, 2025 505 505 420 Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - - August 1, 2025 501 501 415 Total Controlled Affiliate Debt Investments 6,687 5,550 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Controlled Affiliate Equity — Technology — 0.0 Better Place Forests Co. (12) Consumer-related Technologies Common Stock 2,278,272 2,060 — Better Place Forests Co. (12) Consumer-related Technologies Preferred Stock 5,350,142 2,500 — Total Controlled Affiliate Equity 4,560 — Controlled Affiliate Other Investments — Life Sciences — 1.8 HIMV LLC (12)(17) Biotechnology Other Investment 5,925 5,836 Total Controlled Affiliate Other 5,925 5,836 Total Controlled Affiliate Portfolio Investment Assets $ 17,172 $ 11,386 Total Portfolio Investment Assets — 196.7 $ 725,430 $ 646,862 Short Term Investments - Unrestricted Investments - 9.8 US Bank Money Market Deposit Account 32,320 32,320 Total Short Term Investments - Unrestricted Investments $ 32,320 $ 32,320 Short Term Investments - Restricted Investments - 1.0 US Bank Money Market Deposit Account 3,221 3,221 Total Short Term Investments - Restricted Investments $ 3,221 $ 3,221 ( 1 All investments of the Company are in entities which are organized under the laws of the United States and have a principal place of business in the United States, unless otherwise noted. ( 2 Has been pledged as collateral under the revolving credit facility (the “

Note 1 - Organization

Note 1 - Organization	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. Horizon Technology Finance Corporation (the “Company”) was organized as a Delaware corporation on March 16, 2010 1940 1986, not On October 28, 2010, Horizon Credit II LLC (“Credit II”) was formed as a Delaware limited liability company on June 28, 2011, not The Company formed Horizon Funding 2019‑1 “2019‑1 May 2, 2019 2019‑1 May 15, 2019 “2019‑1 2019‑1 “2019‑1 2019‑1 2019‑1 August 13, 2019 ( “2019 2019 1 February 27, 2024. Horizon Funding I, LLC (“HFI”) was formed as a Delaware limited liability company on May 9, 2018, not April 21, 2020, The Company formed Horizon Funding 2022‑1 “2022‑1 September 30, 2022 2022‑1 October 18, 2022 ( “2022‑1 2022‑1 “2022‑1 2022‑1 2022‑1 2022 2022 1 Horizon Funding II, LLC (“HFII”) was formed as a Delaware limited liability company o May 13, 20 24, not The Company has established wholly owned subsidiaries, which are structured as Delaware limited liability companies, either to hold assets of portfolio companies acquired in connection with a foreclosure or bankruptcy or to hold equity in portfolio companies which the Company may The Company, together with its co-lender to IMV, established HIMV LLC, a Delaware limited liability company to purchase and sell the assets of IMV, a past borrower of the Company. The assets of IMV were sold for (i) the right to receive certain payments, if any, in connection with the potential future development and licensing of the assets sold and (ii) equity in the buyer of such assets. HIMV LLC is 70% owned by the Company and 30% owned by a third The Company’s investment strategy is to maximize the investment portfolio’s return by generating current income from the debt investments the Company makes and capital appreciation from the warrants the Company receives when making such debt investments. The Company has entered into an investment management agreement with Horizon Technology Finance Management LLC (the “Advisor”) under which the Advisor manages the day-to-day operations of, and provides investment advisory services to, the Company.

Note 2 - Basis of Presentation

Note 2 - Basis of Presentation and Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	Note 2. The consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the requirements for reporting on Form 10‑Q 6 10 X X” 1933, not may December 31, 2023 Principles of consolidation As required under GAAP and Regulation S- X, Assets related to transactions that do not 860, Transfers and Servicing 2019‑1 2022 1 not Use of estimates In preparing the consolidated financial statements in accordance with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the balance sheet and income and expenses for the period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the valuation of investments. Fair value The Company records all of its investments at fair value in accordance with relevant GAAP, which establishes a framework used to measure fair value and requires disclosures for fair value measurements. The Company has categorized its investments carried at fair value, based on the priority of the valuation technique, into a three 6. not The availability of observable inputs can vary depending on the financial instrument and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new, whether the product is traded on an active exchange or in the secondary market and the current market conditions. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for financial instruments classified as Level 3. See Note 6 Segments The Company has determined that it has a single reporting segment and operating unit structure. The Company lends to and invests in portfolio companies in various technology, life science, healthcare information and services and sustainability industries. The Company separately evaluates the performance of each of its lending and investment relationships. However, because each of these debt investments and investment relationships has similar business and economic characteristics, they have been aggregated into a single lending and investment segment. Investments Investments are recorded at fair value. Pursuant to the amended SEC Rule 2a 5 1940 July 29, 2022, Interest on debt investments is accrued and included in income based on contractual rates applied to principal amounts outstanding. Interest income is determined using a method that results in a level rate of return on principal amounts outstanding. Generally, when a debt investment becomes 90 not may may June 30, 2024 six December 31, 2023 four three six June 30, 2024 2023, not The Company has a limited number of debt investments in its portfolio that contain a PIK provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. For the three June 30, 2024 2023, 3.4%, six June 30, 2024 2023, 3.8%, not three June 30, 2024, six June 30, 2024 one six June 30, 2024 three six June 30, 2023, three three six June 30, 2023, The Company receives a variety of fees from borrowers in the ordinary course of conducting its business, including advisory fees, commitment fees, amendment fees, non-utilization fees, success fees and prepayment fees. In a limited number of cases, the Company may Certain debt investment agreements also require the borrower to make an ETP, that is accrued into interest receivable and taken into income over the life of the debt investment to the extent such amounts are expected to be collected. The Company will generally cease accruing the income if there is insufficient value to support the accrual or the Company does not not three June 30, 2024 2023 not six June 30, 2024 2023 In connection with substantially all lending arrangements, the Company receives warrants to purchase shares of stock from the borrower. The warrants are recorded as assets at estimated fair value on the grant date using the Black-Scholes valuation model. The warrants are considered loan fees and are recorded as unearned income on the grant date. The unearned income is recognized as interest income over the contractual life of the related debt investment in accordance with the Company’s income recognition policy. Subsequent to debt investment origination, the fair value of the warrants is determined using the Black-Scholes valuation model. Any adjustment to fair value is recorded through earnings as net unrealized appreciation or depreciation on investments. Gains and losses from the disposition of the warrants or stock acquired from the exercise of warrants are recognized as realized gains and losses on investments. Realized gains or losses on the sale of investments, or upon the determination that an investment balance, or portion thereof, is not Debt issuance costs Debt issuance costs are fees and other direct incremental costs incurred by the Company in obtaining debt financing from its lenders and issuing debt securities. The unamortized balance of debt issuance costs as of June 30, 2024 December 31, 2023 June 30, 2024 December 31, 2023 three June 30, 2024 2023 six June 30, 2024 2023 Income taxes As a BDC, the Company has elected to be treated as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to qualify as a RIC and to avoid the imposition of corporate-level income tax on the portion of its taxable income distributed to stockholders, among other things, the Company is required to meet certain source of income and asset diversification requirements and to timely distribute dividends out of assets legally available for distribution to its stockholders of an amount generally at least equal to 90% no 946, Financial Services Investment Companies no Depending on the level of taxable income earned in a tax year, the Company may three June 30, 2024 2023 six June 30, 2024 2023 The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than- not” 740, Income Taxes 946. not not June 30, 2024 December 31, 2023 2024, 2023, 2022 2021 Distributions Distributions to common stockholders are recorded on the declaration date. The amount to be paid out as distributions is determined by the Board. Net realized capital gains, if any, may may The Company has adopted a dividend reinvestment plan that provides for reinvestment of cash distributions on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Board declares a cash distribution, then stockholders who have not may Stockholders Equity On August 2, 2021, “2021 2021 may On September 22, 2023, 2021 “2023 2021 2023 may may 415 During the three June 30, 2024 2023 During the three June 30, 2023 2021 During the six June 30, 2024 2023 During the six June 30, 2023 2021 The Company generally uses net proceeds from these offerings to make investments, to pay down liabilities and for general corporate purposes. As of June 30, 2024 2023 On June 2, 2023, Stock Repurchase Program On April 26, 2024, may, not 10b‑18 1934, 1940 June 30, 2025 $5.0 three six June 30, 2024 2023 not June 30, 2024 Transfers of financial assets Assets related to transactions that do not 860, Transfers and Servicing not Transfers of financial assets are accounted for as sales when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when ( 1 2 3 not Recently issued accounting pronouncement In November 2023, 2023 07, 280 2023 07” 2023 07 may one December 15, 2023, December 15, 2024, Recently adopted accounting pronouncement In June 2022, No. 2022 03, 2022 03” 2022 03 2022 03 December 15, 2023, 2022 03 not

Note 3 - Related Party Transact

Note 3 - Related Party Transactions	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 3. Investment Management Agreement At a meeting of the stockholders convened on May 25, 2023 June 28, 2023, June 30, 2023 ( March 7, 2019. The Advisor’s services under the Investment Management Agreement are not not two The base management fee is calculated at an annual rate of 2.00% of the Company’s gross assets (less cash and cash equivalents) including any assets acquired with the proceeds of leverage; provided, that, to the extent the Company’s gross assets (less cash and cash equivalents) exceed $250 $250 The base management fee payable at June 30, 2024 December 31, 2023 three June 30, 2024 2023 six June 30, 2024 2023 The incentive fee has two The first zero not no 1.75%, 2.1875% 20.00% not Pre-Incentive Fee Net Investment Income does not may 2.00% three The incentive fee on Pre-Incentive Fee Net Investment Income is subject to a fee cap and deferral mechanism which is determined based upon a look-back period of up to three 11 may 20.00% zero not three The second 20.00% not There was no performance based incentive fee expense for the three June 30, 2024 three June 30, 2023. six June 30, 2024 2023, three June 30, 2024 2023, six June 30, 2024 2023, not may three The following table provides the expiration dates of the Company’s Incentive Fee Cap and Deferral Mechanism contingent future liability as of June 30, 2024 Expiration Total (In thousands) December 31, 2025 $ 1,037 March 31, 2026 219 June 30, 2026 3,120 September 30, 2026 3,471 December 31, 2026 3,002 March 31, 2027 2,285 June 30, 2027 2,582 Total $ 15,716 There was no performance based incentive fee payable as of June 30, 2024 December 31, 2023 Administration Agreement The Company entered into an administration agreement (the “Administration Agreement”) with the Advisor to provide administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Advisor for the Company’s allocable portion of overhead and other expenses incurred by the Advisor in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions and the Company’s allocable portion of the costs of compensation and related expenses of the Company’s Chief Financial Officer and Chief Compliance Officer and their respective staffs. The administrative fee expense was $0.4 million for the three June 30, 2024 2023 six June 30, 2024 2023 June 30, 2024 December 31, 2023

Note 4 - Investments

Note 4 - Investments	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Investment Holdings [Text Block]	Note 4. The following table shows the Company’s investments as of June 30, 2024 December 31, 2023 June 30, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Investments Debt $ 675,295 $ 609,068 $ 721,231 $ 670,172 Warrants 17,463 21,459 16,526 24,594 Other 14,298 9,183 6,982 6,430 Equity 18,374 7,152 14,443 7,889 Total investments $ 725,430 $ 646,862 $ 759,182 $ 709,085 The following table shows the Company’s investments by industry sector as of June 30, 2024 December 31, 2023 June 30, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Life Science Biotechnology $ 133,486 $ 118,846 $ 145,544 $ 117,781 Medical Device 163,383 149,839 147,064 145,019 Technology Communications 15,462 18,263 19,192 22,188 Consumer-Related 78,244 59,113 105,669 101,327 Data Storage 417 428 417 418 Internet and Media 329 1,203 329 1,582 Networking 1,511 1,309 5,451 5,297 Power Management 1,585 2,700 1,585 2,700 Semiconductors 45 — 45 — Software 163,033 159,279 164,133 160,749 Sustainability Energy Efficiency 111 10 111 13 Other Sustainability 100,274 69,809 98,906 80,370 Healthcare Information and Services Diagnostics 16,210 14,281 19,735 19,701 Other 102 979 102 1,366 Software 51,238 50,803 50,899 50,574 Total investments $ 725,430 $ 646,862 $ 759,182 $ 709,085

Note 5 - Transactions With Affi

Note 5 - Transactions With Affiliated Companies	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Investments in and Advances to Affiliates, Schedule of Investments [Text Block]	Note 5. A non-controlled affiliated company is generally a portfolio company in which the Company owns 5% not 25% Transactions related to investments in non-controlled affiliated companies for the three June 30, 2024 Three months ended June 30, 2024 Fair value at Transfers Net Fair value at Portfolio March 31, Principal in/(out) at Discount unrealized Net realized June 30, Company 2024 Purchases Payments fair value accretion gain/(loss) gain/(loss) 2024 (In thousands) Aulea Medical, Inc. $ — $ — $ (40 ) $ — $ — $ — $ 40 $ — Evelo Biosciences, Inc. 2,790 — — — — 713 — 3,503 4,207 92 — — — 1,041 — 5,340 1,674 — — — — 427 — 2,101 1,674 — — — — 427 — 2,101 1,116 — — — — 285 — 1,401 1,116 — — — — 285 — 1,401 Total non-controlled affiliates $ 12,577 $ 92 $ (40 ) $ — $ — $ 3,178 $ 40 $ 15,847 Transactions related to investments in non-controlled affiliated companies for the three June 30, 2023 Three months ended June 30, 2023 Fair value at Transfers Net Fair value at Portfolio March 31, in/(out) at Discount unrealized Net realized June 30, Company 2023 Purchases Sales fair value Accretion gain/(loss) gain/(loss) 2023 (In thousands) Cadrenal Therapeutics, Inc. 846 — — — — 60 — 906 Total non-controlled affiliates $ 846 $ — $ — $ — $ — $ 60 $ — $ 906 Transactions related to investments in non-controlled affiliated companies for the six June 30, 2024 Six months ended June 30, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized June 30, Company 2023 Purchases Payments fair value accretion gain/(loss) gain/(loss) 2024 (In thousands) Aulea Medical, Inc. $ — $ 3 $ (40 ) $ — $ — $ — $ 37 $ — Evelo Biosciences, Inc. 222 — — — — 3,281 — 3,503 336 104 — — — 4,900 — 5,340 133 — — — — 1,968 — 2,101 133 — — — — 1,968 — 2,101 88 — — — — 1,313 — 1,401 88 — — — — 1,313 — 1,401 132 — — — — (132 ) — — Total non-controlled affiliates $ 1,132 $ 107 $ (40 ) $ — $ — $ 14,611 $ 37 $ 15,847 Transactions related to investments in non-controlled affiliated companies for the six June 30, 2023 Six months ended June 30, 2023 Fair value at Transfers Net Fair value at Portfolio December 31, in/(out) at Discount unrealized Net realized June 30, Company 2022 Purchases Sales fair value Accretion gain/(loss) gain/(loss) 2023 (In thousands) Cadrenal Therapeutics, Inc. — — — — — 906 — 906 Total non-controlled affiliates $ — $ — $ — $ — $ — $ 906 $ — $ 906 A controlled affiliated company is generally a portfolio company in which the Company owns more than 25% Transactions related to investments in controlled affiliated companies for the three June 30, 2024 Three months ended June 30, 2024 Fair value at Transfers Net Fair value at Portfolio March 31, Principal in/(out) at Discount unrealized Net realized June 30, Interest Company 2024 Purchases Payments PIK fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Better Place Forests Co. $ 3,455 $ — $ — $ 115 $ — $ 2 $ (406 ) $ — $ 3,166 $ 120 1,688 — — 57 — 1 (197 ) — 1,549 62 — 500 — 5 — — (85 ) — 420 5 — 500 — 1 — — (86 ) — 415 1 2,656 500 — — — — (3,156 ) — — — HIMV LLC 5,845 — — — 463 — (472 ) — 5,836 — Total controlled affiliates $ 13,644 $ 1,500 $ — $ 178 $ 463 $ 3 $ (4,402 ) $ — $ 11,386 $ 188 Transactions related to investments in controlled affiliated companies for the six June 30, 2024 Six months ended June 30, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized June 30, Interest Company 2023 Purchases Payments PIK fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Better Place Forests Co. $ 3,339 $ — $ — $ 226 $ — $ 4 $ (403 ) $ — $ 3,166 $ 236 1,630 — — 112 — 3 (196 ) — 1,549 123 — 500 — 5 — — (85 ) 420 5 — 500 — 1 — — (86 ) 415 1 3,024 1,250 — — — — (4,274 ) — — — HIMV LLC 6,230 227 (547 ) — 463 — (537 ) — 5,836 — Total controlled affiliates $ 14,223 $ 2,477 $ (547 ) $ 344 $ 463 $ 7 $ (5,581 ) $ — $ 11,386 $ 365 For the three six June 30, 2023,

Note 6 - Fair Value

Note 6 - Fair Value	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 6. Prior to July 30, 2022, 2a 5 1940 July 29, 2022, twelve The Company uses fair value measurements made by the valuation designee to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is best determined based upon quoted market prices. However, in certain instances, there are no not may not Fair value measurements focus on exit prices in an orderly transaction (that is, not may The Company’s fair value measurements are classified into a fair value hierarchy in accordance with ASC Topic 820, Fair Value Measurement three Level 1 Quoted prices in active markets for identical assets and liabilities. Level 2 Observable inputs other than Level 1 not Level 3 Unobservable inputs that are supported by little or no 3 Due to the inherent uncertainty of determining the fair value of investments that do not may may may may Cash and interest receivable: not 1 Money market funds: 2 Debt investments: 3 Under certain circumstances, the Company may Warrant investments: ● Underlying asset value of the issuer is estimated based on information available, including any information regarding the most recent rounds of borrower funding. Significant increases (decreases) in this unobservable input would result in a significantly higher (lower) fair value measurement. ● Volatility, or the amount of uncertainty or risk about the size of the changes in the warrant price, is based on indices of publicly traded companies similar in nature to the underlying company issuing the warrant. A total of seven ● The risk-free interest rates are derived from the U.S. Treasury yield curve. The risk-free interest rates are calculated based on a weighted average of the risk-free interest rates that correspond closest to the expected remaining life of the warrant. ● Other adjustments, including a marketability discount on private company warrants, are estimated based on management’s judgment about the general industry environment. ● Historical portfolio experience on cancellations and exercises of the Company’s warrants are utilized as the basis for determining the estimated time to exit of the warrants in each financial reporting period. Warrants may Under certain circumstances the Company may may The fair value of the Company’s warrants held in publicly traded companies is determined based on inputs that are readily available in public markets or can be derived from information available in public markets. Therefore, the Company has categorized these warrants as Level 2 3 Equity investments: third may 3 1 Other investments: 3 The following tables detail the assets that are carried at fair value and measured at fair value on a recurring basis as of June 30, 2024 December 31, 2023 June 30, 2024 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 609,068 $ 609,068 Warrant investments — 328 21,131 21,459 Other investments — — 9,183 9,183 Equity investments 302 — 6,850 7,152 Total investments $ 302 $ 328 $ 646,232 $ 646,862 December 31, 2023 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 670,172 $ 670,172 Warrant investments — 1,619 22,975 24,594 Other investments — — 6,430 6,430 Equity investments 608 — 7,281 7,889 Total investments $ 608 $ 1,619 $ 706,858 $ 709,085 The following tables provide a summary of quantitative information about the Company’s Level 3 June 30, 2024 December 31, 2023 may The following table is not 3 June 30, 2024 June 30, 2024 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 556,542 Discounted Expected Future Cash Flows Hypothetical Market Yield 12% – 25% 15 % 52,526 Multiple Probability Weighted Cash Flow Model Probability Weighting 5% - 100% 64 % Warrant investments 21,069 Black-Scholes Valuation Model Price Per Share 0.00 –1,898.58 $ 74.78 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 17 % Estimated Time to Exit (in years) 1 to 5 3 62 Expected Proceeds Price Per Share $0.25 $ 0.25 Other investments 9,183 Multiple Probability Weighted Cash Flow Model Discount Rate 25% 25 % Probability Weighting 30% – 100% 75 % Equity investments 6,850 Last Equity Financing Price Per Share 0.00 215.03 $ 22.31 Total Level 3 investments $ 646,232 ( 1 Weighted average is calculated by multiplying (a) the unobservable input for each investment in the investment type by (b) ( 1 2 The following table is not 3 December 31, 2023 December 31, 2023 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 617,529 Discounted Expected Future Cash Flows Hypothetical Market Yield 11% – 24% 15 % 52,643 Multiple Probability Weighted Cash Flow Model Probability Weighting 20% - 100% 50 % Warrant investments 22,913 Black-Scholes Valuation Model Price Per Share 0.00 –1,899.00 $ 64.95 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 18 % Estimated Time to Exit (in years) 1 to 5 3 62 Expected Proceeds Price Per Share $0.25 $ 0.25 Other investments 6,430 Multiple Probability Weighted Cash Flow Model Discount Rate 25% 25 % Probability Weighting 30% – 100% 81 % Equity investments 7,281 Last Equity Financing Price Per Share 0.56 215.03 $ 17.15 Total Level 3 investments $ 706,858 ( 1 Weighted average is calculated by multiplying (a) the unobservable input for each investment in the investment type by (b) ( 1 2 Borrowings: 2 2026 7 June 30, 2024 2026 1 2027 7 June 30, 2024 2027 1 June 30, 2024 2022 3 not Off-balance-sheet instruments: 3 The following table shows a reconciliation of the beginning and ending balances for Level 3 three June 30, 2024 Three months ended June 30, 2024 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 670,773 $ 23,156 $ 6,825 $ 9,192 $ 709,946 Purchase of investments 11,605 — 500 (40 ) 12,065 Warrants received and classified as Level 3 — 1,089 — — 1,089 Principal payments received on investments (56,906 ) — — 493 (56,413 ) Payment-in-kind interest on investments 355 — — — 355 Proceeds from sale of investments (3 ) (4 ) — (40 ) (47 ) Net realized gain on investments 3 2,617 — 40 2,660 Unrealized depreciation included in earnings (17,501 ) (3,046 ) (3,156 ) (462 ) (24,165 ) Transfer out of warrant investments — (2,681 ) 2,681 — — Other 742 — — — 742 Level 3 assets, end of period $ 609,068 $ 21,131 $ 6,850 $ 9,183 $ 646,232 During the three June 30, 2024, 3. The following table shows a reconciliation of the beginning and ending balances for Level 3 three June 30, 2023 Three months ended June 30, 2023 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 684,554 $ 24,638 $ 2,915 $ 1,300 $ 713,407 Purchase of investments 40,545 — — — 40,545 Warrants and equity received and classified as Level 3 — 515 89 — 604 Principal payments received on investments (24,740 ) — — — (24,740 ) Payment-in-kind interest on investments 950 — — — 950 Proceeds from sale of investments (528 ) (1,458 ) — — (1,986 ) Net realized (loss) gain on investments (17,672 ) 1,287 (127 ) — (16,512 ) Unrealized appreciation (depreciation) included in earnings 2,118 (606 ) (1,307 ) — 205 Transfer out of Level 3 — — (111 ) — (111 ) Transfer out of debt investments (2,800 ) — 2,800 — — Other 882 — — — 882 Level 3 assets, end of period $ 683,309 $ 24,376 $ 4,259 $ 1,300 $ 713,244 During the three June 30, 2023 one 3. one 3 one 1 three June 30, 2023, 3. The following table shows a reconciliation of the beginning and ending balances for Level 3 six June 30, 2024 Six months ended June 30, 2024 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 670,172 $ 22,975 $ 7,281 $ 6,430 $ 706,858 Purchase of investments 33,782 — 1,250 352 35,384 Warrants received and classified as Level 3 — 1,217 — — 1,217 Principal payments received on investments (75,986 ) — — (70 ) (76,056 ) Payment-in-kind interest on investments 1,737 — — — 1,737 Proceeds from sale of investments (44 ) (4 ) — (40 ) (88 ) Net realized gain (loss) on investments 41 2,600 — 40 2,681 Unrealized depreciation included in earnings (19,010 ) (2,976 ) (4,362 ) (720 ) (27,068 ) Transfer out of debt and warrant investments (3,191 ) (2,681 ) 2,681 3,191 — Other 1,567 — — — 1,567 Level 3 assets, end of period $ 609,068 $ 21,131 $ 6,850 $ 9,183 $ 646,232 During the six June 30, 2024 3. The change in unrealized depreciation included in the consolidated statement of operations attributable to Level 3 June 30, 2024 The following table shows a reconciliation of the beginning and ending balances for Level 3 six June 30, 2023 Six months ended June 30, 2023 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 686,458 $ 26,145 $ 2,416 $ 1,300 $ 716,319 Purchase of investments 87,543 — 10 — 87,553 Warrants and equity received and classified as Level 3 — 656 89 — 745 Principal payments received on investments (64,496 ) — — — (64,496 ) Payment-in-kind interest on investments 2,154 — — — 2,154 Proceeds from sale of investments (7,036 ) (1,470 ) — — (8,506 ) Net realized (loss) gain on investments (17,665 ) 1,146 (127 ) — (16,646 ) Unrealized depreciation included in earnings (2,448 ) (2,096 ) (1,118 ) — (5,662 ) Transfer out of Level 3 — — (111 ) — (111 ) Transfer out of debt investments (3,095 ) (5 ) 3,100 — — Other 1,894 — — — 1,894 Level 3 assets, end of period $ 683,309 $ 24,376 $ 4,259 $ 1,300 $ 713,244 During the six June 30, 2023 one 3. one 3 one 1 six June 30, 2023, 3. The change in unrealized depreciation included in the consolidated statement of operations attributable to Level 3 June 30, 2023 The Company discloses fair value information about financial instruments, whether or not not The fair value amounts have been measured as of the reporting date and have not may As of June 30, 2024 December 31, 2023 Market risk The Company assumes interest rate risk (the risk that general interest rate levels will change) as a result of its normal operations. As a result, the fair values of the Company’s financial instruments may may

Note 7 - Borrowings

Note 7 - Borrowings	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 7. The following table shows the Company’s borrowings as of June 30, 2024 December 31, 2023 June 30, 2024 December 31, 2023 Total Balance Unused Total Balance Unused Commitment Outstanding Commitment Commitment Outstanding Commitment (In thousands) Key Facility $ 150,000 $ — $ 150,000 $ 150,000 $ 70,000 $ 80,000 NYL Facility 250,000 181,000 69,000 250,000 181,000 69,000 Nuveen Facility 100,000 50,000 50,000 — — — 2022 Asset-Backed Notes 100,000 100,000 — 100,000 100,000 — 2027 Notes 57,500 57,500 — 57,500 57,500 — 2026 Notes 57,500 57,500 — 57,500 57,500 — Total before debt issuance costs 715,000 446,000 269,000 615,000 466,000 149,000 Unamortized debt issuance costs attributable to term borrowings — (3,256 ) — — (3,765 ) — Total borrowings outstanding, net $ 715,000 $ 442,744 $ 269,000 $ 615,000 $ 462,235 $ 149,000 As of June 30, 2024 1940 June 30, 2024 Credit Facilities Key Facility The Company entered into the Key Facility with Key effective November 4, 2013. June 20, 2024, may June 20, 2027 June 20, 2029 June 29, 2023, June 30, 2024 December 31, 2023. three June 30, 2024 2023 six June 30, 2024 2023 June 30, 2024 December 31, 2023 June 30, 2024 December 31, 2023 NYL Facility HFI entered into the NYL Facility with the NYL Noteholders for an aggregate purchase price of up to $100.0 million, with an accordion feature of up to $200.0 million at the mutual discretion and agreement of HSLFI and the NYL Noteholders. On June 1, 2018, three On May 24, 2023, May 24, 2023, 4.60% 3.50%, On May 6, 2024, June 2025 June 2030. May 6, 2024, There were $181.0 million in advances made by the NYL Noteholders as of June 30, 2024 December 31, 2023 June 30, 2024 2023, June 30, 2024 December 31, 2023 June 30, 2024 December 31, 2023 Under the terms of the NYL Facility, the Company is required to maintain a reserve cash balance, which may June 30, 2024 December 31, 2023 Nuveen Facility HFII entered into the Nuveen Facility with the Nuveen Noteholders for an aggregate purchase price of up to $100.0 million, with an accordion feature of up to $200.0 million at the mutual discretion and agreement of HFII and the Nuveen Noteholders. On June 21, 2024, H.15” may June 21, 2027 June 10, 2033. There were $50.0 million in advances made by the Nuveen Noteholders as of June 30, 2024. June 30, 2024 June 30, 2024, June 30, 2024, not December 31, 2023. Under the terms of the Nuveen Facility, the Company is required to maintain a reserve cash balance, which may June 30, 2024, Securitizations 2019 On August 13, 2019, 2019 2019 no August 13, 2019. 2019 November 22, 2023. The 2019 2019‑1 August 13, 2019, 2019 2019 July 15, 2021 September 15, 2027. As of December 31, 2023, 2019 2022 On November 9, 2022, 2022 2022 no November 9, 2022. The 2022 2022‑1 November 9, 2022, 2022 2022 November 15, 2024 November 15, 2030. As of June 30, 2024 December 31, 2023 2022 Under the terms of the 2022 2022 may 2022 June 30, 2024 December 31, 2023 Unsecured Notes 2026 On March 30, 2021, 2026 “2026 2026 2026 March 30, 2026 may March 30, 2023 2026 4.875% March 30, June 30, September 30 December 30 2026 2026 June 30, 2024 2026 2026 2027 On June 15, 2022, 2027 July 11, 2022, 30 “2027 2027 June 15, 2027 may June 15, 2024 2027 6.25% March 30, June 30, September 30 December 30 September 30, 2022. 2027 2027 June 30, 2024 2027 2027

Note 8 - Financial Instruments

Note 8 - Financial Instruments With Off-balance-sheet Risk	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Financial Instruments Disclosure [Text Block]	Note 8. In the normal course of business, the Company is party to financial instruments with off-balance-sheet risk to meet the financing needs of its borrowers. These financial instruments include commitments to extend credit and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the consolidated statement of assets and liabilities. The Company attempts to limit its credit risk by conducting extensive due diligence and obtaining collateral where appropriate. The balance of unfunded commitments to extend credit was $137.5 million and $180.5 million as of June 30, 2024 December 31, 2023 may not The following table provides the Company’s unfunded commitments by portfolio company as of June 30, 2024 December 31, 2023 June 30, 2024 December 31, 2023 Fair Value of Fair Value of Unfunded Unfunded Commitment Commitment Commitment Commitment Amount Liability Amount Liability (In thousands) (In thousands) Better Place Forests Co. $ 1,500 $ — $ — — BrightInsight, Inc. 10,000 132 15,500 $ 241 Britecore Holdings, Inc. 2,500 36 5,000 72 Candesant Biomedical Corporation 10,000 151 10,000 151 Ceribell, Inc. 21,000 120 — — Divergent Technologies, Inc. — — 11,250 118 Elligo Healthcare Research, Inc. 15,000 194 15,000 194 MicroTransponder, Inc. 22,500 — 22,500 — Mirantis, Inc. 15,000 136 15,000 136 Optoro, Inc. — — 6,250 — Parse Biosciences, Inc. 15,000 251 15,000 251 SafelyYou, Inc. 10,000 147 20,000 270 Sonex Health, Inc. — — 15,000 176 Standvast Holdings, LLC 5,000 175 Supply Network Visibility Holdings, LLC 5,000 17 10,000 35 Tallac Therapeutics, Inc. 5,000 115 10,000 229 Viken Detection Corporation — — 10,000 160 Total $ 137,500 $ 1,474 $ 180,500 $ 2,033 The table above also provides the fair value of the Company’s unfunded commitment liability as of June 30, 2024 December 31, 2023,

Note 9 - Concentrations of Cred

Note 9 - Concentrations of Credit Risk	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	Note 9. The Company’s debt investments consist primarily of loans to development-stage companies at various stages of development in the technology, life science, healthcare information and services and sustainability industries. Many of these companies may may The Company’s largest debt investments may five June 30, 2024 December 31, 2023 five June 30, 2024 December 31, 2023 No 10% June 30, 2024 December 31, 2023 five three June 30, 2024 2023 five three June 30, 2024 2023 five six June 30, 2024 2023 five six June 30, 2024 2023

Note 10 - Distributions

Note 10 - Distributions	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Equity [Text Block]	Note 10. The Company’s distributions are recorded on the declaration date. The following table summarizes the Company’s distribution activity for the six June 30, 2024 December 31, 2023 DRIP DRIP Date Amount Cash Shares Share Declared Record Date Payment Date Per Share Distribution Issued Value (In thousands, except share and per share data) Six Months Ended June 30, 2024 4/26/2024 8/16/2024 9/13/2024 $ 0.11 $ — — $ — 4/26/2024 7/17/2024 8/15/2024 0.11 — — — 4/26/2024 6/17/2024 7/16/2024 0.11 3,766 15,860 199 2/23/2024 5/17/2024 6/14/2024 0.11 3,701 16,686 203 2/23/2024 4/18/2024 5/15/2024 0.11 3,654 16,687 199 2/23/2024 3/19/2024 4/16/2024 0.05 1,625 7,598 85 2/23/2024 3/19/2024 4/16/2024 0.11 3,574 16,717 188 $ 0.71 $ 16,320 73,548 $ 874 Year Ended December 31, 2023 10/27/2023 2/16/2024 3/15/2024 $ 0.11 $ 3,463 18,257 $ 210 10/27/2023 1/18/2024 2/14/2024 0.11 3,462 15,873 210 10/27/2023 12/19/2023 1/16/2024 0.11 3,472 14,563 199 10/27/2023 11/17/2023 12/15/2023 0.05 1,574 7,137 93 7/28/2023 11/17/2023 12/15/2023 0.11 3,463 15,701 206 7/28/2023 10/18/2023 11/15/2023 0.11 3,493 14,022 173 7/28/2023 9/19/2023 10/16/2023 0.11 3,445 15,067 184 4/28/2023 8/17/2023 9/15/2023 0.11 3,458 8,665 106 4/28/2023 7/18/2023 8/15/2023 0.11 3,427 8,307 105 4/28/2023 6/16/2023 7/14/2023 0.11 3,434 7,424 96 2/23/2023 5/18/2023 6/14/2023 0.11 3,087 7,128 86 2/23/2023 4/18/2023 5/16/2023 0.11 3,068 6,705 84 2/23/2023 3/17/2023 4/14/2023 0.11 3,035 6,894 81 $ 1.37 $ 41,881 145,743 $ 1,833 On July 26, 2024, Monthly distributions Ex-Dividend Date Record Date Payment Date Distributions Declared November 15, 2024 November 15, 2024 December 13, 2024 $ 0.11 October 17, 2024 October 17, 2024 November 14, 2024 $ 0.11 September 16, 2024 September 16, 2024 October 16, 2024 $ 0.11 After paying distributions of $0.38 per share and earning net investment income of $0.36 per share for the quarter, the Company’s undistributed spillover income as of June 30, 2024 not

Note 11 - Financial Highlights

Note 11 - Financial Highlights	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Investment Company, Financial Highlights [Text Block]	Note 11. The following table shows financial highlights for the Company: Six months ended June 30, 2024 2023 (In thousands, except share and per share data) Per share data: Net asset value at beginning of period $ 9.71 $ 11.47 Net investment income 0.74 1.00 Realized gain (loss) 0.07 (0.58 ) Unrealized depreciation on investments (0.82 ) (0.23 ) Net increase in net assets resulting from operations (0.01 ) 0.19 Distributions declared (1) (0.71 ) (0.66 ) From net investment income (0.71 ) (0.66 ) From net realized gain on investments — — Return of capital — — Other (2) 0.13 0.07 Net asset value at end of period $ 9.12 $ 11.07 Per share market value, beginning of period $ 13.17 $ 11.60 Per share market value, end of period $ 12.04 $ 12.08 Total return based on a market value (3) (3.2 )% 9.8 % Shares outstanding at end of period 36,043,815 32,096,259 Ratios to average net assets: Expenses without incentive fee (4) 15.6 % 14.2 % Incentive fees (4) — 1.9 % Net expenses (4) 15.6 % 16.1 % Net investment income with incentive fee (4) 15.5 % 17.5 % Net assets at the end of the period $ 328,778 $ 355,419 Average net asset value $ 328,293 $ 331,850 Average debt per share $ 13.03 $ 15.11 Portfolio turnover ratio 5.4 % (5) 7.6 % (5) ( 1 Distributions are determined based on taxable income calculated in accordance with income tax regulations, which may ( 2 Includes the impact of the different share amounts as a result of calculating per share data based on the weighted average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date. The issuance of common stock on a per share basis reflects the incremental net asset value changes as a result of the issuance of common stock in the Company’s continuous public offering and pursuant to the Company’s distribution reinvestment plan. The issuance of common stock at an offering price, net of sales commissions and dealer manager fees, that is greater than the net asset value per share results in an increase in net asset value per share. ( 3 The total return equals the change in the ending market value over the beginning of period price per share plus distributions paid per share during the period, divided by the beginning price. ( 4 Annualized. ( 5 Calculated by dividing (A) the lesser of purchases or sales of portfolio securities for the fiscal year by (B) the monthly average of the value of portfolio securities owned by the Company during the fiscal year, with certain securities excluded from the numerator and denominator pursuant to applicable federal securities laws.

Note 12 - Subsequent Events

Note 12 - Subsequent Events	6 Months Ended
	Jun. 30, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	Note 12. On July 10, 2024, On July 11, 2024, On July 12, 2024, On July 24, 2024, June 21, 2024 June 28, 2024 June 30, 2024 On July 30, 2024,

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]		5: Rule 10b5 1 During the fiscal quarter ended June 30, 2024, none 10b5 1 10b5 1
Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of consolidation As required under GAAP and Regulation S- X, Assets related to transactions that do not 860, Transfers and Servicing 2019‑1 2022 1 not
Use of Estimates, Policy [Policy Text Block]	Use of estimates In preparing the consolidated financial statements in accordance with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the balance sheet and income and expenses for the period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the valuation of investments.
Fair Value Measurement, Policy [Policy Text Block]	Fair value The Company records all of its investments at fair value in accordance with relevant GAAP, which establishes a framework used to measure fair value and requires disclosures for fair value measurements. The Company has categorized its investments carried at fair value, based on the priority of the valuation technique, into a three 6. not The availability of observable inputs can vary depending on the financial instrument and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new, whether the product is traded on an active exchange or in the secondary market and the current market conditions. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for financial instruments classified as Level 3. See Note 6
Segment Reporting, Policy [Policy Text Block]	Segments The Company has determined that it has a single reporting segment and operating unit structure. The Company lends to and invests in portfolio companies in various technology, life science, healthcare information and services and sustainability industries. The Company separately evaluates the performance of each of its lending and investment relationships. However, because each of these debt investments and investment relationships has similar business and economic characteristics, they have been aggregated into a single lending and investment segment.
Investment, Policy [Policy Text Block]	Investments Investments are recorded at fair value. Pursuant to the amended SEC Rule 2a 5 1940 July 29, 2022, Interest on debt investments is accrued and included in income based on contractual rates applied to principal amounts outstanding. Interest income is determined using a method that results in a level rate of return on principal amounts outstanding. Generally, when a debt investment becomes 90 not may may June 30, 2024 six December 31, 2023 four three six June 30, 2024 2023, not The Company has a limited number of debt investments in its portfolio that contain a PIK provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. For the three June 30, 2024 2023, 3.4%, six June 30, 2024 2023, 3.8%, not three June 30, 2024, six June 30, 2024 one six June 30, 2024 three six June 30, 2023, three three six June 30, 2023, The Company receives a variety of fees from borrowers in the ordinary course of conducting its business, including advisory fees, commitment fees, amendment fees, non-utilization fees, success fees and prepayment fees. In a limited number of cases, the Company may Certain debt investment agreements also require the borrower to make an ETP, that is accrued into interest receivable and taken into income over the life of the debt investment to the extent such amounts are expected to be collected. The Company will generally cease accruing the income if there is insufficient value to support the accrual or the Company does not not three June 30, 2024 2023 not six June 30, 2024 2023 In connection with substantially all lending arrangements, the Company receives warrants to purchase shares of stock from the borrower. The warrants are recorded as assets at estimated fair value on the grant date using the Black-Scholes valuation model. The warrants are considered loan fees and are recorded as unearned income on the grant date. The unearned income is recognized as interest income over the contractual life of the related debt investment in accordance with the Company’s income recognition policy. Subsequent to debt investment origination, the fair value of the warrants is determined using the Black-Scholes valuation model. Any adjustment to fair value is recorded through earnings as net unrealized appreciation or depreciation on investments. Gains and losses from the disposition of the warrants or stock acquired from the exercise of warrants are recognized as realized gains and losses on investments. Realized gains or losses on the sale of investments, or upon the determination that an investment balance, or portion thereof, is not
Debt, Policy [Policy Text Block]	Debt issuance costs Debt issuance costs are fees and other direct incremental costs incurred by the Company in obtaining debt financing from its lenders and issuing debt securities. The unamortized balance of debt issuance costs as of June 30, 2024 December 31, 2023 June 30, 2024 December 31, 2023 three June 30, 2024 2023 six June 30, 2024 2023
Income Tax, Policy [Policy Text Block]	Income taxes As a BDC, the Company has elected to be treated as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to qualify as a RIC and to avoid the imposition of corporate-level income tax on the portion of its taxable income distributed to stockholders, among other things, the Company is required to meet certain source of income and asset diversification requirements and to timely distribute dividends out of assets legally available for distribution to its stockholders of an amount generally at least equal to 90% no 946, Financial Services Investment Companies no Depending on the level of taxable income earned in a tax year, the Company may three June 30, 2024 2023 six June 30, 2024 2023 The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than- not” 740, Income Taxes 946. not not June 30, 2024 December 31, 2023 2024, 2023, 2022 2021
Distributions [Policy Text Block]	Distributions Distributions to common stockholders are recorded on the declaration date. The amount to be paid out as distributions is determined by the Board. Net realized capital gains, if any, may may The Company has adopted a dividend reinvestment plan that provides for reinvestment of cash distributions on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Board declares a cash distribution, then stockholders who have not may
Stockholders' Equity, Policy [Policy Text Block]	Stockholders Equity On August 2, 2021, “2021 2021 may On September 22, 2023, 2021 “2023 2021 2023 may may 415 During the three June 30, 2024 2023 During the three June 30, 2023 2021 During the six June 30, 2024 2023 During the six June 30, 2023 2021 The Company generally uses net proceeds from these offerings to make investments, to pay down liabilities and for general corporate purposes. As of June 30, 2024 2023 On June 2, 2023,
Stock Repurchase Program [Policy Text Block]	Stock Repurchase Program On April 26, 2024, may, not 10b‑18 1934, 1940 June 30, 2025 $5.0 three six June 30, 2024 2023 not June 30, 2024
Transfers and Servicing of Financial Assets, Policy [Policy Text Block]	Transfers of financial assets Assets related to transactions that do not 860, Transfers and Servicing not Transfers of financial assets are accounted for as sales when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when ( 1 2 3 not
New Accounting Pronouncements, Policy [Policy Text Block]	Recently issued accounting pronouncement In November 2023, 2023 07, 280 2023 07” 2023 07 may one December 15, 2023, December 15, 2024, Recently adopted accounting pronouncement In June 2022, No. 2022 03, 2022 03” 2022 03 2022 03 December 15, 2023, 2022 03 not

Consolidated Schedule of Inve_2

Consolidated Schedule of Investments (Unaudited) (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Investment [Table Text Block]	Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Investments — 188.4 Non-Affiliate Debt Investments — 178.8 Non-Affiliate Debt Investments — Life Science — 71.5 Castle Creek Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 4,583 4,570 4,570 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 4,583 4,570 4,570 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 2,750 2,742 2,742 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 4,583 4,570 4,570 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 4,583 4,570 4,570 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 2,750 2,742 2,742 Emalex Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % November 1, 2025 5,000 4,964 4,964 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % May 1, 2026 5,000 4,967 4,967 Greenlight Biosciences, Inc. (2)(12) Biotechnology Term Loan 14.25 % Prime 5.75 % 9.00 % - 3.00 % July 1, 2025 2,167 2,110 2,110 Term Loan 14.25 % Prime 5.75 % 9.00 % - 3.00 % July 1, 2025 1,083 1,055 1,055 KSQ Therapeutics, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.50 % May 1, 2027 6,250 6,210 6,210 Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.50 % May 1, 2027 6,250 6,210 6,210 Native Microbials, Inc (2)(12) Biotechnology Term Loan 13.75 % Prime 5.25 % 8.50 % - 5.00 % November 1, 2026 3,625 3,605 3,605 Term Loan 13.75 % Prime 5.25 % 8.50 % - 5.00 % November 1, 2026 2,417 2,403 2,403 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 10,000 9,937 9,937 Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 3,750 3,726 3,726 Term Loan 14.25 % Prime 5.75 % 9.75 % - 3.75 % September 1, 2026 3,750 3,726 3,726 Provivi, Inc. (2)(12) Biotechnology Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.30 % January 1, 2027 3,482 3,399 3,206 Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.30 % January 1, 2027 3,482 3,399 3,206 Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.31 % January 1, 2027 1,741 1,696 1,598 Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.31 % January 1, 2027 1,741 1,696 1,598 Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.31 % January 1, 2027 1,741 1,695 1,597 Term Loan 13.86 % Prime 5.36 % 9.50 % - 4.31 % January 1, 2027 1,741 1,695 1,597 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % October 1, 2025 3,238 3,197 3,197 Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % October 1, 2025 1,619 1,599 1,599 Tallac Therapeutics, Inc. (2)(12) Biotechnology Term Loan 12.75 % Prime 4.25 % 12.25 % - 4.00 % August 1, 2027 2,500 2,350 2,350 Term Loan 12.75 % Prime 4.25 % 12.25 % - 4.00 % August 1, 2027 2,500 2,465 2,465 Aerobiotix, LLC (2)(12) Medical Device Term Loan 9.00 % Fixed - - - 18.00 % April 1, 2028 2,500 2,474 2,354 Term Loan 9.00 % Fixed - - - 18.00 % April 1, 2028 2,500 2,474 2,354 Term Loan 9.00 % Fixed - - - 18.00 % April 1, 2028 200 187 178 Candesant Biomedical, Inc. (2)(12) Medical Device Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 5,000 4,770 4,770 Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 2,500 2,460 2,460 Term Loan 12.00 % Prime 3.50 % 11.50 % - 5.00 % September 1, 2027 2,500 2,460 2,460 Ceribell, Inc. (2)(12) Medical Device Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 5,000 4,814 4,814 Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 5,000 4,935 4,935 Term Loan 11.25 % Prime 2.75 % 9.25 % - 4.00 % March 1, 2029 4,000 3,948 3,948 Cognoa, Inc. (2)(12) Medical Device Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % August 1, 2026 4,028 3,993 3,993 Term Loan 14.00 % Prime 5.50 % 8.75 % - 6.00 % August 1, 2026 2,014 1,997 1,997 Conventus Orthopaedics, Inc. (2)(12) Medical Device Term Loan 13.32 % Prime 4.82 % 9.25 % - 10.36 % July 1, 2025 3,766 3,729 3,729 Term Loan 13.32 % Prime 4.82 % 9.25 % - 10.36 % July 1, 2025 3,766 3,729 3,729 CSA Medical, Inc. (2)(12) Medical Device Term Loan 13.59 % Prime 5.09 % 10.00 % - 5.00 % January 1, 2024 391 391 391 Term Loan 13.59 % Prime 5.09 % 10.00 % - 5.00 % March 1, 2024 533 533 533 MicroTransponder, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % - 3.50 % January 1, 2029 3,750 3,694 3,694 Term Loan 12.25 % Prime 3.75 % 12.25 % - 3.50 % January 1, 2029 3,750 3,694 3,694 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Scientia Vascular, Inc. (2)(12) Medical Device Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.00 % January 1, 2027 3,750 3,730 3,730 Term Loan 13.25 % Prime 4.75 % 8.50 % - 5.00 % January 1, 2027 3,750 3,729 3,729 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % January 1, 2027 5,000 4,953 4,953 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % January 1, 2027 5,000 4,918 4,918 Sonex Health, Inc. (2)(12) Medical Device Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 2,500 2,477 2,477 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 2,500 2,477 2,477 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 5,000 4,953 4,953 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % September 1, 2027 5,000 4,953 4,953 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,708 3,708 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,708 3,708 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,708 3,708 Term Loan 12.00 % Prime 3.50 % 11.75 % - 8.00 % April 1, 2028 3,750 3,708 3,708 Spineology, Inc. (2)(12) Medical Device Term Loan 15.50 % Prime 7.00 % 10.25 % - 1.00 % October 1, 2025 5,000 4,972 4,972 Term Loan 15.50 % Prime 7.00 % 10.25 % - 1.00 % April 1, 2026 2,500 2,488 2,488 Swift Health Systems Inc. (2)(12)(20) Medical Device Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,473 876 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,473 876 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,462 874 Term Loan 13.75 % Prime 5.25 % 9.00 % - 5.00 % July 1, 2027 3,500 3,462 874 Vero Biotech, Inc. (2)(12) Medical Device Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 15,000 14,704 14,704 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 10,000 9,803 9,803 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 5,000 4,902 4,902 Term Loan 12.25 % Prime 3.75 % 12.25 % - 4.00 % January 1, 2029 2,500 2,451 2,451 Total Non-Affiliate Debt Investments — Life Science 246,362 234,965 Non-Affiliate Debt Investments — Sustainability — 21.0 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 4.33 % December 1, 2026 3,750 3,705 3,705 Term Loan 15.25 % Prime 6.75 % 10.00 % - 4.33 % December 1, 2026 3,750 3,705 3,705 Nexii Building Solutions Inc. (2)(12)(13)(14)(18) Other Sustainability Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,871 8,222 2,189 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,871 7,996 2,129 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 8,871 7,996 2,129 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 5,914 5,325 1,418 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - 2.50 % March 31, 2024 5,914 5,325 1,418 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 773 705 188 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 616 561 149 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 307 280 75 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 305 278 74 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 183 166 44 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 842 767 204 Term Loan 15.50 % (11) Prime 7.00 % 10.25 % - - March 31, 2024 1,145 1,050 279 Term Loan 15.50 % (11) Fixed - - - - August 30, 2024 422 384 102 Term Loan 15.50 % (11) Fixed - - - - August 30, 2024 557 485 129 Term Loan 15.50 % (11) Fixed - - - - August 30, 2024 414 392 104 Term Loan 15.50 % (11) Fixed - - - - August 30, 2024 491 471 125 Term Loan 15.50 % (11) Fixed - - - - August 30, 2024 490 486 129 Soli Organic, Inc. (2)(12) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % April 1, 2026 5,000 4,922 4,922 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % April 1, 2026 2,500 2,461 2,461 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % May 1, 2026 5,000 4,924 4,924 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.75 % May 1, 2026 2,500 2,462 2,462 Term Loan 14.00 % Prime 5.50 % 11.75 % - 2.75 % December 1, 2026 5,000 4,936 4,936 Term Loan 14.00 % Prime 5.50 % 11.75 % - 2.75 % December 1, 2026 2,500 2,468 2,468 Temperpack Technologies, Inc. (2)(12) Other Sustainability Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,700 3,700 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,700 3,700 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 7,500 7,393 7,393 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,697 3,697 Term Loan 15.25 % Prime 6.75 % 10.00 % - 2.50 % April 1, 2028 3,750 3,697 3,697 Term Loan 14.50 % Prime 6.00 % 10.00 % - 2.00 % January 1, 2029 4,500 4,449 4,449 Term Loan 14.50 % Prime 6.00 % 10.00 % - 2.00 % January 1, 2029 2,000 1,977 1,977 Total Non-Affiliate Debt Investments — Sustainability 99,085 69,081 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Debt Investments — Technology — 66.6 Axiom Space, Inc. (2)(12) Communications Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,000 4,975 4,975 Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,000 4,975 4,975 Term Loan 14.50 % Prime 6.00 % 9.25 % - 2.50 % June 1, 2026 5,000 4,975 4,975 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Term Loan 15.75 % Prime 7.25 % 10.50 % - 3.00 % March 1, 2027 2,033 1,975 1,975 Clara Foods Co. (2)(12) Consumer-related Technologies Term Loan 14.25 % Prime 5.75 % 9.00 % - 5.50 % August 1, 2025 1,083 1,076 1,076 Term Loan 14.25 % Prime 5.75 % 9.00 % - 5.50 % August 1, 2025 1,083 1,076 1,076 Havenly, Inc. (2)(12) Consumer-related Technologies Term Loan 13.50 % Prime 5.00 % 5.00 % - 10.40 % March 1, 2027 2,000 1,367 1,367 Term Loan 13.50 % Prime 5.00 % 5.00 % - 10.40 % March 1, 2027 3,000 2,354 2,354 Term Loan 12.00 % Prime 3.50 % 10.50 % - 7.78 % February 1, 2028 2,813 2,813 2,813 Term Loan 12.00 % Prime 3.50 % 10.50 % - 7.78 % February 1, 2028 2,813 2,813 2,813 Lyrical Foods, Inc. (2)(12) Consumer-related Technologies Term Loan 12.00 % Prime 3.50 % 9.00 % - 1.00 % September 1, 2027 2,500 2,591 2,228 MyForest Foods Co. (2)(12) Consumer-related Technologies Term Loan 15.25 % Prime 6.75 % 10.00 % - 3.00 % October 1, 2025 2,667 2,657 2,657 Term Loan 15.25 % Prime 6.75 % 10.00 % - 3.00 % October 1, 2025 1,333 1,328 1,328 NextCar Holding Company, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 5,780 5,572 3,331 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,890 2,786 1,665 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,312 2,229 1,332 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,890 2,786 1,665 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 3,468 3,343 1,999 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,890 2,786 1,665 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 5,780 5,572 3,331 Term Loan 14.25 % (11) Prime 5.75 % 9.00 % - 5.25 % October 31, 2023 2,890 2,786 1,665 Optoro, Inc. (2)(12) Consumer-related Technologies Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % August 1, 2027 2,500 2,432 2,432 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % July 1, 2028 1,875 1,796 1,796 Standvast Holdings, LLC (2)(12) Consumer-related Technologies Term Loan 12.75 % Prime 4.25 % 12.75 % - 3.00 % June 1, 2028 2,500 2,240 2,240 Term Loan 12.75 % Prime 4.25 % 12.75 % - 3.00 % June 1, 2028 2,500 2,415 2,415 Unagi, Inc. (2)(12)(13) Consumer-related Technologies Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 1,306 1,086 570 Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 653 543 285 Term Loan 16.25 % (11) Prime 7.75 % 11.00 % - - May 1, 2027 653 543 285 Liqid, Inc. (2)(12) Networking Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 333 329 329 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 333 329 329 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 167 164 164 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 167 164 164 Term Loan 14.75 % Prime 6.25 % 9.50 % - 4.00 % September 1, 2024 167 161 161 BriteCore Holdings, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 5,000 4,902 4,902 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,469 2,469 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,469 2,469 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % October 1, 2028 2,500 2,469 2,469 Term Loan 14.00 % Prime 5.50 % 14.00 % - 3.00 % April 1, 2029 2,500 2,466 2,466 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Dropoff, Inc. (2)(12) Software Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % April 1, 2026 6,777 6,695 6,093 Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % April 1, 2026 6,256 6,180 5,624 Term Loan 15.00 % (19) Prime 6.50 % 9.75 % - 3.50 % August 1, 2026 2,607 2,576 2,345 Kodiak Robotics, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 10,000 9,929 9,929 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 10,000 9,929 9,929 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 5,000 4,964 4,964 Term Loan 14.00 % Prime 5.50 % 10.25 % - 4.00 % April 1, 2026 5,000 4,964 4,964 Lemongrass Holdings, Inc. (2)(12) Software Term Loan 15.00 % Prime 6.50 % 9.75 % - 2.50 % March 1, 2026 4,375 4,358 4,358 Term Loan 15.00 % Prime 6.50 % 9.75 % - 2.50 % March 1, 2026 2,187 2,179 2,179 Lytics, Inc. (2)(12) Software Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % November 1, 2026 2,500 2,476 2,476 Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % December 1, 2026 1,250 1,240 1,240 Term Loan 14.50 % Prime 6.00 % 14.25 % - 5.00 % April 1, 2027 1,000 995 995 Mirantis, Inc. (2)(12) Software Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,788 4,788 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,924 4,924 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,924 4,924 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2028 5,000 4,924 4,924 Noodle Partners, Inc. (2)(12) Software Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 10,000 9,905 9,905 Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 5,000 4,953 4,953 Term Loan 13.50 % Prime 5.00 % 12.00 % - 3.00 % March 1, 2027 5,000 4,953 4,953 Reputation Institute, Inc. (2)(12) Software Term Loan 15.75 % Prime 7.25 % 10.50 % - 3.00 % August 1, 2025 2,583 2,542 2,542 Slingshot Aerospace, Inc. (2)(12) Software Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,971 4,971 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,971 4,971 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,971 4,971 Term Loan 14.25 % Prime 5.75 % 9.75 % - 5.00 % August 1, 2026 5,000 4,971 4,971 Supply Network Visibility Holdings LLC (2)(12) Software Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 2,500 2,476 2,476 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 3,500 3,490 3,490 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 2,500 2,493 2,493 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % June 1, 2028 1,500 1,496 1,496 Term Loan 12.75 % Prime 4.25 % 12.00 % - 2.50 % July 1, 2029 5,000 4,983 4,983 Viken Detection Corporation (2)(12) Software Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 5,000 4,945 4,945 Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 2,500 2,472 2,472 Term Loan 12.50 % Prime 4.00 % 11.75 % - 3.50 % June 1, 2027 2,500 2,472 2,472 Total Non-Affiliate Debt Investments — Technology 232,921 218,930 Non-Affiliate Debt Investments — Healthcare information and services — 19.7 Hound Labs Inc. (2) (12)(20) Diagnostics Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 1,607 1,596 1,124 Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 1,607 1,596 1,124 Term Loan 14.50 % Prime 6.00 % 9.25 % - 3.50 % June 1, 2026 3,214 3,193 2,248 Parse Biosciences, Inc. (2)(12) Diagnostics Term Loan 11.75 % Prime 3.25 % 11.50 % - 5.00 % January 1, 2028 5,000 4,645 4,645 Term Loan 11.75 % Prime 3.25 % 11.50 % - 5.00 % January 1, 2028 5,000 4,897 4,897 BrightInsight, Inc. (2)(12) Software Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 7,000 6,807 6,807 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 3,500 3,470 3,470 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % August 1, 2027 3,500 3,470 3,470 Term Loan 14.00 % Prime 5.50 % 9.50 % - 3.00 % April 1, 2028 2,750 2,715 2,715 Elligo Health Research, Inc. (2)(12) Software Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 10,000 9,675 9,675 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,935 4,935 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,935 4,935 Term Loan 12.00 % Prime 3.50 % 11.75 % - 4.00 % October 1, 2027 5,000 4,935 4,935 SafelyYou, Inc. (2)(12) Software Term Loan 11.75 % Prime 3.25 % 11.00 % - 5.00 % June 1, 2027 5,000 4,784 4,784 Term Loan 11.75 % Prime 3.25 % 11.00 % - 5.00 % June 1, 2027 5,000 4,931 4,931 Total Non-Affiliate Debt Investments — Healthcare information and services 66,584 64,695 Total Non- Affiliate Debt Investments 644,952 587,671 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrant Investments — 6.5 Non-Affiliate Warrants — Life Science — 1.9 Avalo Therapeutics, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 117 311 — Castle Creek Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 7,404 214 225 Emalex Biosciences, Inc. (2)(12) Biotechnology Preferred Stock Warrant 110,402 176 136 Imunon, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 19,671 64 — KSQ Therapeutics, Inc. (2) (12) Biotechnology Preferred Stock Warrant 48,076 49 55 Mustang Bio, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 16,611 146 — Native Microbials, Inc (2)(12) Biotechnology Preferred Stock Warrant 103,679 64 64 PDS Biotechnology Corporation (2)(5)(12) Biotechnology Common Stock Warrant 299,848 160 157 Provivi, Inc. (2)(12) Biotechnology Common Stock Warrant 175,098 278 — Provivi, Inc. (2)(12) Biotechnology Preferred Stock Warrant 709,981 312 229 Stealth Biotherapeutics Inc. (2)(12) Biotechnology Common Stock Warrant 318,181 265 117 Tallac Therapeutics, Inc. (2)(12) Biotechnology Preferred Stock Warrant 1,600,002 195 173 Xeris Pharmaceuticals, Inc. (2)(5)(12) Biotechnology Common Stock Warrant 126,000 73 29 AccuVein Inc. (2)(12) Medical Device Common Stock Warrant 271 7 — Aerin Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 1,818,183 66 1,036 Aerobiotix, LLC (2)(12) Medical Device Preferred Stock Warrant 8,800 48 10 Canary Medical Inc. (2)(12) Medical Device Preferred Stock Warrant 12,153 86 1,280 Candesant Biomedical, Inc. (2)(12) Medical Device Preferred Stock Warrant 93,336 152 139 Ceribell, Inc. (2)(12) Medical Device Preferred Stock Warrant 219,866 139 237 Cognoa, Inc. (2)(12) Medical Device Common Stock Warrant 30,585 — 1 Cognoa, Inc. (2)(12) Medical Device Preferred Stock Warrant 4,635,992 162 213 Conventus Orthopaedics, Inc. (2)(12) Medical Device Preferred Stock Warrant 9,313,541 256 208 CSA Medical, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,839,739 174 135 CVRx, Inc. (2)(5)(12) Medical Device Common Stock Warrant 47,410 76 142 Infobionic, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,010,424 124 50 Magnolia Medical Technologies, Inc. (2)(12) Medical Device Preferred Stock Warrant 809,931 194 381 Meditrina, Inc. (2)(12) Medical Device Preferred Stock Warrant 233,993 83 41 MicroTransponder, Inc. (2)(12) Medical Device Preferred Stock Warrant 103,172 47 49 Scientia Vascular, Inc (2)(12) Medical Device Preferred Stock Warrant 34,410 103 341 Sonex Health, Inc. (2)(12) Medical Device Preferred Stock Warrant 2,637,133 275 278 VERO Biotech LLC (2)(12) Medical Device Preferred Stock Warrant 4,109 432 355 Spineology, Inc. (2)(12) Medical Device Preferred Stock Warrant 128,848 21 21 Swift Health Systems Inc. (2)(12) Medical Device Preferred Stock Warrant 135,484 71 — Total Non-Affiliate Warrants — Life Science 4,823 6,102 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrants — Sustainability — 0.2 New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(15) Other Sustainability Preferred Stock Warrant 400,000 81 74 LiquiGlide, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 61,359 39 30 Nexii Building Solutions, Inc. (2)(12)(14)(18) Other Sustainability Common Stock Warrant 215,171 490 — Soli Organic, Inc. (2)(12) Other Sustainability Common Stock Warrant 296 19 19 Soli Organic, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 1,076 382 516 Temperpack Technologies, Inc. (2)(12) Other Sustainability Preferred Stock Warrant 49,693 178 89 Total Non-Affiliate Warrants — Sustainability 1,189 728 Non-Affiliate Warrants — Technology — 4.0 Axiom Space Holdings, Inc. (2)(12) Communications Common Stock Warrant 1,991 46 62 Intelepeer Holdings, Inc. (2)(12) Communications Preferred Stock Warrant 2,936,535 138 2,838 PebblePost, Inc. (2)(12) Communications Preferred Stock Warrant 598,850 92 132 Alula Holdings, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 20,000 93 8 CAMP NYC, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 112,356 36 41 Clara Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 46,745 30 125 CZV, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 65,569 79 74 Divergent Technologies, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 53,264 454 622 Havenly, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 1,446,429 3,178 2,490 MyForest Foods Co. (2)(12) Consumer-related Technologies Preferred Stock Warrant 250 28 27 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Common Stock Warrant 12,618 188 — NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 1,224,752 9 — Optoro, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 11,550 181 145 Primary Kids, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 553,778 57 594 Quip NYC Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 6,191 325 — Standvast Holdings, LLC (2)(12) Consumer-related Technologies Preferred Stock Warrant 1,225,492 275 273 Unagi, Inc. (2)(12) Consumer-related Technologies Preferred Stock Warrant 171,081 32 — Updater, Inc.(2)(12) Consumer-related Technologies Preferred Stock Warrant 108,333 34 27 CPG Beyond, Inc. (2)(12) Data Storage Preferred Stock Warrant 500,000 242 300 Silk, Inc. (2)(12) Data Storage Preferred Stock Warrant 394,110 175 128 Global Worldwide LLC (2)(12) Internet and Media Preferred Stock Warrant 245,810 75 62 Rocket Lawyer Incorporated (2)(12) Internet and Media Preferred Stock Warrant 261,721 92 324 Skillshare, Inc. (2)(12) Internet and Media Preferred Stock Warrant 139,074 162 817 Liqid, Inc. (2)(12) Networking Preferred Stock Warrant 344,102 364 162 Halio, Inc. (2)(12) Power Management Common Stock Warrant 38,241,466 1,585 2,700 Avalanche Technology, Inc. (2)(12) Semiconductors Preferred Stock Warrant 5,938 45 — BriteCore Holdings, Inc. (2)(12) Software Preferred Stock Warrant 161,215 98 182 Dropoff, Inc. (2)(12) Software Common Stock Warrant 516,732 455 63 E La Carte, Inc. (2)(5)(12) Software Common Stock Warrant 147,361 60 — Everstream Holdings, LLC (2)(12) Software Preferred Stock Warrant 350,000 70 65 Kodiak Robotics, Inc. (2)(12) Software Preferred Stock Warrant 639,918 273 7 Lemongrass Holdings, Inc. (2)(12) Software Preferred Stock Warrant 101,308 34 138 Lotame Solutions, Inc. (2)(12) Software Preferred Stock Warrant 71,305 18 42 Lytics, Inc. (2)(12) Software Preferred Stock Warrant 85,543 43 — Mirantis, Inc. (2)(12) Software Common Stock Warrant 948,275 223 255 Noodle Partners, Inc. (2)(12) Software Preferred Stock Warrant 84,037 116 — Reputation Institute, Inc. (2)(12) Software Preferred Stock Warrant 4,104 63 94 Revinate Holdings, Inc. (2)(12) Software Preferred Stock Warrant 682,034 44 94 SIGNiX, Inc. (12) Software Preferred Stock Warrant 186,235 225 — Slingshot Aerospace, Inc. (2)(12) Software Preferred Stock Warrant 309,208 123 72 Supply Network Visibility Holdings LLC (2)(12) Software Preferred Stock Warrant 682 65 78 Topia Mobility, Inc. (2)(12) Software Preferred Stock Warrant 3,049,607 138 — Viken Detection Corporation (2)(12) Software Preferred Stock Warrant 345,443 120 212 xAd, Inc. (2)(12) Software Preferred Stock Warrant 4,343,348 177 8 Total Non-Affiliate Warrants — Technology 10,360 13,261 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-Affiliate Warrants — Healthcare information and services — 0.4 Hound Labs, Inc (2)(12) Diagnostics Preferred Stock Warrant 171,370 46 — Parse Biosciences, Inc. (2)(12) Diagnostics Common Stock Warrant 32,244 71 70 Parse Biosciences, Inc. (2)(12) Diagnostics Preferred Stock Warrant 184,253 166 173 Kate Farms, Inc. (2)(12) Other Healthcare Preferred Stock Warrant 82,965 102 979 BrightInsight, Inc. (2)(12) Software Preferred Stock Warrant 85,066 167 — Elligo Health Research, Inc. (2)(12) Software Preferred Stock Warrant 652,250 191 95 Medsphere Systems Corporation (2)(12) Software Preferred Stock Warrant 7,097,792 60 — SafelyYou, Inc. (2)(12) Software Preferred Stock Warrant 150,353 163 51 Total Non-Affiliate Warrants — Healthcare information and services 966 1,368 Total Non-Affiliate Warrants 17,338 21,459 Non-Affiliate Other Investments — Life Science — 1.0 Lumithera, Inc. (12) Medical Device Royalty Agreement 1,146 100 Robin Healthcare, Inc. (2)(12) Medical Device Royalty Agreement 7,227 3,247 ZetrOZ, Inc. (12) Medical Device Royalty Agreement — — Total Non-Affiliate Other Investments 8,373 3,347 Non-Affiliate Equity — 2.1 Cadrenal Therapeutics, Inc. (5) Biotechnology Common Stock 600,000 — 283 Castle Creek Biosciences, Inc. (12) Biotechnology Common Stock 1,162 250 250 Emalex Biosciences, Inc. (12) Biotechnology Common Stock 32,831 355 355 Axiom Space, Inc. (12) Communications Preferred Stock 1,810 261 306 Caastle, Inc. (2)(12) Consumer-related Technologies Preferred Stock 242,180 2,681 2,681 Getaround, Inc. (2)(5) Consumer-related Technologies Common Stock 87,082 253 12 NextCar Holding Company, Inc. (2)(12) Consumer-related Technologies Preferred Stock 2,688,971 89 — SnagAJob.com, Inc. (12) Consumer-related Technologies Common Stock 82,974 10 81 Lumithera, Inc. (12) Medical Device Common Stock 392,651 2,000 1,700 Tigo Energy, Inc. (5) Other Sustainability Common Stock 5,205 111 10 Decisyon, Inc. (12) Software Preferred Stock 280,000 2,800 1,281 Lotame, Inc. (12) Software Preferred Stock 66,127 4 193 Total Non-Affiliate Equity 8,814 7,152 Total Non-Affiliate Portfolio Investment Assets $ 679,477 $ 619,629 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Controlled Affiliate Investments — 4.8 Non-Controlled Affiliate Debt Investments — Life Sciences — 4.8 Evelo Biosciences, Inc. (2)(5)(12)(13) Biotechnology Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 5,898 5,228 3,503 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 8,847 7,972 5,340 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 3,539 3,137 2,101 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 3,539 3,137 2,101 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 2,359 2,091 1,401 Term Loan 12.75 % (11) Prime 4.25 % 11.00 % - 4.25 % January 1, 2028 2,359 2,091 1,401 Total Non-Controlled Affiliate Debt Investments 23,656 15,847 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Non-controlled Affiliate Equity — Life Sciences — 0.0 Aulea Medical, Inc. (12)(16) Medical Device Common Stock 660,537 — — Evelo Biosciences, Inc. (5)(12) Biotechnology Common Stock 2,164,502 5,000 — Total Non-Controlled Affiliate Equity 5,000 — Non-controlled Affiliate Warrants — Life Sciences — 0.0 Evelo Biosciences, Inc. (2)(5)(12) Biotechnology Common Stock 23,196 125 — Total Non-Controlled Affiliate Warrants 125 — Total Non-Controlled Affiliate Portfolio Investment Assets $ 28,781 $ 15,847 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Controlled Affiliate Investments — 3.5 Controlled Affiliate Debt Investments — Technology — 1.7 Better Place Forests Co. (12) Consumer-related Technologies Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - 2.78 % August 1, 2029 3,772 3,814 3,166 Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - 2.78 % August 1, 2029 1,886 1,867 1,549 Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - - August 1, 2025 505 505 420 Term Loan 12.25 % (11) Prime 3.75 % 12.00 % - - August 1, 2025 501 501 415 Total Controlled Affiliate Debt Investments 6,687 5,550 Cost of Fair Portfolio Company (1)(3) Sector Type of Investment (7) Number of Shares Investments (6)(9) Value (9) Controlled Affiliate Equity — Technology — 0.0 Better Place Forests Co. (12) Consumer-related Technologies Common Stock 2,278,272 2,060 — Better Place Forests Co. (12) Consumer-related Technologies Preferred Stock 5,350,142 2,500 — Total Controlled Affiliate Equity 4,560 — Controlled Affiliate Other Investments — Life Sciences — 1.8 HIMV LLC (12)(17) Biotechnology Other Investment 5,925 5,836 Total Controlled Affiliate Other 5,925 5,836 Total Controlled Affiliate Portfolio Investment Assets $ 17,172 $ 11,386 Total Portfolio Investment Assets — 196.7 $ 725,430 $ 646,862 Short Term Investments - Unrestricted Investments - 9.8 US Bank Money Market Deposit Account 32,320 32,320 Total Short Term Investments - Unrestricted Investments $ 32,320 $ 32,320 Short Term Investments - Restricted Investments - 1.0 US Bank Money Market Deposit Account 3,221 3,221 Total Short Term Investments - Restricted Investments $ 3,221 $ 3,221 Portfolio Company (1)(3) Sector Type of Investment (7) Cash Rate (4) Index Margin Floor Ceiling ETP (10) Maturity Date Principal Amount Cost of Investments (6)(9) Fair Value (9) Non-Affiliate Investments — 214.2 Non-Affiliate Debt Investments — 205.0 Non-Affiliate Debt Investments — Life Science — 75.6 Castle Creek Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 $ 5,000 $ 4,979 $ 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,979 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,000 2,987 2,987 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,979 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 5,000 4,979 4,979 Term Loan 13.25 % Prime 4.75 % 9.55 % 13.50 % 5.50 % May 1, 2026 3,000 2,987 2,987 Emalex Biosciences, Inc. (2)(12) Biotechnology Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % June 1, 2024 1,414 1,410 1,410 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % June 1, 2024 1,414 1,410 1,410 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % November 1, 2025 5,000 4,950 4,950 Term Loan 13.22 % Prime 4.72 % 9.75 % - 5.00 % May 1, 2026 5,000 4,949 4,949 Greenlight Bio

Note 3 - Related Party Transa_2

Note 3 - Related Party Transactions (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Related Party Transactions [Table Text Block]	Expiration Total (In thousands) December 31, 2025 $ 1,037 March 31, 2026 219 June 30, 2026 3,120 September 30, 2026 3,471 December 31, 2026 3,002 March 31, 2027 2,285 June 30, 2027 2,582 Total $ 15,716

Note 4 - Investments (Tables)

Note 4 - Investments (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Investment Holdings, Schedule of Investments [Table Text Block]	June 30, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Investments Debt $ 675,295 $ 609,068 $ 721,231 $ 670,172 Warrants 17,463 21,459 16,526 24,594 Other 14,298 9,183 6,982 6,430 Equity 18,374 7,152 14,443 7,889 Total investments $ 725,430 $ 646,862 $ 759,182 $ 709,085 June 30, 2024 December 31, 2023 Cost Fair Value Cost Fair Value (In thousands) Life Science Biotechnology $ 133,486 $ 118,846 $ 145,544 $ 117,781 Medical Device 163,383 149,839 147,064 145,019 Technology Communications 15,462 18,263 19,192 22,188 Consumer-Related 78,244 59,113 105,669 101,327 Data Storage 417 428 417 418 Internet and Media 329 1,203 329 1,582 Networking 1,511 1,309 5,451 5,297 Power Management 1,585 2,700 1,585 2,700 Semiconductors 45 — 45 — Software 163,033 159,279 164,133 160,749 Sustainability Energy Efficiency 111 10 111 13 Other Sustainability 100,274 69,809 98,906 80,370 Healthcare Information and Services Diagnostics 16,210 14,281 19,735 19,701 Other 102 979 102 1,366 Software 51,238 50,803 50,899 50,574 Total investments $ 725,430 $ 646,862 $ 759,182 $ 709,085

Note 5 - Transactions With Af_2

Note 5 - Transactions With Affiliated Companies (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Investments in and Advances to Affiliates [Table Text Block]	Three months ended June 30, 2024 Fair value at Transfers Net Fair value at Portfolio March 31, Principal in/(out) at Discount unrealized Net realized June 30, Company 2024 Purchases Payments fair value accretion gain/(loss) gain/(loss) 2024 (In thousands) Aulea Medical, Inc. $ — $ — $ (40 ) $ — $ — $ — $ 40 $ — Evelo Biosciences, Inc. 2,790 — — — — 713 — 3,503 4,207 92 — — — 1,041 — 5,340 1,674 — — — — 427 — 2,101 1,674 — — — — 427 — 2,101 1,116 — — — — 285 — 1,401 1,116 — — — — 285 — 1,401 Total non-controlled affiliates $ 12,577 $ 92 $ (40 ) $ — $ — $ 3,178 $ 40 $ 15,847 Three months ended June 30, 2023 Fair value at Transfers Net Fair value at Portfolio March 31, in/(out) at Discount unrealized Net realized June 30, Company 2023 Purchases Sales fair value Accretion gain/(loss) gain/(loss) 2023 (In thousands) Cadrenal Therapeutics, Inc. 846 — — — — 60 — 906 Total non-controlled affiliates $ 846 $ — $ — $ — $ — $ 60 $ — $ 906 Six months ended June 30, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized June 30, Company 2023 Purchases Payments fair value accretion gain/(loss) gain/(loss) 2024 (In thousands) Aulea Medical, Inc. $ — $ 3 $ (40 ) $ — $ — $ — $ 37 $ — Evelo Biosciences, Inc. 222 — — — — 3,281 — 3,503 336 104 — — — 4,900 — 5,340 133 — — — — 1,968 — 2,101 133 — — — — 1,968 — 2,101 88 — — — — 1,313 — 1,401 88 — — — — 1,313 — 1,401 132 — — — — (132 ) — — Total non-controlled affiliates $ 1,132 $ 107 $ (40 ) $ — $ — $ 14,611 $ 37 $ 15,847 Six months ended June 30, 2023 Fair value at Transfers Net Fair value at Portfolio December 31, in/(out) at Discount unrealized Net realized June 30, Company 2022 Purchases Sales fair value Accretion gain/(loss) gain/(loss) 2023 (In thousands) Cadrenal Therapeutics, Inc. — — — — — 906 — 906 Total non-controlled affiliates $ — $ — $ — $ — $ — $ 906 $ — $ 906 Three months ended June 30, 2024 Fair value at Transfers Net Fair value at Portfolio March 31, Principal in/(out) at Discount unrealized Net realized June 30, Interest Company 2024 Purchases Payments PIK fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Better Place Forests Co. $ 3,455 $ — $ — $ 115 $ — $ 2 $ (406 ) $ — $ 3,166 $ 120 1,688 — — 57 — 1 (197 ) — 1,549 62 — 500 — 5 — — (85 ) — 420 5 — 500 — 1 — — (86 ) — 415 1 2,656 500 — — — — (3,156 ) — — — HIMV LLC 5,845 — — — 463 — (472 ) — 5,836 — Total controlled affiliates $ 13,644 $ 1,500 $ — $ 178 $ 463 $ 3 $ (4,402 ) $ — $ 11,386 $ 188 Six months ended June 30, 2024 Fair value at Transfers Net Fair value at Portfolio December 31, Principal in/(out) at Discount unrealized Net realized June 30, Interest Company 2023 Purchases Payments PIK fair value accretion gain/(loss) gain/(loss) 2024 income (In thousands) Better Place Forests Co. $ 3,339 $ — $ — $ 226 $ — $ 4 $ (403 ) $ — $ 3,166 $ 236 1,630 — — 112 — 3 (196 ) — 1,549 123 — 500 — 5 — — (85 ) 420 5 — 500 — 1 — — (86 ) 415 1 3,024 1,250 — — — — (4,274 ) — — — HIMV LLC 6,230 227 (547 ) — 463 — (537 ) — 5,836 — Total controlled affiliates $ 14,223 $ 2,477 $ (547 ) $ 344 $ 463 $ 7 $ (5,581 ) $ — $ 11,386 $ 365

Note 6 - Fair Value (Tables)

Note 6 - Fair Value (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Fair Value, Assets Measured on Recurring Basis [Table Text Block]	June 30, 2024 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 609,068 $ 609,068 Warrant investments — 328 21,131 21,459 Other investments — — 9,183 9,183 Equity investments 302 — 6,850 7,152 Total investments $ 302 $ 328 $ 646,232 $ 646,862 December 31, 2023 Level 1 Level 2 Level 3 Total (In thousands) Debt investments $ — $ — $ 670,172 $ 670,172 Warrant investments — 1,619 22,975 24,594 Other investments — — 6,430 6,430 Equity investments 608 — 7,281 7,889 Total investments $ 608 $ 1,619 $ 706,858 $ 709,085
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	June 30, 2024 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 556,542 Discounted Expected Future Cash Flows Hypothetical Market Yield 12% – 25% 15 % 52,526 Multiple Probability Weighted Cash Flow Model Probability Weighting 5% - 100% 64 % Warrant investments 21,069 Black-Scholes Valuation Model Price Per Share 0.00 –1,898.58 $ 74.78 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 17 % Estimated Time to Exit (in years) 1 to 5 3 62 Expected Proceeds Price Per Share $0.25 $ 0.25 Other investments 9,183 Multiple Probability Weighted Cash Flow Model Discount Rate 25% 25 % Probability Weighting 30% – 100% 75 % Equity investments 6,850 Last Equity Financing Price Per Share 0.00 215.03 $ 22.31 Total Level 3 investments $ 646,232 December 31, 2023 Fair Valuation Techniques/ Unobservable Weighted Investment Type Value Methodologies Input Range Average(1) (Dollars in thousands, except per share data) Debt investments $ 617,529 Discounted Expected Future Cash Flows Hypothetical Market Yield 11% – 24% 15 % 52,643 Multiple Probability Weighted Cash Flow Model Probability Weighting 20% - 100% 50 % Warrant investments 22,913 Black-Scholes Valuation Model Price Per Share 0.00 –1,899.00 $ 64.95 Average Industry Volatility 25% 25 % Marketability Discount 0 - 20% 18 % Estimated Time to Exit (in years) 1 to 5 3 62 Expected Proceeds Price Per Share $0.25 $ 0.25 Other investments 6,430 Multiple Probability Weighted Cash Flow Model Discount Rate 25% 25 % Probability Weighting 30% – 100% 81 % Equity investments 7,281 Last Equity Financing Price Per Share 0.56 215.03 $ 17.15 Total Level 3 investments $ 706,858
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Three months ended June 30, 2024 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 670,773 $ 23,156 $ 6,825 $ 9,192 $ 709,946 Purchase of investments 11,605 — 500 (40 ) 12,065 Warrants received and classified as Level 3 — 1,089 — — 1,089 Principal payments received on investments (56,906 ) — — 493 (56,413 ) Payment-in-kind interest on investments 355 — — — 355 Proceeds from sale of investments (3 ) (4 ) — (40 ) (47 ) Net realized gain on investments 3 2,617 — 40 2,660 Unrealized depreciation included in earnings (17,501 ) (3,046 ) (3,156 ) (462 ) (24,165 ) Transfer out of warrant investments — (2,681 ) 2,681 — — Other 742 — — — 742 Level 3 assets, end of period $ 609,068 $ 21,131 $ 6,850 $ 9,183 $ 646,232 Three months ended June 30, 2023 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 684,554 $ 24,638 $ 2,915 $ 1,300 $ 713,407 Purchase of investments 40,545 — — — 40,545 Warrants and equity received and classified as Level 3 — 515 89 — 604 Principal payments received on investments (24,740 ) — — — (24,740 ) Payment-in-kind interest on investments 950 — — — 950 Proceeds from sale of investments (528 ) (1,458 ) — — (1,986 ) Net realized (loss) gain on investments (17,672 ) 1,287 (127 ) — (16,512 ) Unrealized appreciation (depreciation) included in earnings 2,118 (606 ) (1,307 ) — 205 Transfer out of Level 3 — — (111 ) — (111 ) Transfer out of debt investments (2,800 ) — 2,800 — — Other 882 — — — 882 Level 3 assets, end of period $ 683,309 $ 24,376 $ 4,259 $ 1,300 $ 713,244 Six months ended June 30, 2024 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 670,172 $ 22,975 $ 7,281 $ 6,430 $ 706,858 Purchase of investments 33,782 — 1,250 352 35,384 Warrants received and classified as Level 3 — 1,217 — — 1,217 Principal payments received on investments (75,986 ) — — (70 ) (76,056 ) Payment-in-kind interest on investments 1,737 — — — 1,737 Proceeds from sale of investments (44 ) (4 ) — (40 ) (88 ) Net realized gain (loss) on investments 41 2,600 — 40 2,681 Unrealized depreciation included in earnings (19,010 ) (2,976 ) (4,362 ) (720 ) (27,068 ) Transfer out of debt and warrant investments (3,191 ) (2,681 ) 2,681 3,191 — Other 1,567 — — — 1,567 Level 3 assets, end of period $ 609,068 $ 21,131 $ 6,850 $ 9,183 $ 646,232 Six months ended June 30, 2023 Debt Warrant Equity Other Investments Investments Investments Investments Total (In thousands) Level 3 assets, beginning of period $ 686,458 $ 26,145 $ 2,416 $ 1,300 $ 716,319 Purchase of investments 87,543 — 10 — 87,553 Warrants and equity received and classified as Level 3 — 656 89 — 745 Principal payments received on investments (64,496 ) — — — (64,496 ) Payment-in-kind interest on investments 2,154 — — — 2,154 Proceeds from sale of investments (7,036 ) (1,470 ) — — (8,506 ) Net realized (loss) gain on investments (17,665 ) 1,146 (127 ) — (16,646 ) Unrealized depreciation included in earnings (2,448 ) (2,096 ) (1,118 ) — (5,662 ) Transfer out of Level 3 — — (111 ) — (111 ) Transfer out of debt investments (3,095 ) (5 ) 3,100 — — Other 1,894 — — — 1,894 Level 3 assets, end of period $ 683,309 $ 24,376 $ 4,259 $ 1,300 $ 713,244

Note 7 - Borrowings (Tables)

Note 7 - Borrowings (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Debt [Table Text Block]	June 30, 2024 December 31, 2023 Total Balance Unused Total Balance Unused Commitment Outstanding Commitment Commitment Outstanding Commitment (In thousands) Key Facility $ 150,000 $ — $ 150,000 $ 150,000 $ 70,000 $ 80,000 NYL Facility 250,000 181,000 69,000 250,000 181,000 69,000 Nuveen Facility 100,000 50,000 50,000 — — — 2022 Asset-Backed Notes 100,000 100,000 — 100,000 100,000 — 2027 Notes 57,500 57,500 — 57,500 57,500 — 2026 Notes 57,500 57,500 — 57,500 57,500 — Total before debt issuance costs 715,000 446,000 269,000 615,000 466,000 149,000 Unamortized debt issuance costs attributable to term borrowings — (3,256 ) — — (3,765 ) — Total borrowings outstanding, net $ 715,000 $ 442,744 $ 269,000 $ 615,000 $ 462,235 $ 149,000

Note 8 - Financial Instrument_2

Note 8 - Financial Instruments With Off-balance-sheet Risk (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Schedule of Fair Value, off-Balance-Sheet Risks [Table Text Block]	June 30, 2024 December 31, 2023 Fair Value of Fair Value of Unfunded Unfunded Commitment Commitment Commitment Commitment Amount Liability Amount Liability (In thousands) (In thousands) Better Place Forests Co. $ 1,500 $ — $ — — BrightInsight, Inc. 10,000 132 15,500 $ 241 Britecore Holdings, Inc. 2,500 36 5,000 72 Candesant Biomedical Corporation 10,000 151 10,000 151 Ceribell, Inc. 21,000 120 — — Divergent Technologies, Inc. — — 11,250 118 Elligo Healthcare Research, Inc. 15,000 194 15,000 194 MicroTransponder, Inc. 22,500 — 22,500 — Mirantis, Inc. 15,000 136 15,000 136 Optoro, Inc. — — 6,250 — Parse Biosciences, Inc. 15,000 251 15,000 251 SafelyYou, Inc. 10,000 147 20,000 270 Sonex Health, Inc. — — 15,000 176 Standvast Holdings, LLC 5,000 175 Supply Network Visibility Holdings, LLC 5,000 17 10,000 35 Tallac Therapeutics, Inc. 5,000 115 10,000 229 Viken Detection Corporation — — 10,000 160 Total $ 137,500 $ 1,474 $ 180,500 $ 2,033

Note 10 - Distributions (Tables

Note 10 - Distributions (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Dividends Declared [Table Text Block]	DRIP DRIP Date Amount Cash Shares Share Declared Record Date Payment Date Per Share Distribution Issued Value (In thousands, except share and per share data) Six Months Ended June 30, 2024 4/26/2024 8/16/2024 9/13/2024 $ 0.11 $ — — $ — 4/26/2024 7/17/2024 8/15/2024 0.11 — — — 4/26/2024 6/17/2024 7/16/2024 0.11 3,766 15,860 199 2/23/2024 5/17/2024 6/14/2024 0.11 3,701 16,686 203 2/23/2024 4/18/2024 5/15/2024 0.11 3,654 16,687 199 2/23/2024 3/19/2024 4/16/2024 0.05 1,625 7,598 85 2/23/2024 3/19/2024 4/16/2024 0.11 3,574 16,717 188 $ 0.71 $ 16,320 73,548 $ 874 Year Ended December 31, 2023 10/27/2023 2/16/2024 3/15/2024 $ 0.11 $ 3,463 18,257 $ 210 10/27/2023 1/18/2024 2/14/2024 0.11 3,462 15,873 210 10/27/2023 12/19/2023 1/16/2024 0.11 3,472 14,563 199 10/27/2023 11/17/2023 12/15/2023 0.05 1,574 7,137 93 7/28/2023 11/17/2023 12/15/2023 0.11 3,463 15,701 206 7/28/2023 10/18/2023 11/15/2023 0.11 3,493 14,022 173 7/28/2023 9/19/2023 10/16/2023 0.11 3,445 15,067 184 4/28/2023 8/17/2023 9/15/2023 0.11 3,458 8,665 106 4/28/2023 7/18/2023 8/15/2023 0.11 3,427 8,307 105 4/28/2023 6/16/2023 7/14/2023 0.11 3,434 7,424 96 2/23/2023 5/18/2023 6/14/2023 0.11 3,087 7,128 86 2/23/2023 4/18/2023 5/16/2023 0.11 3,068 6,705 84 2/23/2023 3/17/2023 4/14/2023 0.11 3,035 6,894 81 $ 1.37 $ 41,881 145,743 $ 1,833 Ex-Dividend Date Record Date Payment Date Distributions Declared November 15, 2024 November 15, 2024 December 13, 2024 $ 0.11 October 17, 2024 October 17, 2024 November 14, 2024 $ 0.11 September 16, 2024 September 16, 2024 October 16, 2024 $ 0.11

Note 11 - Financial Highlights

Note 11 - Financial Highlights (Tables)	6 Months Ended
	Jun. 30, 2024
Notes Tables
Investment Company, Financial Highlights [Table Text Block]	Six months ended June 30, 2024 2023 (In thousands, except share and per share data) Per share data: Net asset value at beginning of period $ 9.71 $ 11.47 Net investment income 0.74 1.00 Realized gain (loss) 0.07 (0.58 ) Unrealized depreciation on investments (0.82 ) (0.23 ) Net increase in net assets resulting from operations (0.01 ) 0.19 Distributions declared (1) (0.71 ) (0.66 ) From net investment income (0.71 ) (0.66 ) From net realized gain on investments — — Return of capital — — Other (2) 0.13 0.07 Net asset value at end of period $ 9.12 $ 11.07 Per share market value, beginning of period $ 13.17 $ 11.60 Per share market value, end of period $ 12.04 $ 12.08 Total return based on a market value (3) (3.2 )% 9.8 % Shares outstanding at end of period 36,043,815 32,096,259 Ratios to average net assets: Expenses without incentive fee (4) 15.6 % 14.2 % Incentive fees (4) — 1.9 % Net expenses (4) 15.6 % 16.1 % Net investment income with incentive fee (4) 15.5 % 17.5 % Net assets at the end of the period $ 328,778 $ 355,419 Average net asset value $ 328,293 $ 331,850 Average debt per share $ 13.03 $ 15.11 Portfolio turnover ratio 5.4 % (5) 7.6 % (5)

Consolidated Schedule of Inve_3

Consolidated Schedule of Investments (Unaudited) (Details Textual) - USD ($) $ in Thousands	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Jul. 31, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Nov. 09, 2022
Debt Instrument, Face Amount	$ 715,000		$ 615,000
Percentage of Nonqualifying Assets on a Cost Basis	4.80%		4.70%
Percentage of Nonqualifying Assets on a Fair Value Basis	1.40%		2.70%
Investment Owned, Fair Value	$ 646,862		$ 709,085
Software Sector [Member]
Investment Owned, Fair Value	159,279		160,749
Medical Device Sector [Member]
Investment Owned, Fair Value	149,839		145,019
Investment, Affiliated Issuer, Controlled [Member]
Investment Owned, Fair Value	11,386	$ 13,644	14,223
Investment, Affiliated Issuer, Controlled [Member] | Nexii Building Solutions, Inc [Member]
Investment Owned, Fair Value	10,900
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investment Owned, Fair Value	5,836	$ 5,845	$ 6,230
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Co-lender [Member]
Investment Owned, Net Assets, Percentage			30%
Investment, Unaffiliated Issuer [Member]
Investment Owned, Fair Value	619,629		$ 693,730
Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Software Sector [Member]
Investment, Interest Rate, Paid in Kind		4.50%	4.50%
Investment, Affiliated Issuer, Noncontrolled [Member]
Investment Owned, Fair Value	$ 15,847	$ 12,577	$ 1,132		$ 906	$ 846	$ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical Inc 1[Member] | Medical Device Sector [Member]
Investment Owned, Balance, Shares (in shares)				660,537
Horizon Technology Finance Corporation [Member] | Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investment Owned, Net Assets, Percentage	70%		70%
Asset-backed Notes 2022 [Member]
Debt Instrument, Face Amount	$ 100,000		$ 100,000					$ 157,800
Asset-backed Notes 2022 [Member] | Affiliated Entity [Member]
Debt Instrument, Face Amount								$ 100,000

Consolidated Schedule of Inve_4

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Investments at cost	$ 725,430		$ 759,182
Investments at fair value	646,862		709,085
Warrant [Member]
Investments at cost	17,463		16,526
Investments at fair value	21,459		24,594
Investment, Unaffiliated Issuer [Member]
Investments at cost	679,477		716,077
Investments at fair value	619,629		693,730
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost	644,952		692,345
Investments at fair value	587,671		664,203
Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost	17,338		16,400
Investments at fair value	21,459		24,594
Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at cost	28,781		28,677
Investments at fair value	15,847	$ 12,577	1,132	$ 906	$ 846	$ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member]
Investments at fair value	15,847
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member]
Investments at cost	125		126
Investments at fair value	0		0
Investment, Affiliated Issuer, Controlled [Member]
Investments at cost	17,172		14,428
Investments at fair value	11,386	13,644	14,223
Investment, Affiliated Issuer, Controlled [Member] | Debt Investments [Member]
Investments at cost	6,687
Investments at fair value	5,550
Biotechnology Sector [Member]
Investments at cost	133,486		145,544
Investments at fair value	118,846		117,781
Medical Device Sector [Member]
Investments at cost	163,383		147,064
Investments at fair value	149,839		145,019
Communications Sector [Member]
Investments at cost	15,462		19,192
Investments at fair value	18,263		22,188
Software Sector [Member]
Investments at cost	163,033		164,133
Investments at fair value	159,279		160,749
Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member]
Investments at cost			5,335
Investments at fair value			4,969
Other Sustainability Sector [Member]
Investments at cost	100,274		98,906
Investments at fair value	69,809		80,370
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost	1,189		999
Investments at fair value	728		$ 542
Number of Shares (in shares)
Diagnostics Sector [Member]
Investments at cost	16,210		$ 19,735
Investments at fair value	14,281		19,701
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost	232,921		275,026
Investments at fair value	218,930		269,790
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost	10,360		9,733
Investments at fair value	13,261		14,506
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost	246,362		249,642
Investments at fair value	234,965		244,815
Life Science [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member]
Investments at cost	23,656		23,551
Investments at fair value			1,000
Other Healthcare Sector [Member]
Investments at cost	102		102
Investments at fair value	979		1,366
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost	66,584		69,770
Investments at fair value	64,695		69,770
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost	966		966
Investments at fair value	1,368		1,871
Data Storage Sector [Member]
Investments at cost	417		417
Investments at fair value	428		418
Networking Sector [Member]
Investments at cost	1,511		5,451
Investments at fair value	1,309		5,297
Internet and Media Sector [Member]
Investments at cost	329		329
Investments at fair value	1,203		1,582
Power Management Sector [Member]
Investments at cost	1,585		1,585
Investments at fair value	2,700		2,700
Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member]
Investments at cost	4,823		4,702
Investments at fair value	6,102		7,675
Semiconductor Sector [Member]
Investments at cost	45		45
Investments at fair value	0		0
Software, Healthcare Information and Service [Member]
Investments at cost	51,238		50,899
Investments at fair value	50,803		50,574
Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member]
Investments at cost	99,085		97,907
Investments at fair value	69,081		79,828
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member]
Investments at cost	125		126
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	23,196		23,196
Aulea Medical, Inc. [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at fair value	$ 0	0	$ 0
Nexii Building Solutions, Inc [Member] | Debt Securities [Member]
Investments at fair value	10,900
Nexii Building Solutions, Inc [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments at fair value	10,900
HIMV LLC [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments at fair value	5,836	$ 5,845	6,230
Cadrenal Therapeutics, Inc. [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at fair value				$ 906	$ 846	$ 0
Unrestricted Short Term Investments [Member]
Investments at cost	32,320		26,450
Investments at fair value	32,320		26,450
Unrestricted Short Term Investments [Member] | U S Bank Money Market Deposit Account [Member]
Investments at cost	32,320		26,450
Investments at fair value	$ 32,320		$ 26,450
Term Loan, Prime Index, One [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.25%		13.25%
Margin	4.75%		4.75%
Floor	9.55%		9.55%
Ceiling	13.50%		13.50%
ETP	5.50%		5.50%
Maturity Date	May 01, 2026		May 01, 2026
Principal Amount	$ 4,583		$ 5,000
Investments at cost	4,570		4,979
Investments at fair value	$ 4,570		$ 4,979
Term Loan, Prime Index, One [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.25%		13.25%
Margin	4.75%		4.75%
Floor	8.50%		8.50%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jan. 01, 2027		Jan. 01, 2027
Principal Amount	$ 3,750		$ 3,750
Investments at cost	3,730		3,722
Investments at fair value	$ 3,730		$ 3,722
Term Loan, Prime Index, One [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.50%		14.50%
Margin	6%		6%
Floor	9.25%		9.25%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Jun. 01, 2026		Jun. 01, 2026
Principal Amount	$ 5,000		$ 6,250
Investments at cost	4,975		6,218
Investments at fair value	$ 4,975		$ 6,218
Term Loan, Prime Index, One [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15%		15%
Margin	6.50%		6.50%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	3.50%		3.50%
Maturity Date	Apr. 01, 2026		Apr. 01, 2026
Principal Amount	$ 6,777		$ 6,625
Investments at cost	6,695		6,519
Investments at fair value	$ 6,093		$ 6,176
Term Loan, Prime Index, One [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Cash Rate	12.75%		12.75%
Margin	4.25%		4.25%
Floor	11%		11%
Ceiling	0%		0%
ETP	4.25%		2.27%
Maturity Date	Jan. 01, 2028		Jan. 01, 2028
Principal Amount	$ 5,898		$ 5,532
Investments at cost	5,228		5,228
Investments at fair value	$ 3,503		$ 222
Term Loan, Prime Index, One [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member]
Cash Rate	12.25%		12.25%
Margin	3.75%		3.75%
Floor	12%		12%
Ceiling	0%		0%
ETP	2.78%		1.85%
Maturity Date	Aug. 01, 2029		Aug. 01, 2029
Principal Amount	$ 3,772		$ 3,547
Investments at cost	3,814		3,585
Investments at fair value	$ 3,166		$ 3,339
Term Loan, Prime Index, One [Member] | Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			14%
Margin			5.50%
Floor			10.25%
Ceiling			0%
ETP			4%
Maturity Date			Nov. 01, 2026
Principal Amount			$ 3,500
Investments at cost			3,469
Investments at fair value			$ 1,574
Term Loan, Prime Index, One [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	4.33%		4.33%
Maturity Date	Dec. 01, 2026		Dec. 01, 2026
Principal Amount	$ 3,750		$ 3,750
Investments at cost	3,705		3,685
Investments at fair value	$ 3,705		$ 3,685
Term Loan, Prime Index, One [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.50%		14.50%
Margin	6%		6%
Floor	9.25%		9.25%
Ceiling	0%		0%
ETP	3.50%		3.50%
Maturity Date	Jun. 01, 2026		Jun. 01, 2026
Principal Amount	$ 1,607		$ 2,500
Investments at cost	1,596		2,484
Investments at fair value	$ 1,124		$ 2,484
Term Loan, Prime Index, One [Member] | Parse Biosciences, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	11.75%		11.75%
Margin	3.25%		3.25%
Floor	11.50%		11.50%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jan. 01, 2028		Jan. 01, 2028
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,645		4,633
Investments at fair value	$ 4,645		$ 4,633
Term Loan, Prime Index, One [Member] | CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.75%		15.75%
Margin	7.25%		7.25%
Floor	10.50%		10.50%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Mar. 01, 2027		May 01, 2026
Principal Amount	$ 2,033		$ 3,383
Investments at cost	1,975		3,356
Investments at fair value	$ 1,975		$ 3,356
Term Loan, Prime Index, One [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Apr. 01, 2026		Apr. 01, 2026
Principal Amount	$ 10,000		$ 10,000
Investments at cost	9,929		9,895
Investments at fair value	$ 9,929		$ 9,895
Term Loan, Prime Index, One [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.22%		13.22%
Margin	4.72%		4.72%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Nov. 01, 2025		Jun. 01, 2024
Principal Amount	$ 5,000		$ 1,414
Investments at cost	4,964		1,410
Investments at fair value	$ 4,964		$ 1,410
Term Loan, Prime Index, One [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 8,871		$ 8,425
Investments at cost	8,222		8,353
Investments at fair value	$ 2,189		$ 4,549
Term Loan, Prime Index, One [Member] | Engage3, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			14.75%
Margin			6.25%
Floor			9.75%
Ceiling			0%
ETP			4.50%
Maturity Date			Jul. 01, 2027
Principal Amount			$ 3,750
Investments at cost			3,728
Investments at fair value			$ 3,728
Term Loan, Prime Index, One [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	8%		8%
Maturity Date	Sep. 01, 2027		Sep. 01, 2027
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,477		2,297
Investments at fair value	$ 2,477		$ 2,297
Term Loan, Prime Index, One [Member] | Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9%		9%
Ceiling	0%		0%
ETP	5.50%		5.50%
Maturity Date	Aug. 01, 2025		Aug. 01, 2025
Principal Amount	$ 1,083		$ 1,667
Investments at cost	1,076		1,656
Investments at fair value	$ 1,076		$ 1,656
Term Loan, Prime Index, One [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	2.75%		2.75%
Maturity Date	Apr. 01, 2026		Apr. 01, 2026
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,922		4,959
Investments at fair value	$ 4,922		$ 4,959
Term Loan, Prime Index, One [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.25%		13.25%
Margin	4.75%		4.75%
Floor	8.50%		8.50%
Ceiling	0%		0%
ETP	5.50%		5.50%
Maturity Date	May 01, 2027		May 01, 2027
Principal Amount	$ 6,250		$ 6,250
Investments at cost	6,210		6,199
Investments at fair value	$ 6,210		$ 6,199
Term Loan, Prime Index, One [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Aug. 01, 2027		Aug. 01, 2027
Principal Amount	$ 7,000		$ 7,000
Investments at cost	6,807		6,684
Investments at fair value	$ 6,807		$ 6,684
Term Loan, Prime Index, One [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.50%		13.50%
Margin	5%		5%
Floor	5%		5%
Ceiling	0%		0%
ETP	10.40%		4%
Maturity Date	Mar. 01, 2027		Mar. 01, 2027
Principal Amount	$ 2,000		$ 2,000
Investments at cost	1,367		1,421
Investments at fair value	$ 1,367		$ 1,421
Term Loan, Prime Index, One [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Apr. 01, 2028		Apr. 01, 2028
Principal Amount	$ 3,750		$ 3,750
Investments at cost	3,700		3,694
Investments at fair value	$ 3,700		$ 3,694
Term Loan, Prime Index, One [Member] | Elligo Health Research, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Oct. 01, 2027		Oct. 01, 2027
Principal Amount	$ 10,000		$ 10,000
Investments at cost	9,675		9,656
Investments at fair value	$ 9,675		$ 9,656
Term Loan, Prime Index, One [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.25%
Margin			6%
Floor			9.50%
Ceiling			11.25%
ETP			3%
Maturity Date			Jul. 01, 2027
Principal Amount			$ 3,750
Investments at cost			3,608
Investments at fair value			$ 3,608
Term Loan, Prime Index, One [Member] | Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15%		15%
Margin	6.50%		6.50%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Mar. 01, 2026		Mar. 01, 2026
Principal Amount	$ 4,375		$ 5,000
Investments at cost	4,358		4,971
Investments at fair value	$ 4,358		$ 4,971
Term Loan, Prime Index, One [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.75%		13.75%
Margin	5.25%		5.25%
Floor	8.50%		8.50%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Nov. 01, 2026		Nov. 01, 2026
Principal Amount	$ 3,625		$ 3,750
Investments at cost	3,605		3,716
Investments at fair value	$ 3,605		$ 3,716
Term Loan, Prime Index, One [Member] | Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9%		9%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Jul. 01, 2025		Jul. 01, 2025
Principal Amount	$ 2,167		$ 3,000
Investments at cost	2,110		2,914
Investments at fair value	$ 2,110		$ 2,870
Term Loan, Prime Index, One [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	3.75%		3.75%
Maturity Date	Sep. 01, 2026		Sep. 01, 2026
Principal Amount	$ 10,000		$ 10,000
Investments at cost	9,937		9,911
Investments at fair value	$ 9,937		$ 9,911
Term Loan, Prime Index, One [Member] | SafelyYou, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	11.75%		11.75%
Margin	3.25%		3.25%
Floor	11%		11%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jun. 01, 2027		Jun. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,784		4,648
Investments at fair value	$ 4,784		$ 4,648
Term Loan, Prime Index, One [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.50%		14.50%
Margin	6%		6%
Floor	14.25%		14.25%
Ceiling	0%		0%
ETP	5%		4%
Maturity Date	Nov. 01, 2026		Nov. 01, 2026
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,476		2,471
Investments at fair value	$ 2,476		$ 2,373
Term Loan, Prime Index, One [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.86%		13.86%
Margin	5.36%		5.36%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	4.30%		5.50%
Maturity Date	Jan. 01, 2027		Dec. 01, 2024
Principal Amount	$ 3,482		$ 4,666
Investments at cost	3,399		4,579
Investments at fair value	$ 3,206		$ 4,414
Term Loan, Prime Index, One [Member] | Lyrical Foods, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	9%		9%
Ceiling	0%		0%
ETP	1%		1%
Maturity Date	Sep. 01, 2027		Sep. 01, 2027
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,591		2,591
Investments at fair value	$ 2,228		$ 2,429
Term Loan, Prime Index, One [Member] | Spineology, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	1%		1%
Maturity Date	Oct. 01, 2025		Oct. 01, 2025
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,972		4,978
Investments at fair value	$ 4,972		$ 4,978
Term Loan, Prime Index, One [Member] | MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Oct. 01, 2025		Oct. 01, 2025
Principal Amount	$ 2,667		$ 3,667
Investments at cost	2,657		3,647
Investments at fair value	$ 2,657		$ 3,647
Term Loan, Prime Index, One [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	8.75%		8.75%
Ceiling	0%		0%
ETP	6%		6%
Maturity Date	Oct. 01, 2025		Oct. 01, 2025
Principal Amount	$ 3,238		$ 4,250
Investments at cost	3,197		4,193
Investments at fair value	$ 3,197		$ 4,193
Term Loan, Prime Index, One [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Oct. 01, 2028		Oct. 01, 2028
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,788		4,779
Investments at fair value	$ 4,788		$ 4,779
Term Loan, Prime Index, One [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.75%		12.75%
Margin	4.25%		4.25%
Floor	12.25%		12.25%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Aug. 01, 2027		Aug. 01, 2027
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,350		2,230
Investments at fair value	$ 2,350		$ 2,230
Term Loan, Prime Index, One [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.75%		13.75%
Margin	5.25%		5.25%
Floor	9%		9%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jul. 01, 2027		Jul. 01, 2027
Principal Amount	$ 3,500		$ 3,500
Investments at cost	3,473		3,467
Investments at fair value	$ 876		$ 3,467
Term Loan, Prime Index, One [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9%		9%
Ceiling	0%		0%
ETP	5.25%		5.25%
Maturity Date	Oct. 31, 2023		Oct. 31, 2023
Principal Amount	$ 5,780		$ 5,752
Investments at cost	5,572		5,752
Investments at fair value	$ 3,331		$ 5,018
Term Loan, Prime Index, One [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.50%		13.50%
Margin	5%		5%
Floor	12%		12%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Mar. 01, 2027		Mar. 01, 2027
Principal Amount	$ 10,000		$ 10,000
Investments at cost	9,905		9,885
Investments at fair value	$ 9,905		$ 9,885
Term Loan, Prime Index, One [Member] | VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.25%		12.25%
Margin	3.75%		3.75%
Floor	12.25%		12.25%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Jan. 01, 2029		Jan. 01, 2029
Principal Amount	$ 15,000		$ 15,000
Investments at cost	14,704		14,675
Investments at fair value	$ 14,704		$ 14,675
Term Loan, Prime Index, One [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.50%		11.50%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Sep. 01, 2027		Sep. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,770		4,757
Investments at fair value	$ 4,770		$ 4,757
Term Loan, Prime Index, One [Member] | Reputation Institute, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.75%		15.75%
Margin	7.25%		7.25%
Floor	10.50%		10.50%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Aug. 01, 2025		Aug. 01, 2025
Principal Amount	$ 2,583		$ 3,667
Investments at cost	2,542		3,625
Investments at fair value	$ 2,542		$ 3,625
Term Loan, Prime Index, One [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	11.25%		12%
Margin	2.75%		3.50%
Floor	9.25%		8.25%
Ceiling	0%		0%
ETP	4%		5.50%
Maturity Date	Mar. 01, 2029		Oct. 01, 2024
Principal Amount	$ 5,000		$ 3,750
Investments at cost	4,814		3,738
Investments at fair value	$ 4,814		$ 3,738
Term Loan, Prime Index, One [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Aug. 01, 2026		Aug. 01, 2026
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,971		4,959
Investments at fair value	$ 4,971		$ 4,959
Term Loan, Prime Index, One [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	8.75%		8.75%
Ceiling	0%		0%
ETP	6%		6%
Maturity Date	Aug. 01, 2026		Aug. 01, 2026
Principal Amount	$ 4,028		$ 4,583
Investments at cost	3,993		4,546
Investments at fair value	$ 3,993		$ 4,546
Term Loan, Prime Index, One [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.75%		14.75%
Margin	6.25%		6.25%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Aug. 01, 2027		Aug. 01, 2027
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,432		2,416
Investments at fair value	$ 2,432		$ 2,416
Term Loan, Prime Index, One [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.32%		13.32%
Margin	4.82%		4.82%
Floor	9.25%		9.25%
Ceiling	0%		0%
ETP	10.36%		10.36%
Maturity Date	Jul. 01, 2025		Jul. 01, 2025
Principal Amount	$ 3,766		$ 3,960
Investments at cost	3,729		3,923
Investments at fair value	$ 3,729		$ 3,923
Term Loan, Prime Index, One [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.59%		13.59%
Margin	5.09%		5.09%
Floor	10%		10%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jan. 01, 2024		Jan. 01, 2024
Principal Amount	$ 391		$ 500
Investments at cost	391		500
Investments at fair value	$ 391		$ 500
Term Loan, Prime Index, One [Member] | Standvast Holdings, LLC [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.75%
Margin	4.25%
Floor	12.75%
Ceiling	0%
ETP	3%
Maturity Date	Jun. 01, 2028
Principal Amount	$ 2,500
Investments at cost	2,240
Investments at fair value	$ 2,240
Term Loan, Prime Index, One [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.75%		12.75%
Margin	4.25%		4.25%
Floor	12%		12%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Jun. 01, 2028		Jun. 01, 2028
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,476		2,457
Investments at fair value	$ 2,476		$ 2,457
Term Loan, Prime Index, One [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	16.25%		16.25%
Margin	7.75%		7.75%
Floor	11%		11%
Ceiling	0%		0%
ETP	0%		0%
Maturity Date	May 01, 2027		May 01, 2027
Principal Amount	$ 1,306		$ 1,204
Investments at cost	1,086		1,086
Investments at fair value	$ 570		$ 872
Term Loan, Prime Index, One [Member] | MicroTransponder, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.25%		12.25%
Margin	3.75%		3.75%
Floor	12.25%		12.25%
Ceiling	0%		0%
ETP	3.50%		3.50%
Maturity Date	Jan. 01, 2029		Jan. 01, 2029
Principal Amount	$ 3,750		$ 3,750
Investments at cost	3,694		3,689
Investments at fair value	$ 3,694		$ 3,689
Term Loan, Prime Index, One [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.75%		14.75%
Margin	6.25%		6.25%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Sep. 01, 2024		Sep. 01, 2024
Principal Amount	$ 333		$ 1,500
Investments at cost	329		1,481
Investments at fair value	$ 329		$ 1,481
Term Loan, Prime Index, One [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.50%		12.50%
Margin	4%		4%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	3.50%		3.50%
Maturity Date	Jun. 01, 2027		Jun. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,945		4,773
Investments at fair value	$ 4,945		$ 4,773
Term Loan, Prime Index, One [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	14%		14%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Oct. 01, 2028		Oct. 01, 2028
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,902		4,860
Investments at fair value	$ 4,902		$ 4,860
Term Loan, Prime Index Two [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.25%		13.25%
Margin	4.75%		4.75%
Floor	9.55%		9.55%
Ceiling	13.50%		13.50%
ETP	5.50%		5.50%
Maturity Date	May 01, 2026		May 01, 2026
Principal Amount	$ 4,583		$ 5,000
Investments at cost	4,570		4,979
Investments at fair value	$ 4,570		$ 4,979
Term Loan, Prime Index Two [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.25%		13.25%
Margin	4.75%		4.75%
Floor	8.50%		8.50%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jan. 01, 2027		Jan. 01, 2027
Principal Amount	$ 3,750		$ 3,750
Investments at cost	3,729		3,722
Investments at fair value	$ 3,729		$ 3,722
Term Loan, Prime Index Two [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.50%		14.50%
Margin	6%		6%
Floor	9.25%		9.25%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Jun. 01, 2026		Jun. 01, 2026
Principal Amount	$ 5,000		$ 6,250
Investments at cost	4,975		6,218
Investments at fair value	$ 4,975		$ 6,218
Term Loan, Prime Index Two [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15%		15%
Margin	6.50%		6.50%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	3.50%		3.50%
Maturity Date	Apr. 01, 2026		Apr. 01, 2026
Principal Amount	$ 6,256		$ 6,116
Investments at cost	6,180		6,018
Investments at fair value	$ 5,624		$ 5,701
Term Loan, Prime Index Two [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Cash Rate	12.75%		12.75%
Margin	4.25%		4.25%
Floor	11%		11%
Ceiling	0%		0%
ETP	4.25%		2.27%
Maturity Date	Jan. 01, 2028		Jan. 01, 2028
Principal Amount	$ 8,847		$ 8,298
Investments at cost	7,972		7,867
Investments at fair value	$ 5,340		$ 336
Term Loan, Prime Index Two [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member]
Cash Rate	12.25%		12.25%
Margin	3.75%		3.75%
Floor	12%		12%
Ceiling	0%		0%
ETP	2.78%		1.85%
Maturity Date	Aug. 01, 2029		Aug. 01, 2029
Principal Amount	$ 1,886		$ 1,773
Investments at cost	1,867		1,750
Investments at fair value	$ 1,549		$ 1,630
Term Loan, Prime Index Two [Member] | Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			14%
Margin			5.50%
Floor			10.25%
Ceiling			0%
ETP			4%
Maturity Date			Nov. 01, 2026
Principal Amount			$ 3,500
Investments at cost			3,563
Investments at fair value			$ 1,617
Term Loan, Prime Index Two [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	4.33%		4.33%
Maturity Date	Dec. 01, 2026		Dec. 01, 2026
Principal Amount	$ 3,750		$ 3,750
Investments at cost	3,705		3,685
Investments at fair value	$ 3,705		$ 3,685
Term Loan, Prime Index Two [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.50%		14.50%
Margin	6%		6%
Floor	9.25%		9.25%
Ceiling	0%		0%
ETP	3.50%		3.50%
Maturity Date	Jun. 01, 2026		Jun. 01, 2026
Principal Amount	$ 1,607		$ 2,500
Investments at cost	1,596		2,484
Investments at fair value	$ 1,124		$ 2,484
Term Loan, Prime Index Two [Member] | Parse Biosciences, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	11.75%		11.75%
Margin	3.25%		3.25%
Floor	11.50%		11.50%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jan. 01, 2028		Jan. 01, 2028
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,897		4,884
Investments at fair value	$ 4,897		$ 4,884
Term Loan, Prime Index Two [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Apr. 01, 2026		Apr. 01, 2026
Principal Amount	$ 10,000		$ 10,000
Investments at cost	9,929		9,895
Investments at fair value	$ 9,929		$ 9,895
Term Loan, Prime Index Two [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.22%		13.22%
Margin	4.72%		4.72%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	May 01, 2026		Jun. 01, 2024
Principal Amount	$ 5,000		$ 1,414
Investments at cost	4,967		1,410
Investments at fair value	$ 4,967		$ 1,410
Term Loan, Prime Index Two [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 8,871		$ 8,425
Investments at cost	7,996		8,229
Investments at fair value	$ 2,129		$ 4,481
Term Loan, Prime Index Two [Member] | Engage3, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			14.75%
Margin			6.25%
Floor			9.75%
Ceiling			0%
ETP			4.50%
Maturity Date			Jul. 01, 2027
Principal Amount			$ 3,750
Investments at cost			3,728
Investments at fair value			$ 3,728
Term Loan, Prime Index Two [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	8%		8%
Maturity Date	Sep. 01, 2027		Sep. 01, 2027
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,477		2,473
Investments at fair value	$ 2,477		$ 2,473
Term Loan, Prime Index Two [Member] | Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9%		9%
Ceiling	0%		0%
ETP	5.50%		5.50%
Maturity Date	Aug. 01, 2025		Aug. 01, 2025
Principal Amount	$ 1,083		$ 1,583
Investments at cost	1,076		1,573
Investments at fair value	$ 1,076		$ 1,573
Term Loan, Prime Index Two [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.25%
Margin	0%		6.75%
Floor	0%		10%
Ceiling	0%		0%
ETP	0%		2.75%
Maturity Date	Aug. 30, 2024		Apr. 01, 2026
Principal Amount	$ 490		$ 2,500
Investments at cost	486		2,479
Investments at fair value	$ 129		$ 2,479
Term Loan, Prime Index Two [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		13.25%
Margin	5.75%		4.75%
Floor	9.75%		8.50%
Ceiling	0%		0%
ETP	3.75%		5.50%
Maturity Date	Sep. 01, 2026		May 01, 2027
Principal Amount	$ 3,750		$ 6,250
Investments at cost	3,726		6,199
Investments at fair value	$ 3,726		$ 6,199
Term Loan, Prime Index Two [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Aug. 01, 2027		Aug. 01, 2027
Principal Amount	$ 3,500		$ 3,500
Investments at cost	3,470		3,463
Investments at fair value	$ 3,470		$ 3,463
Term Loan, Prime Index Two [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.50%		13.50%
Margin	5%		5%
Floor	5%		5%
Ceiling	0%		0%
ETP	10.40%		4%
Maturity Date	Mar. 01, 2027		Mar. 01, 2027
Principal Amount	$ 3,000		$ 3,000
Investments at cost	2,354		2,131
Investments at fair value	$ 2,354		$ 2,131
Term Loan, Prime Index Two [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Apr. 01, 2028		Apr. 01, 2028
Principal Amount	$ 3,750		$ 3,750
Investments at cost	3,700		3,694
Investments at fair value	$ 3,700		$ 3,694
Term Loan, Prime Index Two [Member] | Elligo Health Research, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Oct. 01, 2027		Oct. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,935		4,925
Investments at fair value	$ 4,935		$ 4,925
Term Loan, Prime Index Two [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.25%
Margin			6%
Floor			9.50%
Ceiling			11.25%
ETP			3%
Maturity Date			Jul. 01, 2027
Principal Amount			$ 1,250
Investments at cost			1,242
Investments at fair value			$ 1,242
Term Loan, Prime Index Two [Member] | Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15%		15%
Margin	6.50%		6.50%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Mar. 01, 2026		Mar. 01, 2026
Principal Amount	$ 2,187		$ 2,500
Investments at cost	2,179		2,486
Investments at fair value	$ 2,179		$ 2,486
Term Loan, Prime Index Two [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		13.75%
Margin	5.75%		5.25%
Floor	9.75%		8.50%
Ceiling	0%		0%
ETP	3.75%		5%
Maturity Date	Sep. 01, 2026		Nov. 01, 2026
Principal Amount	$ 3,750		$ 2,500
Investments at cost	3,726		2,478
Investments at fair value	$ 3,726		$ 2,478
Term Loan, Prime Index Two [Member] | Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.75%		14.25%
Margin	5.25%		5.75%
Floor	8.50%		9%
Ceiling	0%		0%
ETP	5%		3%
Maturity Date	Nov. 01, 2026		Jul. 01, 2025
Principal Amount	$ 2,417		$ 1,500
Investments at cost	2,403		1,458
Investments at fair value	$ 2,403		$ 1,436
Term Loan, Prime Index Two [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.86%		14.25%
Margin	5.36%		5.75%
Floor	9.50%		9.75%
Ceiling	0%		0%
ETP	4.30%		3.75%
Maturity Date	Jan. 01, 2027		Sep. 01, 2026
Principal Amount	$ 3,482		$ 3,750
Investments at cost	3,399		3,717
Investments at fair value	3,206		$ 3,717
Term Loan, Prime Index Two [Member] | SafelyYou, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.75%
Margin			3.25%
Floor			11%
Ceiling			0%
ETP			5%
Maturity Date			Jun. 01, 2027
Principal Amount			$ 5,000
Investments at cost	4,931		4,918
Investments at fair value	$ 4,931		$ 4,918
Term Loan, Prime Index Two [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.50%		14.50%
Margin	6%		6%
Floor	14.25%		14.25%
Ceiling	0%		0%
ETP	5%		4%
Maturity Date	Dec. 01, 2026		Dec. 01, 2026
Principal Amount	$ 1,250		$ 1,250
Investments at cost	1,240		1,237
Investments at fair value	$ 1,240		$ 1,188
Term Loan, Prime Index Two [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.86%		13.86%
Margin	5.36%		5.36%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	4.31%		5.50%
Maturity Date	Jan. 01, 2027		Dec. 01, 2024
Principal Amount	$ 1,741		$ 4,666
Investments at cost	1,696		4,579
Investments at fair value	$ 1,598		$ 4,414
Term Loan, Prime Index Two [Member] | Spineology, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	1%		1%
Maturity Date	Apr. 01, 2026		Apr. 01, 2026
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,488		2,489
Investments at fair value	$ 2,488		$ 2,489
Term Loan, Prime Index Two [Member] | MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Oct. 01, 2025		Oct. 01, 2025
Principal Amount	$ 1,333		$ 1,833
Investments at cost	1,328		1,824
Investments at fair value	$ 1,328		$ 1,824
Term Loan, Prime Index Two [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	9%		14%
Margin	0%		5.50%
Floor	0%		8.75%
Ceiling	0%		0%
ETP	18%		6%
Maturity Date	Apr. 01, 2028		Oct. 01, 2025
Principal Amount	$ 2,500		$ 2,125
Investments at cost	2,474		2,096
Investments at fair value	$ 2,354		$ 2,096
Term Loan, Prime Index Two [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Oct. 01, 2028		Oct. 01, 2028
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,924		4,915
Investments at fair value	$ 4,924		$ 4,915
Term Loan, Prime Index Two [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	9%		12.75%
Margin	0%		4.25%
Floor	0%		12.25%
Ceiling	0%		0%
ETP	18%		4%
Maturity Date	Apr. 01, 2028		Aug. 01, 2027
Principal Amount	$ 200		$ 2,500
Investments at cost	187		2,459
Investments at fair value	$ 178		$ 2,459
Term Loan, Prime Index Two [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.75%		13.75%
Margin	5.25%		5.25%
Floor	9%		9%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jul. 01, 2027		Jul. 01, 2027
Principal Amount	$ 3,500		$ 3,500
Investments at cost	3,473		3,467
Investments at fair value	$ 876		$ 3,467
Term Loan, Prime Index Two [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9%		9%
Ceiling	0%		0%
ETP	5.25%		5.25%
Maturity Date	Oct. 31, 2023		Oct. 31, 2023
Principal Amount	$ 2,890		$ 2,301
Investments at cost	2,786		2,301
Investments at fair value	$ 1,665		$ 2,007
Term Loan, Prime Index Two [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.50%		13.50%
Margin	5%		5%
Floor	12%		12%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Mar. 01, 2027		Mar. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,953		4,942
Investments at fair value	$ 4,953		$ 4,942
Term Loan, Prime Index Two [Member] | VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.25%		12.25%
Margin	3.75%		3.75%
Floor	12.25%		12.25%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Jan. 01, 2029		Jan. 01, 2029
Principal Amount	$ 10,000		$ 10,000
Investments at cost	9,803		9,784
Investments at fair value	$ 9,803		$ 9,784
Term Loan, Prime Index Two [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	11.25%		12%
Margin	2.75%		3.50%
Floor	9.25%		11.50%
Ceiling	0%		0%
ETP	4%		5%
Maturity Date	Mar. 01, 2029		Sep. 01, 2027
Principal Amount	$ 5,000		$ 2,500
Investments at cost	4,935		2,454
Investments at fair value	$ 4,935		$ 2,454
Term Loan, Prime Index Two [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		12%
Margin	5.50%		3.50%
Floor	8.75%		8.25%
Ceiling	0%		0%
ETP	6%		5.50%
Maturity Date	Aug. 01, 2026		Oct. 01, 2024
Principal Amount	$ 2,014		$ 3,750
Investments at cost	1,997		3,738
Investments at fair value	$ 1,997		$ 3,738
Term Loan, Prime Index Two [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Aug. 01, 2026		Aug. 01, 2026
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,971		4,959
Investments at fair value	$ 4,971		$ 4,959
Term Loan, Prime Index Two [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.59%		14%
Margin	5.09%		5.50%
Floor	10%		8.75%
Ceiling	0%		0%
ETP	5%		6%
Maturity Date	Mar. 01, 2024		Aug. 01, 2026
Principal Amount	$ 533		$ 2,292
Investments at cost	533		2,273
Investments at fair value	$ 533		$ 2,273
Term Loan, Prime Index Two [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			14.75%
Margin			6.25%
Floor			9.50%
Ceiling			0%
ETP			4%
Maturity Date			Jul. 01, 2028
Principal Amount			$ 1,875
Investments at cost			1,787
Investments at fair value			$ 1,787
Term Loan, Prime Index Two [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			13.32%
Margin			4.82%
Floor			9.25%
Ceiling			0%
ETP			10.36%
Maturity Date			Jul. 01, 2025
Principal Amount			$ 3,960
Investments at cost			3,923
Investments at fair value			$ 3,923
Term Loan, Prime Index Two [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			13.59%
Margin			5.09%
Floor			10%
Ceiling			0%
ETP			5%
Maturity Date			Jan. 01, 2024
Principal Amount			$ 33
Investments at cost			33
Investments at fair value			$ 33
Term Loan, Prime Index Two [Member] | Standvast Holdings, LLC [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.75%
Margin	4.25%
Floor	12.75%
Ceiling	0%
ETP	3%
Maturity Date	Jun. 01, 2028
Principal Amount	$ 2,500
Investments at cost	2,415
Investments at fair value	$ 2,415
Term Loan, Prime Index Two [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.75%		12.75%
Margin	4.25%		4.25%
Floor	12%		12%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Jun. 01, 2028		Jun. 01, 2028
Principal Amount	$ 3,500		$ 3,500
Investments at cost	3,490		3,489
Investments at fair value	$ 3,490		$ 3,489
Term Loan, Prime Index Two [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	16.25%		16.25%
Margin	7.75%		7.75%
Floor	11%		11%
Ceiling	0%		0%
ETP	0%		0%
Maturity Date	May 01, 2027		May 01, 2027
Principal Amount	$ 653		$ 602
Investments at cost	543		543
Investments at fair value	$ 285		$ 436
Term Loan, Prime Index Two [Member] | MicroTransponder, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.25%		12.25%
Margin	3.75%		3.75%
Floor	12.25%		12.25%
Ceiling	0%		0%
ETP	3.50%		3.50%
Maturity Date	Jan. 01, 2029		Jan. 01, 2029
Principal Amount	$ 3,750		$ 3,750
Investments at cost	3,694		3,689
Investments at fair value	$ 3,694		$ 3,689
Term Loan, Prime Index Two [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			14.75%
Margin			6.25%
Floor			9.50%
Ceiling			0%
ETP			4%
Maturity Date			Sep. 01, 2024
Principal Amount			$ 1,500
Investments at cost			1,481
Investments at fair value			$ 1,481
Term Loan, Prime Index Two [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.50%		12.50%
Margin	4%		4%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	3.50%		3.50%
Maturity Date	Jun. 01, 2027		Jun. 01, 2027
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,472		2,467
Investments at fair value	$ 2,472		$ 2,467
Term Loan, Prime Index Two [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	14%		14%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Oct. 01, 2028		Oct. 01, 2028
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,469		2,466
Investments at fair value	2,469		2,466
Common Stock Warrants [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	46		47
Investments at fair value	$ 62		$ 61
Number of Shares (in shares)	1,991		1,991
Common Stock Warrants [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 455		$ 455
Investments at fair value	$ 63		$ 46
Number of Shares (in shares)	516,732		516,732
Common Stock Warrants [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 311		$ 311
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	117		117
Common Stock Warrants [Member] | LiquiGlide, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost			$ 39
Investments at fair value			$ 50
Number of Shares (in shares)			61,359
Common Stock Warrants [Member] | Parse Biosciences, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 71		$ 70
Investments at fair value	$ 70		$ 70
Number of Shares (in shares)	32,244		32,244
Common Stock Warrants [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 490		$ 490
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	215,171		215,171
Common Stock Warrants [Member] | Imunon, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 64		$ 65
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	19,671		19,671
Common Stock Warrants [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 19
Investments at fair value	$ 19
Number of Shares (in shares)	296
Common Stock Warrants [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 3,178		$ 2,947
Investments at fair value	$ 2,490		$ 2,259
Number of Shares (in shares)	1,446,429		1,312,500
Common Stock Warrants [Member] | Mustang Bio, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 146		$ 146
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	16,611		16,611
Common Stock Warrants [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 160		$ 160
Investments at fair value	$ 157		$ 606
Number of Shares (in shares)	299,848		299,848
Common Stock Warrants [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 278		$ 278
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	175,098		175,098
Common Stock Warrants [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 265		$ 264
Investments at fair value	$ 117		$ 113
Number of Shares (in shares)	318,181		318,181
Common Stock Warrants [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 223		$ 223
Investments at fair value	$ 255		$ 247
Number of Shares (in shares)	948,275		948,275
Common Stock Warrants [Member] | Aterian, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost			$ 195
Investments at fair value			$ 0
Number of Shares (in shares)			76,923
Common Stock Warrants [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 188		$ 188
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	12,618		12,618
Common Stock Warrants [Member] | Xeris Pharmaceuticals, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 73		$ 72
Investments at fair value	$ 29		$ 33
Number of Shares (in shares)	126,000		126,000
Common Stock Warrants [Member] | AccuVein Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 7		$ 24
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	271		1,175
Common Stock Warrants [Member] | CZV, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 79		$ 81
Investments at fair value	$ 74		$ 71
Number of Shares (in shares)	65,569		65,569
Common Stock Warrants [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 0
Investments at fair value	$ 1
Number of Shares (in shares)	30,585
Common Stock Warrants [Member] | CVRx, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 76		$ 76
Investments at fair value	$ 142		$ 980
Number of Shares (in shares)	47,410		47,410
Common Stock Warrants [Member] | Halio, Inc [Member] | Power Management Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 1,585		$ 1,585
Investments at fair value	$ 2,700		$ 2,700
Number of Shares (in shares)	38,241,466		38,241,466
Common Stock Warrants [Member] | E La Carte, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 60		$ 60
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	147,361		147,361
Preferred Stock Warrants [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 214		$ 214
Investments at fair value	$ 225		$ 318
Number of Shares (in shares)	7,404		7,404
Preferred Stock Warrants [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 103		$ 103
Investments at fair value	$ 341		$ 215
Number of Shares (in shares)	34,410		34,410
Preferred Stock Warrants [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 81		$ 81
Investments at fair value	$ 74		$ 72
Number of Shares (in shares)	400,000		400,000
Preferred Stock Warrants [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 46		$ 46
Investments at fair value	$ 0		$ 12
Number of Shares (in shares)	171,370		171,370
Preferred Stock Warrants [Member] | LiquiGlide, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 39
Investments at fair value	$ 30
Number of Shares (in shares)	61,359
Preferred Stock Warrants [Member] | Parse Biosciences, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 166		$ 166
Investments at fair value	$ 173		$ 166
Number of Shares (in shares)	184,253		184,253
Preferred Stock Warrants [Member] | CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 36		$ 22
Investments at fair value	$ 41		$ 27
Number of Shares (in shares)	112,356		75,997
Preferred Stock Warrants [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 273		$ 273
Investments at fair value	$ 7		$ 13
Number of Shares (in shares)	639,918		639,918
Preferred Stock Warrants [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 176		$ 178
Investments at fair value	$ 136		$ 246
Number of Shares (in shares)	110,402		110,402
Preferred Stock Warrants [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 275		$ 275
Investments at fair value	$ 278		$ 269
Number of Shares (in shares)	2,637,133		2,637,043
Preferred Stock Warrants [Member] | Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 30		$ 29
Investments at fair value	$ 125		$ 122
Number of Shares (in shares)	46,745		46,745
Preferred Stock Warrants [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 382		$ 214
Investments at fair value	$ 516		$ 340
Number of Shares (in shares)	1,076		681
Preferred Stock Warrants [Member] | Kate Farms, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 102		$ 102
Investments at fair value	$ 979		$ 1,366
Number of Shares (in shares)	82,965		82,965
Preferred Stock Warrants [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 49		$ 50
Investments at fair value	$ 55		$ 53
Number of Shares (in shares)	48,076		48,076
Preferred Stock Warrants [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 167		$ 167
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	85,066		85,066
Preferred Stock Warrants [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 178		$ 175
Investments at fair value	$ 89		$ 80
Number of Shares (in shares)	49,693		46,311
Preferred Stock Warrants [Member] | Elligo Health Research, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 191		$ 192
Investments at fair value	$ 95		$ 99
Number of Shares (in shares)	652,250		652,250
Preferred Stock Warrants [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 454		$ 94
Investments at fair value	$ 622		$ 250
Number of Shares (in shares)	53,264		37,282
Preferred Stock Warrants [Member] | Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 34		$ 32
Investments at fair value	$ 138		$ 120
Number of Shares (in shares)	101,308		101,308
Preferred Stock Warrants [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 64		$ 64
Investments at fair value	$ 64		$ 157
Number of Shares (in shares)	103,679		103,679
Preferred Stock Warrants [Member] | Medsphere Systems Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 60		$ 60
Investments at fair value	$ 0		$ 108
Number of Shares (in shares)	7,097,792		7,097,792
Preferred Stock Warrants [Member] | SafelyYou, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 163		$ 163
Investments at fair value	$ 51		$ 50
Number of Shares (in shares)	150,353		150,353
Preferred Stock Warrants [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 43		$ 43
Investments at fair value	$ 0		$ 1
Number of Shares (in shares)	85,543		85,543
Preferred Stock Warrants [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 312		$ 312
Investments at fair value	$ 229		$ 225
Number of Shares (in shares)	709,981		691,895
Preferred Stock Warrants [Member] | Intelepeer Holdings, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 138		$ 138
Investments at fair value	$ 2,838		$ 3,036
Number of Shares (in shares)	2,936,535		2,936,535
Preferred Stock Warrants [Member] | PebblePost, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 92		$ 92
Investments at fair value	$ 132		$ 131
Number of Shares (in shares)	598,850		598,850
Preferred Stock Warrants [Member] | Spineology, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 21
Investments at fair value	$ 21
Number of Shares (in shares)	128,848
Preferred Stock Warrants [Member] | MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 28		$ 29
Investments at fair value	$ 27		$ 56
Number of Shares (in shares)	250		250
Preferred Stock Warrants [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 93		$ 93
Investments at fair value	$ 8		$ 0
Number of Shares (in shares)	20,000		20,000
Preferred Stock Warrants [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 195		$ 194
Investments at fair value	$ 173		$ 172
Number of Shares (in shares)	1,600,002		1,600,002
Preferred Stock Warrants [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 71		$ 71
Investments at fair value	$ 0		$ 1
Number of Shares (in shares)	135,484		135,484
Preferred Stock Warrants [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 9		$ 9
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	1,224,752		1,224,752
Preferred Stock Warrants [Member] | Caastle, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost			$ 65
Investments at fair value			$ 1,055
Number of Shares (in shares)			268,591
Preferred Stock Warrants [Member] | Aerin Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 66		$ 66
Investments at fair value	$ 1,036		$ 1,199
Number of Shares (in shares)	1,818,183		1,818,183
Preferred Stock Warrants [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 116		$ 115
Investments at fair value	$ 0		$ 2
Number of Shares (in shares)	84,037		84,037
Preferred Stock Warrants [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 48		$ 48
Investments at fair value	$ 10		$ 9
Number of Shares (in shares)	8,800		8,800
Preferred Stock Warrants [Member] | VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 432		$ 432
Investments at fair value	$ 355		$ 379
Number of Shares (in shares)	4,109		4,109
Preferred Stock Warrants [Member] | Canary Medical Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 86		$ 86
Investments at fair value	$ 1,280		$ 1,305
Number of Shares (in shares)	12,153		12,153
Preferred Stock Warrants [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 152		$ 152
Investments at fair value	$ 139		$ 135
Number of Shares (in shares)	93,336		93,336
Preferred Stock Warrants [Member] | Reputation Institute, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 63		$ 56
Investments at fair value	$ 94		$ 80
Number of Shares (in shares)	4,104		3,731
Preferred Stock Warrants [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 139		$ 69
Investments at fair value	$ 237		$ 229
Number of Shares (in shares)	219,866		145,483
Preferred Stock Warrants [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 123		$ 123
Investments at fair value	$ 72		$ 135
Number of Shares (in shares)	309,208		309,208
Preferred Stock Warrants [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 162		$ 149
Investments at fair value	$ 213		$ 167
Number of Shares (in shares)	4,635,992		4,106,174
Preferred Stock Warrants [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 181		$ 182
Investments at fair value	$ 145		$ 145
Number of Shares (in shares)	11,550		11,550
Preferred Stock Warrants [Member] | Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 57		$ 57
Investments at fair value	$ 594		$ 591
Number of Shares (in shares)	553,778		553,778
Preferred Stock Warrants [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 256		$ 221
Investments at fair value	$ 208		$ 206
Number of Shares (in shares)	9,313,541		7,972,222
Preferred Stock Warrants [Member] | Quip NYC Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 325		$ 325
Investments at fair value	$ 0		$ 533
Number of Shares (in shares)	6,191		6,191
Preferred Stock Warrants [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 174		$ 174
Investments at fair value	$ 135		$ 124
Number of Shares (in shares)	2,839,739		3,341,376
Preferred Stock Warrants [Member] | Standvast Holdings, LLC [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 275
Investments at fair value	$ 273
Number of Shares (in shares)	1,225,492
Preferred Stock Warrants [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 65		$ 64
Investments at fair value	$ 78		$ 135
Number of Shares (in shares)	682		682
Preferred Stock Warrants [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 32		$ 32
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	171,081		171,081
Preferred Stock Warrants [Member] | InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 124		$ 124
Investments at fair value	$ 50		$ 26
Number of Shares (in shares)	2,010,424		2,010,424
Preferred Stock Warrants [Member] | Lotame Solutions, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 18		$ 18
Investments at fair value	$ 42		$ 42
Number of Shares (in shares)	71,305		71,305
Preferred Stock Warrants [Member] | Updater, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 34		$ 34
Investments at fair value	$ 27		$ 0
Number of Shares (in shares)	108,333		114,659
Preferred Stock Warrants [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 194		$ 194
Investments at fair value	$ 381		$ 368
Number of Shares (in shares)	809,931		809,931
Preferred Stock Warrants [Member] | CPG Beyond, Inc [Member] | Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 242		$ 242
Investments at fair value	$ 300		$ 294
Number of Shares (in shares)	500,000		500,000
Preferred Stock Warrants [Member] | Meditrina, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 83		$ 83
Investments at fair value	$ 41		$ 93
Number of Shares (in shares)	233,993		233,993
Preferred Stock Warrants [Member] | Silk, Inc [Member] | Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 175		$ 175
Investments at fair value	$ 128		$ 124
Number of Shares (in shares)	394,110		394,110
Preferred Stock Warrants [Member] | MicroTransponder, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 47		$ 47
Investments at fair value	$ 49		$ 47
Number of Shares (in shares)	103,172		103,172
Preferred Stock Warrants [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 364		$ 364
Investments at fair value	$ 162		$ 210
Number of Shares (in shares)	344,102		344,102
Preferred Stock Warrants [Member] | Global Worldwide LLC [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 75		$ 75
Investments at fair value	$ 62		$ 63
Number of Shares (in shares)	245,810		245,810
Preferred Stock Warrants [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 120		$ 120
Investments at fair value	$ 212		$ 105
Number of Shares (in shares)	345,443		345,443
Preferred Stock Warrants [Member] | Rocket Lawyer Incorporated [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 92		$ 92
Investments at fair value	$ 324		$ 318
Number of Shares (in shares)	261,721		261,721
Preferred Stock Warrants [Member] | Skillshare, Inc [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 162		$ 162
Investments at fair value	$ 817		$ 1,201
Number of Shares (in shares)	139,074		139,074
Preferred Stock Warrants [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 98		$ 98
Investments at fair value	$ 182		$ 174
Number of Shares (in shares)	161,215		161,215
Preferred Stock Warrants [Member] | Avalanche Technology, Inc [Member] | Semiconductor Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 45		$ 45
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	5,938		5,938
Preferred Stock Warrants [Member] | Everstream Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 70		$ 70
Investments at fair value	$ 65		$ 63
Number of Shares (in shares)	350,000		350,000
Preferred Stock Warrants [Member] | Revinate Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 44		$ 44
Investments at fair value	$ 94		$ 91
Number of Shares (in shares)	682,034		682,034
Preferred Stock Warrants [Member] | SIGNiX, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 225		$ 225
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	186,235		186,235
Preferred Stock Warrants [Member] | Topia Mobility, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 138		$ 138
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	3,049,607		3,049,607
Preferred Stock Warrants [Member] | xAd, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 177		$ 177
Investments at fair value	$ 8		$ 5
Number of Shares (in shares)	4,343,348		4,343,348
Common Stock [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 250		$ 250
Investments at fair value	$ 250		$ 250
Number of Shares (in shares)	1,162		1,162
Common Stock [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at cost	$ 5,000		$ 5,000
Investments at fair value	$ 0		$ 132
Number of Shares (in shares)	2,164,502		2,164,502
Common Stock [Member] | Better Place Forests Co. [Member] | Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments at cost	$ 2,060		$ 2,061
Investments at fair value	$ 0		$ 2,165
Number of Shares (in shares)	2,278,272		2,278,272
Common Stock [Member] | Aulea Medical, Inc. [Member] | Medical Device Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at cost	$ 0		$ 0
Investments at fair value	$ 0		$ 0
Number of Shares (in shares)	660,537		660,537
Common Stock [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 355		$ 355
Investments at fair value	$ 355		$ 355
Number of Shares (in shares)	32,831		32,831
Common Stock [Member] | Lumithera, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 2,000		$ 2,000
Investments at fair value	$ 1,700		$ 1,700
Number of Shares (in shares)	392,651		392,651
Common Stock [Member] | Cadrenal Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 0		$ 0
Investments at fair value	$ 283		$ 443
Number of Shares (in shares)	600,000		600,000
Common Stock [Member] | Getaround, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 253		$ 253
Investments at fair value	$ 12		$ 20
Number of Shares (in shares)	87,082		87,082
Common Stock [Member] | SnagAJob.com, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 10		$ 9
Investments at fair value	$ 81		$ 83
Number of Shares (in shares)	82,974		82,974
Common Stock [Member] | Tigo Energy, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 111		$ 111
Investments at fair value	$ 10		$ 13
Number of Shares (in shares)	5,205		5,205
Restricted Short Term Investments [Member]
Investments at cost	$ 3,221		$ 2,642
Investments at fair value	3,221		2,642
Restricted Short Term Investments [Member] | U S Bank Money Market Deposit Account [Member]
Investments at cost	3,221		2,642
Investments at fair value	$ 3,221		$ 2,642
Term Loan, Prime Index Three [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.25%		13.25%
Margin	4.75%		4.75%
Floor	9.55%		9.55%
Ceiling	13.50%		13.50%
ETP	5.50%		5.50%
Maturity Date	May 01, 2026		May 01, 2026
Principal Amount	$ 2,750		$ 3,000
Investments at cost	2,742		2,987
Investments at fair value	$ 2,742		$ 2,987
Term Loan, Prime Index Three [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.75%		13.75%
Margin	5.25%		5.25%
Floor	9%		9%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jan. 01, 2027		Jan. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,953		4,943
Investments at fair value	$ 4,953		$ 4,943
Term Loan, Prime Index Three [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.50%		14.50%
Margin	6%		6%
Floor	9.25%		9.25%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Jun. 01, 2026		Jun. 01, 2026
Principal Amount	$ 5,000		$ 6,250
Investments at cost	4,975		6,218
Investments at fair value	$ 4,975		$ 6,218
Term Loan, Prime Index Three [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15%		15%
Margin	6.50%		6.50%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	3.50%		3.50%
Maturity Date	Aug. 01, 2026		Aug. 01, 2026
Principal Amount	$ 2,607		$ 2,548
Investments at cost	2,576		2,507
Investments at fair value	$ 2,345		$ 2,375
Term Loan, Prime Index Three [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Cash Rate	12.75%		12.75%
Margin	4.25%		4.25%
Floor	11%		11%
Ceiling	0%		0%
ETP	4.25%		2.27%
Maturity Date	Jan. 01, 2028		Jan. 01, 2028
Principal Amount	$ 3,539		$ 3,319
Investments at cost	3,137		3,137
Investments at fair value	$ 2,101		$ 133
Term Loan, Prime Index Three [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member]
Cash Rate	12.25%
Margin	3.75%
Floor	12%
Ceiling	0%
ETP	0%
Maturity Date	Aug. 01, 2025
Principal Amount	$ 505
Investments at cost	505
Investments at fair value	$ 420
Term Loan, Prime Index Three [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.50%		14.50%
Margin	6%		6%
Floor	9.25%		9.25%
Ceiling	0%		0%
ETP	3.50%		3.50%
Maturity Date	Jun. 01, 2026		Jun. 01, 2026
Principal Amount	$ 3,214		$ 5,000
Investments at cost	3,193		4,968
Investments at fair value	$ 2,248		$ 4,968
Term Loan, Prime Index Three [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Apr. 01, 2026		Apr. 01, 2026
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,964		4,947
Investments at fair value	$ 4,964		$ 4,947
Term Loan, Prime Index Three [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		13.22%
Margin	5.75%		4.72%
Floor	9%		9.75%
Ceiling	0%		0%
ETP	3%		5%
Maturity Date	Jul. 01, 2025		Nov. 01, 2025
Principal Amount	$ 1,083		$ 5,000
Investments at cost	1,055		4,950
Investments at fair value	$ 1,055		$ 4,950
Term Loan, Prime Index Three [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 8,871		$ 8,425
Investments at cost	7,996		8,229
Investments at fair value	$ 2,129		$ 4,481
Term Loan, Prime Index Three [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	8%		8%
Maturity Date	Sep. 01, 2027		Sep. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,953		4,946
Investments at fair value	$ 4,953		$ 4,946
Term Loan, Prime Index Three [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	2.75%		2.75%
Maturity Date	May 01, 2026		May 01, 2026
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,924		4,956
Investments at fair value	$ 4,924		$ 4,956
Term Loan, Prime Index Three [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Aug. 01, 2027		Aug. 01, 2027
Principal Amount	$ 3,500		$ 3,500
Investments at cost	3,470		3,463
Investments at fair value	$ 3,470		$ 3,463
Term Loan, Prime Index Three [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	10.50%		10.50%
Ceiling	0%		0%
ETP	7.78%		7.78%
Maturity Date	Feb. 01, 2028		Feb. 01, 2028
Principal Amount	$ 2,813		$ 2,813
Investments at cost	2,813		2,813
Investments at fair value	$ 2,813		$ 2,813
Term Loan, Prime Index Three [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Apr. 01, 2028		Apr. 01, 2028
Principal Amount	$ 7,500		$ 7,500
Investments at cost	7,393		7,379
Investments at fair value	$ 7,393		$ 7,379
Term Loan, Prime Index Three [Member] | Elligo Health Research, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Oct. 01, 2027		Oct. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,935		4,925
Investments at fair value	$ 4,935		$ 4,925
Term Loan, Prime Index Three [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.25%
Margin			6%
Floor			9.50%
Ceiling			11.25%
ETP			3%
Maturity Date			Jul. 01, 2027
Principal Amount			$ 3,750
Investments at cost			3,726
Investments at fair value			$ 3,726
Term Loan, Prime Index Three [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.86%		14.25%
Margin	5.36%		5.75%
Floor	9.50%		9.75%
Ceiling	0%		0%
ETP	4.31%		3.75%
Maturity Date	Jan. 01, 2027		Sep. 01, 2026
Principal Amount	$ 1,741		$ 3,750
Investments at cost	1,696		3,717
Investments at fair value	$ 1,598		$ 3,717
Term Loan, Prime Index Three [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.50%		14.50%
Margin	6%		6%
Floor	14.25%		14.25%
Ceiling	0%		0%
ETP	5%		4%
Maturity Date	Apr. 01, 2027		Apr. 01, 2027
Principal Amount	$ 1,000		$ 1,000
Investments at cost	995		994
Investments at fair value	$ 995		$ 954
Term Loan, Prime Index Three [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.86%		13.86%
Margin	5.36%		5.36%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	4.31%		5.50%
Maturity Date	Jan. 01, 2027		Dec. 01, 2024
Principal Amount	$ 1,741		$ 2,333
Investments at cost	1,695		2,281
Investments at fair value	$ 1,597		$ 2,199
Term Loan, Prime Index Three [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Oct. 01, 2028		Oct. 01, 2028
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,924		4,915
Investments at fair value	$ 4,924		$ 4,915
Term Loan, Prime Index Three [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.75%		13.75%
Margin	5.25%		5.25%
Floor	9%		9%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jul. 01, 2027		Jul. 01, 2027
Principal Amount	$ 3,500		$ 3,500
Investments at cost	3,462		3,456
Investments at fair value	$ 874		$ 3,456
Term Loan, Prime Index Three [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9%		9%
Ceiling	0%		0%
ETP	5.25%		5.25%
Maturity Date	Oct. 31, 2023		Oct. 31, 2023
Principal Amount	$ 2,312		$ 2,876
Investments at cost	2,229		2,876
Investments at fair value	$ 1,332		$ 2,509
Term Loan, Prime Index Three [Member] | NextCar Holding Company, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.75%
Margin	6.25%
Floor	9.50%
Ceiling	0%
ETP	4%
Maturity Date	Sep. 01, 2024
Principal Amount	$ 333
Investments at cost	329
Investments at fair value	$ 329
Term Loan, Prime Index Three [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.50%		13.50%
Margin	5%		5%
Floor	12%		12%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date			Mar. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,953		4,942
Investments at fair value	$ 4,953		$ 4,942
Term Loan, Prime Index Three [Member] | VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.25%		12.25%
Margin	3.75%		3.75%
Floor	12.25%		12.25%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Jan. 01, 2029		Jan. 01, 2029
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,902		4,892
Investments at fair value	$ 4,902		$ 4,892
Term Loan, Prime Index Three [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	11.25%		12%
Margin	2.75%		3.50%
Floor	9.25%		11.50%
Ceiling	0%		0%
ETP	4%		5%
Maturity Date	Mar. 01, 2029		Sep. 01, 2027
Principal Amount	$ 4,000		$ 2,500
Investments at cost	3,948		2,454
Investments at fair value	$ 3,948		$ 2,454
Term Loan, Prime Index Three [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.32%		12%
Margin	4.82%		3.50%
Floor	9.25%		8.25%
Ceiling	0%		0%
ETP	10.36%		5.50%
Maturity Date	Jul. 01, 2025		Oct. 01, 2024
Principal Amount	$ 3,766		$ 1,875
Investments at cost	3,729		1,866
Investments at fair value	$ 3,729		$ 1,866
Term Loan, Prime Index Three [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			14.25%
Margin	5.75%		5.75%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Aug. 01, 2026		Aug. 01, 2026
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,971		4,959
Investments at fair value	$ 4,971		$ 4,959
Term Loan, Prime Index Three [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.75%
Margin	6.25%
Floor	9.50%
Ceiling	0%
ETP	4%
Maturity Date	Jul. 01, 2028
Principal Amount	$ 1,875
Investments at cost	1,796
Investments at fair value	$ 1,796
Term Loan, Prime Index Three [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			13.59%
Margin			5.09%
Floor			10%
Ceiling			0%
ETP			5%
Maturity Date			Mar. 01, 2024
Principal Amount			$ 800
Investments at cost			794
Investments at fair value			$ 794
Term Loan, Prime Index Three [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.75%		12.75%
Margin	4.25%		4.25%
Floor	12%		12%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Jun. 01, 2028		Jun. 01, 2028
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,493		2,492
Investments at fair value	$ 2,493		$ 2,492
Term Loan, Prime Index Three [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	16.25%		16.25%
Margin	7.75%		7.75%
Floor	11%		11%
Ceiling	0%		0%
ETP	0%		0%
Maturity Date	May 01, 2027		May 01, 2027
Principal Amount	$ 653		$ 602
Investments at cost	543		543
Investments at fair value	$ 285		$ 436
Term Loan, Prime Index Three [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.75%		14.75%
Margin	6.25%		6.25%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Sep. 01, 2024		Sep. 01, 2024
Principal Amount	$ 167		$ 750
Investments at cost	164		740
Investments at fair value	$ 164		$ 740
Term Loan, Prime Index Three [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.50%		12.50%
Margin	4%		4%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	3.50%		3.50%
Maturity Date	Jun. 01, 2027		Jun. 01, 2027
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,472		2,467
Investments at fair value	$ 2,472		$ 2,467
Term Loan, Prime Index Three [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	14%		14%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Oct. 01, 2028		Oct. 01, 2028
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,469		2,466
Investments at fair value	2,469		2,466
Preferred Stock [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	261		261
Investments at fair value	$ 306		$ 306
Number of Shares (in shares)	1,810		1,810
Preferred Stock [Member] | Better Place Forests Co. [Member] | Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments at cost	$ 2,500		$ 1,250
Investments at fair value	$ 0		$ 859
Number of Shares (in shares)	5,350,142		3,124,448
Preferred Stock [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 89		$ 89
Investments at fair value	$ 0		$ 89
Number of Shares (in shares)	2,688,971		2,688,971
Preferred Stock [Member] | Caastle, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 2,681
Investments at fair value	$ 2,681
Number of Shares (in shares)	242,180
Preferred Stock [Member] | Decisyon, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 2,800		$ 2,800
Investments at fair value	$ 1,281		$ 1,281
Number of Shares (in shares)	280,000		280,000
Preferred Stock [Member] | Lotame Solutions, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	$ 4		$ 4
Investments at fair value	$ 193		$ 193
Number of Shares (in shares)	66,127		66,127
Term Loan, Prime Index, Four [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.25%		13.25%
Margin	4.75%		4.75%
Floor	9.55%		9.55%
Ceiling	13.50%		13.50%
ETP	5.50%		5.50%
Maturity Date	May 01, 2026		May 01, 2026
Principal Amount	$ 4,583		$ 5,000
Investments at cost	4,570		4,979
Investments at fair value	$ 4,570		$ 4,979
Term Loan, Prime Index, Four [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.75%		13.75%
Margin	5.25%		5.25%
Floor	9%		9%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jan. 01, 2027		Jan. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,918		4,900
Investments at fair value	$ 4,918		$ 4,900
Term Loan, Prime Index, Four [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Cash Rate	12.75%		12.75%
Margin	4.25%		4.25%
Floor	11%		11%
Ceiling	0%		0%
ETP	4.25%		2.27%
Maturity Date	Jan. 01, 2028		Jan. 01, 2028
Principal Amount	$ 3,539		$ 3,319
Investments at cost	3,137		3,137
Investments at fair value	$ 2,101		$ 133
Term Loan, Prime Index, Four [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member]
Cash Rate	12.25%
Margin	3.75%
Floor	12%
Ceiling	0%
ETP	0%
Maturity Date	Aug. 01, 2025
Principal Amount	$ 501
Investments at cost	501
Investments at fair value	$ 415
Term Loan, Prime Index, Four [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Apr. 01, 2026		Apr. 01, 2026
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,964		4,947
Investments at fair value	$ 4,964		$ 4,947
Term Loan, Prime Index, Four [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.25%		13.22%
Margin	4.75%		4.72%
Floor	8.50%		9.75%
Ceiling	0%		0%
ETP	5.50%		5%
Maturity Date	May 01, 2027		May 01, 2026
Principal Amount	$ 6,250		$ 5,000
Investments at cost	6,210		4,949
Investments at fair value	$ 6,210		$ 4,949
Term Loan, Prime Index, Four [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 5,914		$ 5,617
Investments at cost	5,325		5,480
Investments at fair value	$ 1,418		$ 2,984
Term Loan, Prime Index, Four [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	8%		8%
Maturity Date	Sep. 01, 2027		Sep. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,953		4,946
Investments at fair value	$ 4,953		$ 4,946
Term Loan, Prime Index, Four [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	2.75%		2.75%
Maturity Date	May 01, 2026		May 01, 2026
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,462		2,478
Investments at fair value	$ 2,462		$ 2,478
Term Loan, Prime Index, Four [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Apr. 01, 2028		Apr. 01, 2028
Principal Amount	$ 2,750		$ 2,750
Investments at cost	2,715		2,710
Investments at fair value	$ 2,715		$ 2,710
Term Loan, Prime Index, Four [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	10.50%		10.50%
Ceiling	0%		0%
ETP	7.78%		7.78%
Maturity Date	Feb. 01, 2028		Feb. 01, 2028
Principal Amount	$ 2,813		$ 2,813
Investments at cost	2,813		2,813
Investments at fair value	$ 2,813		$ 2,813
Term Loan, Prime Index, Four [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Apr. 01, 2028		Apr. 01, 2028
Principal Amount	$ 3,750		$ 3,750
Investments at cost	3,697		3,690
Investments at fair value	$ 3,697		$ 3,690
Term Loan, Prime Index, Four [Member] | Elligo Health Research, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Oct. 01, 2027		Oct. 01, 2027
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,935		4,925
Investments at fair value	$ 4,935		$ 4,925
Term Loan, Prime Index, Four [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.25%
Margin			6%
Floor			9.50%
Ceiling			11.25%
ETP			3%
Maturity Date			Jul. 01, 2027
Principal Amount			$ 1,250
Investments at cost			1,242
Investments at fair value			$ 1,242
Term Loan, Prime Index, Four [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.86%		13.86%
Margin	5.36%		5.36%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	4.31%		5.50%
Maturity Date	Jan. 01, 2027		Dec. 01, 2024
Principal Amount	$ 1,741		$ 2,333
Investments at cost	1,695		2,281
Investments at fair value	$ 1,597		$ 2,199
Term Loan, Prime Index, Four [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		12%
Margin	3.50%		3.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Oct. 01, 2028		Oct. 01, 2028
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,924		4,915
Investments at fair value	$ 4,924		$ 4,915
Term Loan, Prime Index, Four [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.75%		13.75%
Margin	5.25%		5.25%
Floor	9%		9%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Jul. 01, 2027		Jul. 01, 2027
Principal Amount	$ 3,500		$ 3,500
Investments at cost	3,462		3,456
Investments at fair value	$ 874		$ 3,456
Term Loan, Prime Index, Four [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9%		9%
Ceiling	0%		0%
ETP	5.25%		5.25%
Maturity Date	Oct. 31, 2023		Oct. 31, 2023
Principal Amount	$ 2,890		$ 3,451
Investments at cost	2,786		3,451
Investments at fair value	$ 1,665		$ 3,011
Term Loan, Prime Index, Four [Member] | VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.25%		12.25%
Margin	3.75%		3.75%
Floor	12.25%		12.25%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Jan. 01, 2029		Jan. 01, 2029
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,451		2,446
Investments at fair value	$ 2,451		$ 2,446
Term Loan, Prime Index, Four [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			12%
Margin			3.50%
Floor			8.25%
Ceiling			0%
ETP			5.50%
Maturity Date			Oct. 01, 2024
Principal Amount			$ 1,875
Investments at cost			1,866
Investments at fair value			$ 1,866
Term Loan, Prime Index, Four [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9.75%		9.75%
Ceiling	0%		0%
ETP	5%		5%
Maturity Date	Aug. 01, 2026		Aug. 01, 2026
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,971		4,959
Investments at fair value	$ 4,971		$ 4,959
Term Loan, Prime Index, Four [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.75%		12.75%
Margin	4.25%		4.25%
Floor	12%		12%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Jun. 01, 2028		Jun. 01, 2028
Principal Amount	$ 1,500		$ 1,500
Investments at cost	1,496		1,495
Investments at fair value	$ 1,496		$ 1,495
Term Loan, Prime Index, Four [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.75%		14.75%
Margin	6.25%		6.25%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Sep. 01, 2024		Sep. 01, 2024
Principal Amount	$ 167		$ 667
Investments at cost	164		656
Investments at fair value	$ 164		$ 656
Term Loan, Prime Index, Four [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	14%		14%
Ceiling	0%		0%
ETP	3%		3%
Maturity Date	Oct. 01, 2028		Oct. 01, 2028
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,469		2,466
Investments at fair value	2,469		2,466
Equity Securities [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	8,814		6,132
Investments at fair value	7,152		4,733
Equity Securities [Member] | Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments at cost	4,560		3,311
Investments at fair value	0		3,024
Equity Securities [Member] | Life Science [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Investments at cost	5,000		5,000
Investments at fair value	$ 0		$ 132
Number of Shares (in shares)
Term Loan, Prime Index, Five [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.25%		13.25%
Margin	4.75%		4.75%
Floor	9.55%		9.55%
Ceiling	13.50%		13.50%
ETP	5.50%		5.50%
Maturity Date	May 01, 2026		May 01, 2026
Principal Amount	$ 4,583		$ 5,000
Investments at cost	4,570		4,979
Investments at fair value	$ 4,570		$ 4,979
Term Loan, Prime Index, Five [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Cash Rate	12.75%		12.75%
Margin	4.25%		4.25%
Floor	11%		11%
Ceiling	0%		0%
ETP	4.25%		2.27%
Maturity Date	Jan. 01, 2028		Jan. 01, 2028
Principal Amount	$ 2,359		$ 2,213
Investments at cost	2,091		2,091
Investments at fair value	$ 1,401		$ 88
Term Loan, Prime Index, Five [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 5,914		$ 5,617
Investments at cost	5,325		5,480
Investments at fair value	$ 1,418		$ 2,984
Term Loan, Prime Index, Five [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%
Margin	3.50%
Floor	11.75%
Ceiling	0%
ETP	8%
Maturity Date	Apr. 01, 2028
Principal Amount	$ 3,750
Investments at cost	3,708
Investments at fair value	$ 3,708
Term Loan, Prime Index, Five [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	2.75%		2.75%
Maturity Date	Dec. 01, 2026		Dec. 01, 2026
Principal Amount	$ 5,000		$ 5,000
Investments at cost	4,936		4,934
Investments at fair value	$ 4,936		$ 4,934
Term Loan, Prime Index, Five [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%		15.25%
Margin	6.75%		6.75%
Floor	10%		10%
Ceiling	0%		0%
ETP	2.50%		2.50%
Maturity Date	Apr. 01, 2028		Apr. 01, 2028
Principal Amount	$ 3,750		$ 3,750
Investments at cost	3,697		3,690
Investments at fair value	$ 3,697		$ 3,690
Term Loan, Prime Index, Five [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.25%
Margin			6%
Floor			9.50%
Ceiling			11.25%
ETP			3%
Maturity Date			Jul. 01, 2027
Principal Amount			$ 3,750
Investments at cost			3,726
Investments at fair value			$ 3,726
Term Loan, Prime Index, Five [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		13.86%
Margin	5.50%		5.36%
Floor	8.75%		9.50%
Ceiling	0%		0%
ETP	6%		5.50%
Maturity Date	Oct. 01, 2025		Dec. 01, 2024
Principal Amount	$ 1,619		$ 2,333
Investments at cost	1,599		2,278
Investments at fair value	$ 1,599		$ 2,196
Term Loan, Prime Index, Five [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9%		9%
Ceiling	0%		0%
ETP	5.25%		5.25%
Maturity Date	Oct. 31, 2023		Oct. 31, 2023
Principal Amount	$ 3,468		$ 2,876
Investments at cost	3,343		2,876
Investments at fair value	$ 1,999		$ 2,510
Term Loan, Prime Index, Five [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.75%
Margin	4.25%
Floor	12%
Ceiling	0%
ETP	2.50%
Maturity Date	Jul. 01, 2029
Principal Amount	$ 5,000
Investments at cost	4,983
Investments at fair value	$ 4,983
Term Loan, Prime Index, Five [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.75%		14.75%
Margin	6.25%		6.25%
Floor	9.50%		9.50%
Ceiling	0%		0%
ETP	4%		4%
Maturity Date	Sep. 01, 2024		Sep. 01, 2024
Principal Amount	$ 167		$ 750
Investments at cost	161		729
Investments at fair value	$ 161		729
Term Loan, Prime Index, Five [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%
Margin	5.50%
Floor	14%
Ceiling	0%
ETP	3%
Maturity Date	Apr. 01, 2029
Principal Amount	$ 2,500
Investments at cost	2,466
Investments at fair value	2,466
Other Investments [Member] | Life Science [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	8,373		1,200
Investments at fair value	3,347		200
Other Investments [Member] | Life Science [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments at cost	5,925		5,782
Investments at fair value	5,836		6,230
Other Investments [Member] | HIMV LLC [Member] | Life Science [Member] | Investment, Affiliated Issuer, Controlled [Member]
Investments at cost	5,925		5,782
Investments at fair value	$ 5,836		$ 6,230
Term Loan, Prime Index, Six [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	13.25%		13.25%
Margin	4.75%		4.75%
Floor	9.55%		9.55%
Ceiling	13.50%		13.50%
ETP	5.50%		5.50%
Maturity Date	May 01, 2026		May 01, 2026
Principal Amount	$ 2,750		$ 3,000
Investments at cost	2,742		2,987
Investments at fair value	$ 2,742		$ 2,987
Term Loan, Prime Index, Six [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
Cash Rate	12.75%		12.75%
Margin	4.25%		4.25%
Floor	11%		11%
Ceiling	0%		0%
ETP	4.25%		2.27%
Maturity Date	Jan. 01, 2028		Jan. 01, 2028
Principal Amount	$ 2,359		$ 2,213
Investments at cost	2,091		2,091
Investments at fair value	$ 1,401		$ 88
Term Loan, Prime Index, Six [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	0%		0%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 773		$ 735
Investments at cost	705		726
Investments at fair value	$ 188		$ 395
Term Loan, Prime Index, Six [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%
Margin	3.50%
Floor	11.75%
Ceiling	0%
ETP	8%
Maturity Date	Apr. 01, 2028
Principal Amount	$ 3,750
Investments at cost	3,708
Investments at fair value	$ 3,708
Term Loan, Prime Index, Six [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14%		14%
Margin	5.50%		5.50%
Floor	11.75%		11.75%
Ceiling	0%		0%
ETP	2.75%		2.75%
Maturity Date	Dec. 01, 2026		Dec. 01, 2026
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,468		2,467
Investments at fair value	$ 2,468		$ 2,467
Term Loan, Prime Index, Six [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.50%		14.50%
Margin	6%		6%
Floor	10%		10%
Ceiling	0%		0%
ETP	2%		2%
Maturity Date	Jan. 01, 2029		Jan. 01, 2029
Principal Amount	$ 4,500		$ 4,500
Investments at cost	4,449		4,446
Investments at fair value	$ 4,449		$ 4,446
Term Loan, Prime Index, Six [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.25%
Margin			6%
Floor			9.50%
Ceiling			11.25%
ETP			3%
Maturity Date			Jul. 01, 2027
Principal Amount			$ 1,250
Investments at cost			1,242
Investments at fair value			$ 1,242
Term Loan, Prime Index, Six [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12.75%		13.86%
Margin	4.25%		5.36%
Floor	12.25%		9.50%
Ceiling	0%		0%
ETP	4%		5.50%
Maturity Date	Aug. 01, 2027		Dec. 01, 2024
Principal Amount	$ 2,500		$ 2,333
Investments at cost	2,465		2,278
Investments at fair value	$ 2,465		$ 2,196
Term Loan, Prime Index, Six [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9%		9%
Ceiling	0%		0%
ETP	5.25%		5.25%
Maturity Date	Oct. 31, 2023		Oct. 31, 2023
Principal Amount	$ 2,890		$ 2,876
Investments at cost	2,786		2,876
Investments at fair value	$ 1,665		$ 2,510
Term Loan, Prime Index, Seven [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	0%		0%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 616		$ 586
Investments at cost	561		578
Investments at fair value	$ 149		$ 315
Term Loan, Prime Index, Seven [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%
Margin	3.50%
Floor	11.75%
Ceiling	0%
ETP	8%
Maturity Date	Apr. 01, 2028
Principal Amount	$ 3,750
Investments at cost	3,708
Investments at fair value	$ 3,708
Term Loan, Prime Index, Seven [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.50%		14.50%
Margin	6%		6%
Floor	10%		10%
Ceiling	0%		0%
ETP	2%		2%
Maturity Date	Jan. 01, 2029		Jan. 01, 2029
Principal Amount	$ 2,000		$ 2,000
Investments at cost	1,977		1,976
Investments at fair value	$ 1,977		$ 1,976
Term Loan, Prime Index, Seven [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.25%
Margin			6%
Floor			9.50%
Ceiling			11.25%
ETP			3%
Maturity Date			Jan. 01, 2028
Principal Amount			$ 3,750
Investments at cost			3,712
Investments at fair value			$ 3,712
Term Loan, Prime Index, Seven [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9%		9%
Ceiling	0%		0%
ETP	5.25%		5.25%
Maturity Date	Oct. 31, 2023		Oct. 31, 2023
Principal Amount	$ 5,780		$ 5,752
Investments at cost	5,572		5,752
Investments at fair value	$ 3,331		$ 5,018
Term Loan, Prime Index, Eight [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	0%		0%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 307		$ 292
Investments at cost	280		288
Investments at fair value	$ 75		$ 157
Term Loan, Prime Index, Eight [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%
Margin	3.50%
Floor	11.75%
Ceiling	0%
ETP	8%
Maturity Date	Apr. 01, 2028
Principal Amount	$ 3,750
Investments at cost	3,708
Investments at fair value	$ 3,708
Term Loan, Prime Index, Eight [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.25%
Margin			6%
Floor			9.50%
Ceiling			11.25%
ETP			3%
Maturity Date			Jan. 01, 2028
Principal Amount			$ 3,750
Investments at cost			3,712
Investments at fair value			$ 3,712
Term Loan, Prime Index, Eight [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	14.25%		14.25%
Margin	5.75%		5.75%
Floor	9%		9%
Ceiling	0%		0%
ETP	5.25%		5.25%
Maturity Date	Oct. 31, 2023		Oct. 31, 2023
Principal Amount	$ 2,890		$ 2,876
Investments at cost	2,786		2,876
Investments at fair value	1,665		2,510
Royalty Agreement [Member] | Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	7,227
Investments at fair value	3,247
Royalty Agreement [Member] | Lumithera, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	1,146		1,200
Investments at fair value	100		200
Royalty Agreement [Member] | ZetrOZ, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Investments at cost	0		0
Investments at fair value	$ 0		$ 0
Term Loan, Prime Index, Nine [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	0%		0%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 305		$ 290
Investments at cost	278		286
Investments at fair value	$ 74		$ 156
Term Loan, Prime Index, Nine [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.25%
Margin			6%
Floor			9.50%
Ceiling			11.25%
ETP			3%
Maturity Date			Apr. 01, 2028
Principal Amount			$ 3,750
Investments at cost			3,706
Investments at fair value			$ 3,706
Term Loan, Prime Index, Ten [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	0%		0%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 183		$ 174
Investments at cost	166		172
Investments at fair value	$ 44		$ 93
Term Loan, Prime Index, Ten [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.25%
Margin			6%
Floor			9.50%
Ceiling			11.25%
ETP			3%
Maturity Date			Jul. 01, 2028
Principal Amount			$ 3,750
Investments at cost			3,707
Investments at fair value			$ 3,707
Term Loan, Prime Index, Eleven [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	0%		0%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 842		$ 802
Investments at cost	767		791
Investments at fair value	$ 204		$ 431
Term Loan, Prime Index, Eleven [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate			11.25%
Margin			6%
Floor			9.50%
Ceiling			11.25%
ETP			3%
Maturity Date			Jul. 01, 2028
Principal Amount			$ 3,750
Investments at cost			3,707
Investments at fair value			$ 3,707
Term Loan, Fixed Index One [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%
Margin	0%
Floor	0%
Ceiling	0%
ETP	0%
Maturity Date	Aug. 30, 2024
Principal Amount	$ 422
Investments at cost	384
Investments at fair value	$ 102
Term Loan, Fixed Index One [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	9%		9%
Margin	0%		0%
Floor	0%		0%
Ceiling	0%		0%
ETP	18%		18%
Maturity Date	Apr. 01, 2028		Apr. 01, 2028
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,474		2,468
Investments at fair value	$ 2,354		$ 2,342
Term Loan, Fixed Index Two [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%
Margin	0%
Floor	0%
Ceiling	0%
ETP	0%
Maturity Date	Aug. 30, 2024
Principal Amount	$ 557
Investments at cost	485
Investments at fair value	$ 129
Term Loan, Fixed Index Two [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		9%
Margin	3.50%		0%
Floor	11.50%		0%
Ceiling	0%		0%
ETP	5%		18%
Maturity Date	Sep. 01, 2027		Apr. 01, 2028
Principal Amount	$ 2,500		$ 2,500
Investments at cost	2,460		2,468
Investments at fair value	$ 2,460		$ 2,342
Term Loan, Fixed Index Three [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%
Margin	0%
Floor	0%
Ceiling	0%
ETP	0%
Maturity Date	Aug. 30, 2024
Principal Amount	$ 414
Investments at cost	392
Investments at fair value	$ 104
Term Loan, Fixed Index Three [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	12%		9%
Margin	3.50%		0%
Floor	11.50%		0%
Ceiling	0%		0%
ETP	5%		18%
Maturity Date	Sep. 01, 2027		Jun. 30, 2024
Principal Amount	$ 2,500		$ 200
Investments at cost	2,460		200
Investments at fair value	$ 2,460		$ 190
Term Loan, Prime Index, Twelve [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%		15.50%
Margin	7%		7%
Floor	10.25%		10.25%
Ceiling	0%		0%
ETP	0%		0%
Maturity Date	Mar. 31, 2024		Mar. 31, 2024
Principal Amount	$ 1,145		$ 1,091
Investments at cost	1,050		1,083
Investments at fair value	$ 279		$ 590
Term Loan, Fixed Index Four [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.50%
Margin	0%
Floor	0%
Ceiling	0%
ETP	0%
Maturity Date	Aug. 30, 2024
Principal Amount	$ 491
Investments at cost	471
Investments at fair value	$ 125
Term Loan, LIBOR Index, Two [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member]
Cash Rate	15.25%
Margin	6.75%
Floor	10%
Ceiling	0%
ETP	2.75%
Maturity Date	Apr. 01, 2026
Principal Amount	$ 2,500
Investments at cost	2,461
Investments at fair value	$ 2,461

Consolidated Schedule of Inve_5

Consolidated Schedule of Investments (Unaudited) - Investments (Details) (Parentheticals)	Jun. 30, 2024	Dec. 31, 2023
NAV %	196.70%	218.90%
Investment, Affiliated Issuer, Controlled [Member]
NAV %		4.40%
Investment, Affiliated Issuer, Controlled [Member] | Debt Investments [Member]
NAV %	3.50%
Investment, Affiliated Issuer, Noncontrolled [Member]
NAV %		0.30%
Investment, Unaffiliated Issuer [Member]
NAV %	188.40%	214.20%
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member]
NAV %	66.60%
Unrestricted Short Term Investments [Member]
NAV %	9.80%	1%
Restricted Short Term Investments [Member]
NAV %	1%	0.80%
Debt Securities [Member] | Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member]
NAV %	1.70%	1.60%
Debt Securities [Member] | Investment, Affiliated Issuer, Noncontrolled [Member]
NAV %	4.80%
Debt Securities [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Life Science [Member]
NAV %	4.80%	0.30%
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member]
NAV %	178.80%	205%
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member] | Life Science [Member]
NAV %		75.60%
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member] | Technology Sector [Member]
NAV %		83.30%
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member]
NAV %	19.70%	21.50%
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member]
NAV %	21%	24.60%
Equity Securities [Member] | Investment, Affiliated Issuer, Controlled [Member] | Technology Sector [Member]
NAV %	0%	0.90%
Equity Securities [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Life Science [Member]
NAV %	0%	0%
Equity Securities [Member] | Investment, Unaffiliated Issuer [Member]
NAV %	2.10%	1.50%
Warrant [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Life Science [Member]
NAV %	0%	0%
Warrant [Member] | Investment, Unaffiliated Issuer [Member]
NAV %	6.50%	7.60%
Warrant [Member] | Investment, Unaffiliated Issuer [Member] | Technology Sector [Member]
NAV %	4%	4.50%
Warrant [Member] | Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member]
NAV %	0.40%	0.60%
Warrant [Member] | Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member]
NAV %	1.90%	2.30%
Warrant [Member] | Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member]
NAV %	0.20%	0.20%
Other Investments [Member] | Investment, Affiliated Issuer, Controlled [Member] | Life Science [Member]
NAV %	1.80%	1.90%
Other Investments [Member] | Investment, Unaffiliated Issuer [Member] | Life Science [Member]
NAV %	1%	0.10%
Debt Investments [Member] | Investment, Unaffiliated Issuer [Member] | Life Science [Member]
NAV %	71.50%

Note 1 - Organization (Details

Note 1 - Organization (Details Textual) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023	Aug. 13, 2019
Debt Instrument, Face Amount	$ 715	$ 615
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Co-lender [Member]
Subsidiary, Ownership Percentage, Noncontrolling Owner	30%
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Co-lender [Member]
Investment Owned, Net Assets, Percentage		30%
Horizon Technology Finance Corporation [Member] | Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investment Owned, Net Assets, Percentage	70%	70%
Asset-backed Notes 2019 [Member]
Debt Instrument, Face Amount			$ 160
Asset-backed Notes 2019 [Member] | Affiliated Entity [Member]
Debt Instrument, Face Amount			$ 100

Note 2 - Basis of Presentatio_2

Note 2 - Basis of Presentation and Significant Accounting Policies (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		6 Months Ended		38 Months Ended
	Jun. 02, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Apr. 26, 2024	Dec. 31, 2023	Sep. 22, 2023	Aug. 02, 2021
Investments, Nonaccrual, Interest Income		$ 0	$ 0	$ 0	$ 0
Investment, Income Attributable to Non-cash Paid-in-Kind Interest, Percent		1.40%	3.40%	3.30%	3.80%
Interest Income, Operating, Paid in Kind				$ 1,737	$ 2,154
Investment, Nonaccrual, Income Not Received in Cash, Percent		6.60%	3.10%	6.70%	4.70%
Debt Issuance Costs, Net		$ 8,300		$ 8,300		$ 8,300		$ 5,800
Accumulated Amortization, Debt Issuance Costs		6,000		6,000		$ 6,000		5,200
Amortization of Debt Issuance Costs		$ 400	$ 500	$ 814	$ 950
Federal Excise Tax, Percent		4%		4%		4%
Excise and Sales Taxes		$ 400	$ 200	$ 700	400
Unrecognized Tax Benefits, Ending Balance		$ 0		$ 0		$ 0		0
Open Tax Year				2024 2023 2022 2021
Proceeds from Issuance of Common Stock				$ 29,110	$ 51,175
Share Repurchase Program, Authorized, Amount							$ 5,000
Stock Repurchased During Period, Shares (in shares)		0	0	0	0	167,465
Stock Repurchased During Period, Per Share (in dollars per share)						$ 11.22
Stock Repurchased During Period, Value						$ 1,900
The 2021 Equity Distribution Agreement [Member]
Equity Sales Agreement, Maximum Value										$ 100,000
Equity Sales Agreement, Remaining Amount Available for Issuance									$ 0
Stock Issued During Period, Shares, New Issues (in shares)			448,175		1,054,023
Proceeds from Issuance of Common Stock			$ 5,100		$ 12,300
Payments of Stock Issuance Costs			100		300
The 2023 Equity Distribution Agreement [Member]
Equity Sales Agreement, Maximum Value									$ 150,000
Equity Sales Agreement, Remaining Amount Available for Issuance		$ 117,000		$ 117,000		117,000
Stock Issued During Period, Shares, New Issues (in shares)		1,516,249		2,570,045
Proceeds from Issuance of Common Stock		$ 17,100		$ 29,100
Payments of Stock Issuance Costs		400		600
Public Offering [Member]
Stock Issued During Period, Shares, New Issues (in shares)	3,250,000
Proceeds from Issuance of Common Stock	$ 12,500
Payments of Stock Issuance Costs	$ 38,900
Six Investments [Member]
Investments, Cost, Nonaccrual Status		114,800		114,800		114,800
Investments, Fair Value, Nonaccrual Status		52,500		52,500		$ 52,500
Four Investments [Member]
Investments, Cost, Nonaccrual Status								72,500
Investments, Fair Value, Nonaccrual Status								$ 27,600
Debt Investments [Member]
Interest Income, Operating, Paid in Kind		$ 0
One Investment [Member]
Interest Income, Operating, Paid in Kind				$ 1,000
Three Investments [Member]
Interest Income, Operating, Paid in Kind			$ 1,000		$ 2,200

Note 3 - Related Party Transa_3

Note 3 - Related Party Transactions (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Management Fee Payable	$ 978		$ 978		$ 1,052
Management Fee Expense	3,027	$ 3,207	6,189	$ 6,408
Administrative Fees Expense	426	368	$ 859	808
Investment Management Agreement [Member]
Base Management Fee, Annual, Percent			2%
Base Management Fee, Annual, Percent, Gross Assets Exceeding $250 Million			1.60%
Management Fee Payable	1,000		$ 1,000		1,100
Incentive Fee to Pre-incentive Net Investment Income			20%
Pre-Incentive Fee Net Investment Income, Hurdle Rate			1.75%
Pre-Incentive Fee Net Investment Income, Hurdle Rate, Annualized			7%
Pre-Incentive Fee Net Investment Income, Catch-up, Percent			100%
Pre-Incentive Fee Net Investment Income, Maximum Rate to Trigger Catch-up			2.1875%
Pre-Incentive Fee Net Investment Income, Maximum Rate to Trigger Catch-up, Annualized			8.75%
Incentive Fee Expense	0	100	$ 300	3,100
Incentive Fee Cap and Deferral Mechanism Reduction to Expense	2,600	3,100	4,900	3,300
Incentive Fee Payable	0		0		0
Administration Agreement [Member]
Administrative Fees Expense	400	$ 400	900	$ 800
Administrative Fees Payable	$ 400		$ 400		$ 400

Note 3 - Related Party Transa_4

Note 3 - Related Party Transactions - Expiration Dates of Contingent Future Liability (Details) - Investment Management Agreement [Member] $ in Thousands	Jun. 30, 2024 USD ($)
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	$ 15,716
December 31, 2025 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	1,037
March 31, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	219
June 30, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	3,120
September 30, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	3,471
December 31, 2026 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	3,002
March 31, 2027 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	2,285
June 30, 2027 Expiration [Member]
Incentive Fee Cap and Deferral Mechanism, Contingent Future Liability	$ 2,582

Note 4 - Investments - Investme

Note 4 - Investments - Investments (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Investments at cost	$ 725,430	$ 759,182
Investments at fair value	646,862	709,085
Biotechnology Sector [Member]
Investments at cost	133,486	145,544
Investments at fair value	118,846	117,781
Medical Device Sector [Member]
Investments at cost	163,383	147,064
Investments at fair value	149,839	145,019
Communications Sector [Member]
Investments at cost	15,462	19,192
Investments at fair value	18,263	22,188
Consumer-related Sector [Member]
Investments at cost	78,244	105,669
Investments at fair value	59,113	101,327
Data Storage Sector [Member]
Investments at cost	417	417
Investments at fair value	428	418
Internet and Media Sector [Member]
Investments at cost	329	329
Investments at fair value	1,203	1,582
Networking Sector [Member]
Investments at cost	1,511	5,451
Investments at fair value	1,309	5,297
Power Management Sector [Member]
Investments at cost	1,585	1,585
Investments at fair value	2,700	2,700
Semiconductor Sector [Member]
Investments at cost	45	45
Investments at fair value	0	0
Software Sector [Member]
Investments at cost	163,033	164,133
Investments at fair value	159,279	160,749
Energy Efficiency [Member]
Investments at cost	111	111
Investments at fair value	10	13
Other Sustainability Sector [Member]
Investments at cost	100,274	98,906
Investments at fair value	69,809	80,370
Diagnostics Sector [Member]
Investments at cost	16,210	19,735
Investments at fair value	14,281	19,701
Other Healthcare Sector [Member]
Investments at cost	102	102
Investments at fair value	979	1,366
Software, Healthcare Information and Service [Member]
Investments at cost	51,238	50,899
Investments at fair value	50,803	50,574
Debt [Member]
Investments at cost	675,295	721,231
Investments at fair value	609,068	670,172
Warrant [Member]
Investments at cost	17,463	16,526
Investments at fair value	21,459	24,594
Other Debt Obligations [Member]
Investments at cost	14,298	6,982
Investments at fair value	9,183	6,430
Equity Securities [Member]
Investments at cost	18,374	14,443
Investments at fair value	$ 7,152	$ 7,889

Note 5 - Transactions With Af_3

Note 5 - Transactions With Affiliated Companies (Details Textual) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023
Investment, Affiliated Issuer, Controlled [Member]
Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)	$ 0	$ 0

Note 5 - Transactions With Af_4

Note 5 - Transactions With Affiliated Companies - Investments in Affiliated Companies (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Investments, fair value			$ 709,085
Net unrealized appreciation (depreciation) on investments	$ (24,511)	$ 608	(28,471)	$ (6,929)
Net realized gain (loss) on investments	2,464	(16,529)	2,472	(16,697)
Investments, fair value	646,862		646,862
Interest Income, Operating, Paid in Kind			1,737	2,154
Investment, Affiliated Issuer, Noncontrolled [Member]
Investments, fair value	12,577	846	1,132	0
Purchases	92	0	107	0
Reductions	(40)	0	(40)	0
Transfers in/(out) at fair value	0	0	0	0
Discount accretion	0	0	0	0
Net unrealized appreciation (depreciation) on investments	3,178	60	14,611	906
Net realized gain (loss) on investments	40	0	37	0
Investments, fair value	15,847	906	15,847	906
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member]
Investments, fair value	0		0
Purchases	0		3
Reductions	(40)		(40)
Transfers in/(out) at fair value	0		0
Discount accretion	0		0
Net unrealized appreciation (depreciation) on investments	0		0
Net realized gain (loss) on investments	40		37
Investments, fair value	0		0
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member]
Investments, fair value		846		0
Purchases		0		0
Reductions		0		0
Transfers in/(out) at fair value		0		0
Discount accretion		0		0
Net unrealized appreciation (depreciation) on investments		60		906
Net realized gain (loss) on investments		0		0
Investments, fair value		906		906
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment One [Member]
Investments, fair value	2,790		222
Purchases	0		0
Reductions	0		0
Transfers in/(out) at fair value	0		0
Discount accretion	0		0
Net unrealized appreciation (depreciation) on investments	713		3,281
Net realized gain (loss) on investments	0		0
Investments, fair value	3,503		3,503
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Two [Member]
Investments, fair value	4,207		336
Purchases	92		104
Reductions	0		0
Transfers in/(out) at fair value	0		0
Discount accretion	0		0
Net unrealized appreciation (depreciation) on investments	1,041		4,900
Net realized gain (loss) on investments	0		0
Investments, fair value	5,340		5,340
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Three [Member]
Investments, fair value	1,674		133
Purchases	0		0
Reductions	0		0
Transfers in/(out) at fair value	0		0
Discount accretion	0		0
Net unrealized appreciation (depreciation) on investments	427		1,968
Net realized gain (loss) on investments	0		0
Investments, fair value	2,101		2,101
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Four [Member]
Investments, fair value	1,674		133
Purchases	0		0
Reductions	0		0
Transfers in/(out) at fair value	0		0
Discount accretion	0		0
Net unrealized appreciation (depreciation) on investments	427		1,968
Net realized gain (loss) on investments	0		0
Investments, fair value	2,101		2,101
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Five [Member]
Investments, fair value	1,116		88
Purchases	0		0
Reductions	0		0
Transfers in/(out) at fair value	0		0
Discount accretion	0		0
Net unrealized appreciation (depreciation) on investments	285		1,313
Net realized gain (loss) on investments	0		0
Investments, fair value	1,401		1,401
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Six [Member]
Investments, fair value	1,116		88
Purchases	0		0
Reductions	0		0
Transfers in/(out) at fair value	0		0
Discount accretion	0		0
Net unrealized appreciation (depreciation) on investments	285		1,313
Net realized gain (loss) on investments	0		0
Investments, fair value	1,401		1,401
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Investment Seven [Member]
Investments, fair value			132
Purchases			0
Reductions			0
Transfers in/(out) at fair value			0
Discount accretion			0
Net unrealized appreciation (depreciation) on investments			(132)
Net realized gain (loss) on investments			0
Investments, fair value	0		0
Investment, Affiliated Issuer, Controlled [Member]
Investments, fair value	13,644		14,223
Purchases	1,500		2,477
Reductions	0		(547)
Transfers in/(out) at fair value	463		463
Discount accretion	3		7
Net unrealized appreciation (depreciation) on investments	(4,402)	0	(5,581)	0
Net realized gain (loss) on investments	0		0
Investments, fair value	11,386		11,386
Interest Income, Operating, Paid in Kind	178		344
Interest income	188	$ 0	365	$ 0
Investment, Affiliated Issuer, Controlled [Member] | Investment [Member]
Interest income	188		365
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment One [Member]
Investments, fair value	3,455		3,339
Purchases	0		0
Reductions	0		0
Transfers in/(out) at fair value	0		0
Discount accretion	2		4
Net unrealized appreciation (depreciation) on investments	(406)		(403)
Net realized gain (loss) on investments	0		0
Investments, fair value	3,166		3,166
Interest Income, Operating, Paid in Kind	115		226
Interest income	120		236
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment Two [Member]
Investments, fair value	1,688		1,630
Purchases	0		0
Reductions	0		0
Transfers in/(out) at fair value	0		0
Discount accretion	1		3
Net unrealized appreciation (depreciation) on investments	(197)		(196)
Net realized gain (loss) on investments	0		0
Investments, fair value	1,549		1,549
Interest Income, Operating, Paid in Kind	57		112
Interest income	62		123
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment Three [Member]
Investments, fair value	0		0
Purchases	500		500
Reductions	0		0
Transfers in/(out) at fair value	0		0
Discount accretion	0		0
Net unrealized appreciation (depreciation) on investments	(85)		(85)
Net realized gain (loss) on investments	0
Investments, fair value	420		420
Interest Income, Operating, Paid in Kind	5		5
Interest income	5		5
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment Four [Member]
Investments, fair value	0		0
Purchases	500		500
Reductions	0		0
Transfers in/(out) at fair value	0		0
Discount accretion	0		0
Net unrealized appreciation (depreciation) on investments	(86)		(86)
Net realized gain (loss) on investments	0
Investments, fair value	415		415
Interest Income, Operating, Paid in Kind	1		1
Interest income	1		1
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Investment Five [Member]
Investments, fair value	2,656		3,024
Purchases	500		1,250
Reductions	0		0
Transfers in/(out) at fair value	0		0
Discount accretion	0		0
Net unrealized appreciation (depreciation) on investments	(3,156)		(4,274)
Net realized gain (loss) on investments	0		0
Investments, fair value	0		0
Interest Income, Operating, Paid in Kind	0		0
Interest income	0		0
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member]
Investments, fair value	5,845		6,230
Purchases	0		227
Reductions	0		(547)
Transfers in/(out) at fair value	463		463
Discount accretion	0		0
Net unrealized appreciation (depreciation) on investments	(472)		(537)
Net realized gain (loss) on investments	0		0
Investments, fair value	5,836		5,836
Interest Income, Operating, Paid in Kind	0		0
Interest income	$ 0		$ 0

Note 6 - Fair Value (Details Te

Note 6 - Fair Value (Details Textual) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024 USD ($) $ / shares	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) $ / shares	Jun. 30, 2023 USD ($)	Jun. 30, 2022
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	$ 0	$ (111)	$ 0	$ (111)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3		100		100
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0		0
Unrealized Gain (Loss) on Investments	$ (24,511)	608	(28,471)	(6,929)
Equity Securities [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		(111)		(111)
Warrant [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		$ 0		0
Fair Value, Inputs, Level 3 [Member] | Debt Securities [Member]
Unrealized Gain (Loss) on Investments			(19,700)	(13,100)
Fair Value, Inputs, Level 3 [Member] | Equity Securities [Member]
Unrealized Gain (Loss) on Investments			(4,400)	(1,300)
Fair Value, Inputs, Level 3 [Member] | Warrant [Member]
Unrealized Gain (Loss) on Investments			$ (2,000)	$ (1,900)
The 2026 Notes [Member]
Debt Instrument, Share Price (in dollars per share) | $ / shares	$ 23.88		$ 23.88
The 2026 Notes [Member] | Fair Value, Inputs, Level 1 [Member]
Debt Instrument, Fair Value Disclosure	$ 54,900		$ 54,900
The 2027 Notes [Member]
Debt Instrument, Share Price (in dollars per share) | $ / shares	$ 23.72		$ 23.72
The 2027 Notes [Member] | Fair Value, Inputs, Level 1 [Member]
Debt Instrument, Fair Value Disclosure	$ 54,600		$ 54,600
Asset-backed Notes 2022 [Member] | Fair Value, Inputs, Level 3 [Member]
Debt Instrument, Fair Value Disclosure	$ 100,000		$ 100,000
Measurement Input, Hypothetical Market Yields [Member]
Debt Instrument, Measurement Input					0.25

Note 6 - Fair Value - Assets at

Note 6 - Fair Value - Assets at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Fair Value, Recurring [Member]
Investments, fair value	$ 646,862	$ 709,085
Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	609,068	670,172
Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	21,459	24,594
Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	9,183	6,430
Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	7,152	7,889
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]
Investments, fair value	302	608
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	302	608
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]
Investments, fair value	328	1,619
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	328	1,619
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	0	0
Fair Value, Inputs, Level 3 [Member]
Investments, fair value	646,232	706,858
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member]
Investments, fair value	646,232	706,858
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Debt [Member]
Investments, fair value	609,068	670,172
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Warrant [Member]
Investments, fair value	21,131	22,975
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Other Investments [Member]
Investments, fair value	9,183	6,430
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Equity Securities [Member]
Investments, fair value	$ 6,850	$ 7,281

Note 6 - Fair Value - Significa

Note 6 - Fair Value - Significant Level 3 Fair Value Measurement Inputs (Details) - Fair Value, Inputs, Level 3 [Member] $ in Thousands		Jun. 30, 2024 USD ($)		Dec. 31, 2023 USD ($)
Investments, fair value		$ 646,232		$ 706,858
Multiple Probability Weighted Cash Flow Model [Member] | Minimum [Member] | Probability Weighting [Member]
Investments, measurement input		0
Multiple Probability Weighted Cash Flow Model [Member] | Maximum [Member] | Probability Weighting [Member]
Investments, measurement input		0.20
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member]
Investments, fair value		$ 556,542		$ 617,529
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member] | Minimum [Member] | Hypothetical Market Yield [Member]
Investments, measurement input		0.12		11
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member] | Maximum [Member] | Hypothetical Market Yield [Member]
Investments, measurement input		0.25		24
Debt [Member] | Valuation Technique, Discounted Cash Flow [Member] | Weighted Average [Member] | Hypothetical Market Yield [Member]
Investments, measurement input	[1]	0.15		15
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member]
Investments, fair value		$ 52,526		$ 52,643
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Minimum [Member] | Probability Weighting [Member]
Investments, measurement input		0.05		20
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Maximum [Member] | Probability Weighting [Member]
Investments, measurement input		1		100
Debt [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Weighted Average [Member] | Probability Weighting [Member]
Investments, measurement input	[1]	0.64		50
Warrant [Member] | Black-scholes Valuation Model [Member]
Investments, fair value		$ 21,069		$ 22,913
Warrant [Member] | Black-scholes Valuation Model [Member] | Measurement Input, Price Volatility [Member]
Investments, measurement input		0.25		25
Warrant [Member] | Black-scholes Valuation Model [Member] | Expected Proceeds [Member]
Investments, fair value				$ 62
Warrant [Member] | Black-scholes Valuation Model [Member] | Minimum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		0		0
Warrant [Member] | Black-scholes Valuation Model [Member] | Minimum [Member] | Measurement Input, Discount for Lack of Marketability [Member]
Investments, measurement input		0.17	[1]	0
Warrant [Member] | Black-scholes Valuation Model [Member] | Minimum [Member] | Estimated Time to Exit [Member]
Investments, measurement input		1		1
Warrant [Member] | Black-scholes Valuation Model [Member] | Maximum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		1,898.58		1,899
Warrant [Member] | Black-scholes Valuation Model [Member] | Maximum [Member] | Measurement Input, Discount for Lack of Marketability [Member]
Investments, measurement input				20
Warrant [Member] | Black-scholes Valuation Model [Member] | Maximum [Member] | Estimated Time to Exit [Member]
Investments, measurement input		5		5
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Measurement Input, Share Price [Member]
Investments, measurement input	[1]	74.78		64.95
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Measurement Input, Price Volatility [Member]
Investments, measurement input	[1]	0.25		25
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Measurement Input, Discount for Lack of Marketability [Member]
Investments, measurement input	[1]			18
Warrant [Member] | Black-scholes Valuation Model [Member] | Weighted Average [Member] | Estimated Time to Exit [Member]
Investments, measurement input	[1]	3		3
Warrant [Member] | Expected Proceeds [Member]
Investments, fair value		$ 62
Warrant [Member] | Expected Proceeds [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		0.25		0.25
Warrant [Member] | Expected Proceeds [Member] | Weighted Average [Member] | Measurement Input, Share Price [Member]
Investments, measurement input	[1]	0.25		0.25
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member]
Investments, fair value		$ 9,183		$ 6,430
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Measurement Input, Discount Rate [Member]
Investments, measurement input		0.25		25
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Minimum [Member] | Probability Weighting [Member]
Investments, measurement input		0.30		30
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Maximum [Member] | Probability Weighting [Member]
Investments, measurement input		1		100
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Weighted Average [Member] | Probability Weighting [Member]
Investments, measurement input	[1]	0.75		81
Other Investments [Member] | Multiple Probability Weighted Cash Flow Model [Member] | Weighted Average [Member] | Measurement Input, Discount Rate [Member]
Investments, measurement input	[1]	0.25		25
Equity Securities [Member] | Last Equity Financing [Member]
Investments, fair value		$ 6,850		$ 7,281
Equity Securities [Member] | Last Equity Financing [Member] | Minimum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		0		0.56
Equity Securities [Member] | Last Equity Financing [Member] | Maximum [Member] | Measurement Input, Share Price [Member]
Investments, measurement input		215.03		215.03
Equity Securities [Member] | Last Equity Financing [Member] | Weighted Average [Member] | Measurement Input, Share Price [Member]
Investments, measurement input	[1]	22.31		17.15
[1]Weighted average is calculated by multiplying (a) the unobservable input for each investment in the investment type by (b) (1) the fair value of the related investment in the investment type divided by (2) the total fair value of the investment type.

Note 6 - Fair Value - Reconcili

Note 6 - Fair Value - Reconciliation of Level 3 Assets Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Balance	$ 709,946	$ 713,407	$ 706,858	$ 716,319
Purchase of investments	12,065	40,545	35,384	87,553
Warrants received and classified as Level 3	1,089	604	1,217	745
Principal payments received on investments	(56,413)	(24,740)	(76,056)	(64,496)
Payment-in-kind interest on investments	355	950	1,737	2,154
Proceeds from sale of investments	(47)	(1,986)	(88)	(8,506)
Net realized gain on investments	2,660	(16,512)	2,681	(16,646)
Unrealized depreciation included in earnings	(24,165)	205	(27,068)	(5,662)
Transfer out of warrant investments	0	0	0	0
Other	742	882	1,567	1,894
Balance	646,232	713,244	646,232	713,244
Transfer out of Level 3	0	(111)	0	(111)
Debt [Member]
Balance	670,773	684,554	670,172	686,458
Purchase of investments	11,605	40,545	33,782	87,543
Warrants received and classified as Level 3	0	0	0	0
Principal payments received on investments	(56,906)	(24,740)	(75,986)	(64,496)
Payment-in-kind interest on investments	355	950	1,737	2,154
Proceeds from sale of investments	(3)	(528)	(44)	(7,036)
Net realized gain on investments	3	(17,672)	41	(17,665)
Unrealized depreciation included in earnings	(17,501)	2,118	(19,010)	(2,448)
Transfer out of warrant investments	0	(2,800)	(3,191)	(3,095)
Other	742	882	1,567	1,894
Balance	609,068	683,309	609,068	683,309
Transfer out of Level 3		0		0
Warrant [Member]
Balance	23,156	24,638	22,975	26,145
Purchase of investments	0	0	0	0
Warrants received and classified as Level 3	1,089	515	1,217	656
Principal payments received on investments	0	0	0	0
Payment-in-kind interest on investments	0	0	0	0
Proceeds from sale of investments	(4)	(1,458)	(4)	(1,470)
Net realized gain on investments	2,617	1,287	2,600	1,146
Unrealized depreciation included in earnings	(3,046)	(606)	(2,976)	(2,096)
Transfer out of warrant investments	(2,681)	0	(2,681)	(5)
Other	0	0	0	0
Balance	21,131	24,376	21,131	24,376
Transfer out of Level 3		0		0
Equity Securities [Member]
Balance	6,825	2,915	7,281	2,416
Purchase of investments	500	0	1,250	10
Warrants received and classified as Level 3	0	89	0	89
Principal payments received on investments	0	0	0	0
Payment-in-kind interest on investments	0	0	0	0
Proceeds from sale of investments	0	0	0	0
Net realized gain on investments	0	(127)	0	(127)
Unrealized depreciation included in earnings	(3,156)	(1,307)	(4,362)	(1,118)
Transfer out of warrant investments	2,681	2,800	2,681	3,100
Other	0	0	0	0
Balance	6,850	4,259	6,850	4,259
Transfer out of Level 3		(111)		(111)
Other Investments [Member]
Balance	9,192	1,300	6,430	1,300
Purchase of investments	(40)	0	352	0
Warrants received and classified as Level 3	0	0	0	0
Principal payments received on investments	493	0	(70)	0
Payment-in-kind interest on investments	0	0	0	0
Proceeds from sale of investments	(40)	0	(40)	0
Net realized gain on investments	40	0	40	0
Unrealized depreciation included in earnings	(462)	0	(720)	0
Transfer out of warrant investments	0	0	3,191	0
Other	0	0	0	0
Balance	$ 9,183	1,300	$ 9,183	1,300
Transfer out of Level 3		$ 0		$ 0

Note 7 - Borrowings (Details Te

Note 7 - Borrowings (Details Textual) - USD ($) $ / shares in Units, $ in Thousands						3 Months Ended		6 Months Ended
	Jun. 21, 2024	Jun. 20, 2024	May 06, 2024	May 24, 2023	Apr. 21, 2020	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Jun. 29, 2023	Nov. 09, 2022	Jun. 15, 2022	Mar. 30, 2021	Aug. 13, 2019
Restricted Investments						$ 3,221		$ 3,221		$ 2,642
Long-Term Debt, Gross						446,000		446,000		466,000
Debt Instrument, Face Amount						$ 715,000		$ 715,000		615,000
Key Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity, Accordian Feature											$ 150,000
Line of Credit Facility, Maximum Borrowing Capacity											$ 300,000
Line of Credit Facility, Advance Rate of Eligible Debt Investments											60%
Long-Term Debt, Weighted Average Interest Rate, over Time						8.73%	8.41%	8.74%	8.17%
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage								0.50%
Line of Credit Facility, Current Borrowing Capacity						$ 150,000		$ 150,000		80,000
Line of Credit Facility, Remaining Borrowing Capacity						14,000		14,000		25,000
Long-Term Debt, Gross						0		0		70,000
Debt Instrument, Face Amount						$ 150,000		$ 150,000		$ 150,000
Key Facility [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		0.10%
Debt Instrument, Variable Rate						8.50%		8.50%		8.50%
NYL Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity				$ 250,000	$ 100,000
Line of Credit Facility, Current Borrowing Capacity						$ 69,000		$ 69,000		$ 69,000
Line of Credit Facility, Remaining Borrowing Capacity						17,900		17,900		17,400
Line of Credit Facility, Maximum Borrowing Capacity, Accordion Feature					$ 200,000
Line of Credit Facility, Advance Rate					67%
Line of Credit Facility, Change in Maximum Borrowing Capacity				$ 50,000
Debt Instrument, Interest Rate, Stated Percentage			4.60%	4.60%
Long-Term Line of Credit						$ 181,000		$ 181,000		181,000
Line of Credit Facility, Interest Rate at Period End						6.34%	5.62%	6.34%	5.62%
Restricted Investments						$ 1,400		$ 1,400		1,400
Long-Term Debt, Gross						181,000		181,000		181,000
Debt Instrument, Face Amount						250,000		250,000		250,000
NYL Facility [Member] | Three Year I Curve [Member]
Debt Instrument, Basis Spread on Variable Rate			3.20%	3.50%
Nuveen Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity, Accordian Feature	$ 200,000
Line of Credit Facility, Maximum Borrowing Capacity	$ 100,000
Line of Credit Facility, Current Borrowing Capacity						50,000		50,000
Line of Credit Facility, Remaining Borrowing Capacity						14,100		14,100
Line of Credit Facility, Advance Rate	67.50%
Long-Term Line of Credit						$ 50,000		$ 50,000		0
Line of Credit Facility, Interest Rate at Period End						7.38%		7.38%
Restricted Investments						$ 700		$ 700
Long-Term Debt, Gross						50,000		50,000		0
Debt Instrument, Face Amount						100,000		100,000		0
Nuveen Facility [Member] | Selected Interest Rates (Daily) [Member]
Debt Instrument, Basis Spread on Variable Rate	3.15%
Asset-backed Notes 2019 [Member]
Debt Instrument, Interest Rate, Stated Percentage															4.21%
Debt Instrument, Face Amount															$ 160,000
Asset-backed Notes 2022 [Member]
Debt Instrument, Interest Rate, Stated Percentage												7.56%
Restricted Investments						1,100		1,100		1,300
Long-Term Debt, Gross						100,000		100,000		100,000
Debt Instrument, Face Amount						100,000		100,000		100,000		$ 157,800
The 2026 Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage														4.875%
Long-Term Debt, Gross						57,500		57,500		57,500
Debt Instrument, Face Amount						57,500		57,500		57,500				$ 57,500
The 2026 Notes Underwriter Option [Member]
Debt Instrument, Face Amount														$ 7,500
Debt Instrument, Convertible, Conversion Price (in dollars per share)														$ 25
The 2027 Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage													6.25%
Long-Term Debt, Gross						57,500		57,500		57,500
Debt Instrument, Face Amount						$ 57,500		$ 57,500		$ 57,500			$ 50,000
The 2027 Notes Underwriter Option [Member]
Debt Instrument, Face Amount													$ 7,500
Debt Instrument, Convertible, Conversion Price (in dollars per share)													$ 25
Minimum [Member]
Asset Coverage to Borrowings, Ratio, Percent								150%
Minimum [Member] | Key Facility [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		4.10%
Minimum [Member] | NYL Facility [Member] | USD Mid-market Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate					3.55%
Minimum [Member] | Nuveen Facility [Member]
Debt Instrument, Interest Rate, Stated Percentage	5%
Minimum [Member] | Nuveen Facility [Member] | Selected Interest Rates (Daily) [Member]
Debt Instrument, Basis Spread on Variable Rate, Treasury Yield Maturity (Year)	3 years
Maximum [Member]
Asset Coverage to Borrowings, Ratio, Percent								174%
Maximum [Member] | NYL Facility [Member] | USD Mid-market Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate					5.15%
Maximum [Member] | Nuveen Facility [Member] | Selected Interest Rates (Daily) [Member]
Debt Instrument, Basis Spread on Variable Rate, Treasury Yield Maturity (Year)	5 years
Weighted Average [Member] | Nuveen Facility [Member] | Selected Interest Rates (Daily) [Member]
Debt Instrument, Basis Spread on Variable Rate, Treasury Yield Maturity (Year)	4 years 10 months 17 days

Note 7 - Borrowings - Borrowing

Note 7 - Borrowings - Borrowings (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023	Nov. 09, 2022	Jun. 15, 2022	Mar. 30, 2021
Total commitment	$ 715,000	$ 615,000
Balance outstanding	446,000	466,000
Unused commitment	269,000	149,000
Unamortized debt issuance costs attributable to term borrowings	(3,256)	(3,765)
Total borrowings outstanding, net	442,744	462,235
Key Facility [Member]
Total commitment	150,000	150,000
Balance outstanding	0	70,000
Unused commitment	150,000	80,000
NYL Facility [Member]
Total commitment	250,000	250,000
Balance outstanding	181,000	181,000
Unused commitment	69,000	69,000
Nuveen Facility [Member]
Total commitment	100,000	0
Balance outstanding	50,000	0
Unused commitment	50,000	0
Asset-backed Notes 2022 [Member]
Total commitment	100,000	100,000	$ 157,800
Balance outstanding	100,000	100,000
Unused commitment	0	0
The 2027 Notes [Member]
Total commitment	57,500	57,500		$ 50,000
Balance outstanding	57,500	57,500
Unused commitment	0	0
The 2026 Notes [Member]
Total commitment	57,500	57,500			$ 57,500
Balance outstanding	57,500	57,500
Unused commitment	$ 0	$ 0

Note 8 - Financial Instrument_3

Note 8 - Financial Instruments With Off-balance-sheet Risk (Details Textual) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Fair Value Disclosure, off-Balance-Sheet Risks, Amount, Liability	$ 1,474	$ 2,033
Commitments to Extend Credit [Member]
Other Commitment	137,500	180,500
Unfunded Loan Commitment [Member]
Fair Value Disclosure, off-Balance-Sheet Risks, Amount, Liability	$ 1,500	$ 2,000

Note 8 - Financial Instrument_4

Note 8 - Financial Instruments With Off-balance-sheet Risk - Unfunded Commitments (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Unfunded commitments, principal balance	$ 137,500	$ 180,500
Fair value of unfunded commitment liability	1,474	2,033
Better Place Forests Co. [Member]
Unfunded commitments, principal balance	1,500	0
Fair value of unfunded commitment liability	0	0
BrightInsight, Inc. [Member]
Unfunded commitments, principal balance	10,000	15,500
Fair value of unfunded commitment liability	132	241
Britecore Holdings, Inc. [Member]
Unfunded commitments, principal balance	2,500	5,000
Fair value of unfunded commitment liability	36	72
Candesant Biomedical Corporation [Member]
Unfunded commitments, principal balance	10,000	10,000
Fair value of unfunded commitment liability	151	151
Ceribell, Inc. [Member]
Unfunded commitments, principal balance	21,000	0
Fair value of unfunded commitment liability	120	0
Divergent Technologies, Inc. [Member]
Unfunded commitments, principal balance	0	11,250
Fair value of unfunded commitment liability	0	118
Elligo Healthcare Research, Inc. [Member]
Unfunded commitments, principal balance	15,000	15,000
Fair value of unfunded commitment liability	194	194
MicroTransponder, Inc. [Member]
Unfunded commitments, principal balance	22,500	22,500
Fair value of unfunded commitment liability	0	0
Mirantis, Inc [Member]
Unfunded commitments, principal balance	15,000	15,000
Fair value of unfunded commitment liability	136	136
Optoro, Inc. [Member]
Unfunded commitments, principal balance	0	6,250
Fair value of unfunded commitment liability	0	0
Parse Biosciences, Inc. [Member]
Unfunded commitments, principal balance	15,000	15,000
Fair value of unfunded commitment liability	251	251
SafelyYou, Inc [Member]
Unfunded commitments, principal balance	10,000	20,000
Fair value of unfunded commitment liability	147	270
Sonex Health, Inc. [Member]
Unfunded commitments, principal balance	0	15,000
Fair value of unfunded commitment liability	0	176
Standvast Holdings, LLC [Member]
Unfunded commitments, principal balance	5,000
Fair value of unfunded commitment liability	175
Supply Network Visibility Holdings, LLC [Member]
Unfunded commitments, principal balance	5,000	10,000
Fair value of unfunded commitment liability	17	35
Tallac Therapeutics, Inc [Member]
Unfunded commitments, principal balance	5,000	10,000
Fair value of unfunded commitment liability	115	229
Viken Detection Corporation [Member]
Unfunded commitments, principal balance	0	10,000
Fair value of unfunded commitment liability	$ 0	$ 160

Note 9 - Concentrations of Cr_2

Note 9 - Concentrations of Credit Risk (Details Textual) - Debt Investments [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Investment Concentration Risk [Member] | Reported Value Measurement [Member]
Concentration Risk, Percentage			24%		23%
Investment Concentration Risk [Member] | Estimate of Fair Value Measurement [Member]
Concentration Risk, Percentage			24%		22%
Interest Income [Member] | Reported Value Measurement [Member]
Concentration Risk, Percentage	20%	23%	18%	23%
Interest Income [Member] | Estimate of Fair Value Measurement [Member]
Concentration Risk, Percentage	24%	23%	22%	23%

Note 10 - Distributions (Detail

Note 10 - Distributions (Details Textual) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Common Stock, Dividends, Per Share, Cash Paid (in dollars per share)	$ 0.38
Earnings Per Share, Basic (in dollars per share)	0.36	$ 0.54	$ 0.74	$ 1
Earnings Per Share, Basic, Undistributed (in dollars per share)	$ 1.28

Note 10 - Distributions - Distr

Note 10 - Distributions - Distribution Activity (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 26, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Distributions declared per share (in dollars per share)		$ 0.33	$ 0.33	$ 0.71	$ 0.66	$ 1.37
Dividends, cash				$ 16,320		$ 41,881
Dividends, shares (in shares)				73,548		145,743
Dividends, stock				$ 874		$ 1,833
O 2024 M11 Dividends [Member] | Forecast [Member]
Record date	Nov. 15, 2024
Payment date	Dec. 13, 2024
Distributions declared per share (in dollars per share)	$ 0.11
O 2024 M10 Dividends [Member] | Forecast [Member]
Record date	Oct. 17, 2024
Payment date	Nov. 14, 2024
Distributions declared per share (in dollars per share)	$ 0.11
O 2024 M4 1 Dividends [Member]
Record date				Aug. 16, 2024
Payment date				Sep. 13, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 0
Dividends, shares (in shares)				0
Dividends, stock				$ 0
O 2024 M9 Dividends [Member] | Forecast [Member]
Record date	Sep. 16, 2024
Payment date	Oct. 16, 2024
Distributions declared per share (in dollars per share)	$ 0.11
O 2024 M4 2 Dividends [Member]
Record date				Jul. 17, 2024
Payment date				Aug. 15, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 0
Dividends, shares (in shares)				0
Dividends, stock				$ 0
O 2024 M4 3 Dividends [Member]
Record date				Jun. 17, 2024
Payment date				Jul. 16, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 3,766
Dividends, shares (in shares)				15,860
Dividends, stock				$ 199
O 2024 M2 1 Dividends [Member]
Record date				May 17, 2024
Payment date				Jun. 14, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 3,701
Dividends, shares (in shares)				16,686
Dividends, stock				$ 203
O 2024 M2 2 Dividends [Member]
Record date				Apr. 18, 2024
Payment date				May 15, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 3,654
Dividends, shares (in shares)				16,687
Dividends, stock				$ 199
O 2024 M2 3 Dividends [Member]
Record date				Mar. 19, 2024
Payment date				Apr. 16, 2024
Distributions declared per share (in dollars per share)				$ 0.05
Dividends, cash				$ 1,625
Dividends, shares (in shares)				7,598
Dividends, stock				$ 85
O 2024 M2 4 Dividends [Member]
Record date				Mar. 19, 2024
Payment date				Apr. 16, 2024
Distributions declared per share (in dollars per share)				$ 0.11
Dividends, cash				$ 3,574
Dividends, shares (in shares)				16,717
Dividends, stock				$ 188
O 2023 M10 1 Dividends [Member]
Record date						Feb. 16, 2024
Payment date						Mar. 15, 2024
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,463
Dividends, shares (in shares)						18,257
Dividends, stock						$ 210
O 2023 M10 2 Dividends [Member]
Record date						Jan. 18, 2024
Payment date						Feb. 14, 2024
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,462
Dividends, shares (in shares)						15,873
Dividends, stock						$ 210
O 2023 M10 3 Dividends [Member]
Record date						Dec. 19, 2023
Payment date						Jan. 16, 2024
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,472
Dividends, shares (in shares)						14,563
Dividends, stock						$ 199
O 2023 M10 4 Dividends [Member]
Record date						Nov. 17, 2023
Payment date						Dec. 15, 2023
Distributions declared per share (in dollars per share)						$ 0.05
Dividends, cash						$ 1,574
Dividends, shares (in shares)						7,137
Dividends, stock						$ 93
O 2023 M7 1 Dividends [Member]
Record date						Nov. 17, 2023
Payment date						Dec. 15, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,463
Dividends, shares (in shares)						15,701
Dividends, stock						$ 206
O 2023 M7 2 Dividends [Member]
Record date						Oct. 18, 2023
Payment date						Nov. 15, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,493
Dividends, shares (in shares)						14,022
Dividends, stock						$ 173
O 2023 M7 3 Dividends [Member]
Record date						Sep. 19, 2023
Payment date						Oct. 16, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,445
Dividends, shares (in shares)						15,067
Dividends, stock						$ 184
O 2023 M4 1 Dividends [Member]
Record date						Aug. 17, 2023
Payment date						Sep. 15, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,458
Dividends, shares (in shares)						8,665
Dividends, stock						$ 106
O 2023 M4 2 Dividends [Member]
Record date						Jul. 18, 2023
Payment date						Aug. 15, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,427
Dividends, shares (in shares)						8,307
Dividends, stock						$ 105
O 2023 M4 3 Dividends [Member]
Record date						Jun. 16, 2023
Payment date						Jul. 14, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,434
Dividends, shares (in shares)						7,424
Dividends, stock						$ 96
O 2023 M2 1 Dividends [Member]
Record date						May 18, 2023
Payment date						Jun. 14, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,087
Dividends, shares (in shares)						7,128
Dividends, stock						$ 86
O 2023 M2 2 Dividends [Member]
Record date						Apr. 18, 2023
Payment date						May 16, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,068
Dividends, shares (in shares)						6,705
Dividends, stock						$ 84
O 2023 M2 3 Dividends [Member]
Record date						Mar. 17, 2023
Payment date						Apr. 14, 2023
Distributions declared per share (in dollars per share)						$ 0.11
Dividends, cash						$ 3,035
Dividends, shares (in shares)						6,894
Dividends, stock						$ 81

Note 11 - Financial Highlight_2

Note 11 - Financial Highlights - Financial Highlights (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Net asset value at beginning of period (in dollars per share)				$ 9.71	$ 11.47
Net investment income (in dollars per share)				0.74	1
Realized gain (loss) (in dollars per share)				0.07	(0.58)
Unrealized (depreciation) appreciation on investments (in dollars per share)				(0.82)	(0.23)
Net increase in net assets resulting from operations (in dollars per share)		$ (0.26)	$ 0.01	(0.01)	0.19
Distributions declared (in dollars per share)	[1]			(0.71)	(0.66)
From net investment income (in dollars per share)				(0.71)	(0.66)
From net realized gain on investments (in dollars per share)		0	0	0	0
Return of capital (in dollars per share)				0	0
Other (in dollars per share)	[2]			0.13	0.07
Net asset value at end of period (in dollars per share)		9.12	11.07	9.12	11.07
Per share market value, beginning of period (in dollars per share)				13.17	11.6
Per share market value, end of period (in dollars per share)		$ 12.04	$ 12.08	$ 12.04	$ 12.08
Total return based on a market value	[3]			(3.20%)	9.80%
Shares outstanding at end of period (in shares)		36,043,815	32,096,259	36,043,815	32,096,259	33,367,389
Expenses without incentive fee (4)	[4]			15.60%	14.20%
Incentive fees	[4]			0%	1.90%
Net expenses	[4]			15.60%	16.10%
Net investment income with incentive fee (4)	[4]			15.50%	17.50%
Net assets at the end of the period		$ 328,778	$ 355,419	$ 328,778	$ 355,419	$ 323,981
Average net asset value		$ 328,293	$ 331,850	$ 328,293	$ 331,850
Average debt per share (in dollars per share)				$ 13.03	$ 15.11
Portfolio turnover ratio	[5]			5.40%	7.60%
[1]Distributions are determined based on taxable income calculated in accordance with income tax regulations, which may differ from amounts determined under GAAP due to (i) changes in unrealized appreciation and depreciation, (ii) temporary and permanent differences in income and expense recognition, and (iii) the amount of spillover income carried over from a given tax year for distribution in the following tax year. The final determination of taxable income for each tax year, as well as the tax attributes for distributions in such tax year, will be made after the close of the tax year.[2]Includes the impact of the different share amounts as a result of calculating per share data based on the weighted average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date. The issuance of common stock on a per share basis reflects the incremental net asset value changes as a result of the issuance of common stock in the Company’s continuous public offering and pursuant to the Company’s distribution reinvestment plan. The issuance of common stock at an offering price, net of sales commissions and dealer manager fees, that is greater than the net asset value per share results in an increase in net asset value per share.[3]The total return equals the change in the ending market value over the beginning of period price per share plus distributions paid per share during the period, divided by the beginning price.[4]Annualized.[5]Calculated by dividing (A) the lesser of purchases or sales of portfolio securities for the fiscal year by (B) the monthly average of the value of portfolio securities owned by the Company during the fiscal year, with certain securities excluded from the numerator and denominator pursuant to applicable federal securities laws.

Note 12 - Subsequent Events (De

Note 12 - Subsequent Events (Details Textual) - USD ($) $ in Thousands	Jul. 30, 2024	Jul. 12, 2024	Jul. 11, 2024	Jul. 10, 2024	Jun. 30, 2024	Dec. 31, 2023
Investment Owned, Fair Value					$ 646,862	$ 709,085
MyForest Foods Co [Member] | Debt Securities [Member] | Subsequent Event [Member]
Proceeds from Sale, Maturity and Collection of Investments				$ 3,800
Lemongrass Holdings, Inc [Member] | Debt Securities [Member] | Subsequent Event [Member]
Proceeds from Sale, Maturity and Collection of Investments			$ 6,300
Slingshot Aerospace, Inc. [Member] | Debt Securities [Member] | Subsequent Event [Member]
Proceeds from Sale, Maturity and Collection of Investments		$ 20,000
Nexii Building Solutions, Inc [Member] | Debt Securities [Member]
Investment Owned, Fair Value					$ 10,900
Hometeam Technologies, Inc [Member] | Debt Securities [Member] | Subsequent Event [Member]
Payments to Acquire Investments	$ 25,000